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ABSTRACT 
Our knowledge of the released human ovulatory components, the cumulus-oocyte complex 
(COC) and follicular fluid, and their physiological effects on spermatozoa and roles in 
fertilisation remain poorly characterised. The aim of this study was to use a multi-pronged 
approach to begin to unravel these interactions and their relation to fertilisation success.  
Experiments designed to better replicate the physiological environment of the female tract 
showed environmental modulation of sperm motility. Mean sperm velocity values VSL, VAP 
and VCL increased by 12.4%, 15%, 16.5% respectively, when exposed to cumulus cells from 
pregnancy-positive donors, compared to pregnancy-negative donors. 
Follicular fluid elicited a [Ca2+]i response in spermatozoa that was independent of treatment 
outcome. The response of spermatozoa exposed to follicular fluid at a 50% (v/v) dilution was 
a large spike on the front of the ‘classical’ progesterone transient response, which has not 
been previously reported. 
Human sperm-zona binding (SZB) studies are hampered by the shortage of oocytes, and thus 
zona pellucida (ZP) available for research. As a possible source of ZP this study investigates 
the development of an in vitro model for oogenesis, utilising follicular fluid and cumulus cell 
co-culture with human embryonic stem cells. The feasibility of SPR technology, using both 
native and recombinant sources of ZP, to measure SZB and identify possible binding 
candidates is also assessed.  
The data in this study addresses just some of the potential effects of the COC and follicular 
fluid on spermatozoa. Further developments within this area may lead to better diagnostics 
and treatments for patients undergoing ART, in addition to providing targets for novel 
contraceptives.  
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Introduction  
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1.1 Foreword to Chapter One 
The interplay between human gametes and their environment is now recognised as being 
important in order to deliver a successful fertilisation outcome. This chapter gives a broad 
overview of key events in the development, transport and environmental interactions of 
both male and female human gametes.  
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1.2 Early gametogenesis  
The formation and development of both male and female mature gametes capable of 
undergoing fertilisation is a long process which starts in the early embryo and continues 
throughout adulthood. Much of our understanding of the mechanisms of early human germ 
cell development is based on mouse models due to the inaccessibility of human germ cells 
during fetal development. 
1.2.1 Mammalian primordial germ cell (PGC) specification 
The specification of the early gamete precursors, known as primordial germ cells (PGCs) is a 
significant event marking the definitive separation of somatic and germ cell lineages. PGCs 
are first identifiable during early embryonic development where they arise independently 
from the primitive gonads in the wall of the yolk sac, near the developing allantois (Ginsburg 
et al. 1990). Although there is limited information regarding the specification of PCGs in 
human embryos, a PGC population of approximately 50-90 cells can be observed at 
approximately 21-22 days gestation (Falin. 1969). 
Unlike non-mammalian species which rely on the asymmetric localisation of germplasm to 
induce PGC specification (Ikenishi. 1998), mammals rely on a series of induction signals 
released by the extraembryonic ectoderm and the visceral endoderm, promoting PGC 
differentiation in cells within the epiblast (Chuva de Sousa Lopes et al. 2008). Although these 
signals have not been fully characterised it is known that members of the bone 
morphogenetic protein (BMP) family are major extrinsic factors in the specification of PGC 
(de Sousa Lopes et al. 2007). Secretions of BMP4 and BMP8b from extraembryonic ectoderm 
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(Lawson et al. 1999;Ying et al. 2000) and BMP2 from visceral endoderm (Ying and Zhao. 
2001) initiate a receptor cascade of SMAD phosphorylation; both SMAD1 and SMAD5 in 
conjunction with SMAD4 (Chang and Matzuk. 2001;Tremblay et al. 2001;Hayashi et al. 
2002;Chu et al. 2004). 
This complex cascade of signals regulates many important genes in PGCs such as the up-
regulation of the transcriptional regulator Blimp1, which itself both down-regulates somatic 
genes such as particular members of the Hox gene family and up-regulates pluripotent genes 
Nanog, Stella and Nanos3 (Saitou et al. 2002;Ohinata et al. 2005;Vincent et al. 2005). An 
early gene expressed in PGCs is Fragilis, and although identified as an early marker of PGC 
specification, is not thought to be functionally important. Similarly, PCGs express 
characteristic alkaline phosphatase activity, stained as small spots within the cytoplasm. 
(Ginsburg, Snow and McLaren. 1990) and although this is characteristic of PCGs, experiments 
mutating alkaline phosphatase liver/bone/kidney (ALPL) have indicated that ALPL is only a 
marker and is not essential for PGC specification or proliferation (MacGregor et al. 1995). 
1.2.2 Mammalian primordial germ cell migration 
After specification PGC cells must migrate from the base of the yolk sac along the hindgut to 
the genital ridges where the somatic gonad precursors reside (Seki et al. 2007). Migrating 
cells exhibit a directional polarity, with a front leading edge that promotes movement 
through protrusion and adhesion, and a back lagging edge that retracts. The process is 
regulated by transmembrane receptors that are sensitive to external chemoattractant 
signals that induce phospholipids and small GTPases to create cytoskeletal changes. Very 
little is known about human PGC migration; much of what is understood is based on 
5 
 
research on the model organisms Drosophila melanogaster, zebrafish and mice which is 
reviewed in Richardson and Lehmann. 2010.  
1.3 The spermatozoon  
1.3.1 Spermatogenesis  
Spermatogenesis is a key and complex biological process, leading to the formation of the 
mature male gamete, a spermatozoon, a motile, haploid cell that is capable of fertilising the 
female oocyte. After decades of investigation, there is too much information to be discussed 
within this chapter, however for an extensive review see Hermo et al. 2010a;Hermo et al. 
2010b;Hermo et al. 2010c;Hermo et al. 2010d;Hermo et al. 2010e. 
The site of spermatogenesis, the adult testis, has two major functions; the production of 
spermatozoa and the synthesis of important steroids. These two functions are completed in 
distinct and physically separate areas of the testes. Spermatozoa develop within the 
seminiferous tubules, numerous coiled hairpin-like structures (Huckins and Clermont. 1968). 
The epithelium lining of these tubules composing of germ cells and a corresponding Sertoli 
cell, which supports the development of the spermatozoa (Fawcett. 1975a). Interstitial 
spaces between seminiferous tubules harbour androgen-producing Leydig cells in addition 
to macrophages, blood, lymphatic channels and nerves (Hermo et al. 2010a). The Leydig and 
Sertoli cells work together to regulate spermatogenesis (Cheng and Mruk. 2002;Mruk and 
Cheng. 2004).  
During spermatogenesis the more developed germ cells occupy successive layers in the 
seminiferous tubules. The first phase involves the continuous mitotic proliferation of diploid 
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(2n) spermatogonia at the basal compartment of the seminiferous tubule. The second phase, 
the initiation of meiotic division, forms haploid (n) spermatids. Finally the cytodifferentiation 
phase focuses on the elongation and development of the spermatids forming spermatozoa 
that have an acrosome, condensed hetrochromatin, mitochondria-containing midpiece, and 
a flagellum (Johnson. 2007b). 
Throughout spermatogenesis, the developing germ cells are dependent on interactions with 
the Sertoli cells via cell-cell junctions and with other developing germ cells via cytoplasmic 
bridges. Once spermatogenesis is completed these attachments are terminated and 
immature spermatozoa are released into the lumen of the seminiferous tubule (Guraya. 
1995) (figure 1.1). 
 
Figure 1.1: Spermatogenesis.  
Image modified from (Hammack's universe of ideas. 2011). 
 
1.3.2 The structure of mature spermatozoa 
The primary function of spermatozoa is to deliver a haploid set of chromosomes to the 
female gamete, the oocyte. All mammalian spermatozoa share the fundamental basic sperm 
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structure composing of a head and tail (flagellum) (figure 1.2) whose structural features 
reflect their functional roles.  
The majority of mammalian spermatozoa, including human have spatulate-shaped heads, 
with the exception of rodents which have heads that resemble a sickle shape (Yanagimachi. 
1981). Each spermatozoa head contains an individual membrane-enclosed nucleus and 
acrosome (Mortimer. 1997).  
The nucleus, as a result of the complete reorganisation mid-spermiogenesis has highly 
condensed chromatin (extensively reviewed in Dadoune. 2003). This is due to the 
nucleosomal histones of the meiotic germ cells being replaced with intermediate proteins 
and protamines, which are low molecular weight highly basic proteins that associate with 
DNA (Wouters-Tyrou et al. 1998). This nuclear hypercondensation gives spermatozoa the 
hydrodynamic shape to permit sperm motility and penetration through the oocyte 
vestments (Brewer et al. 2002). The nuclear envelope is protected by the perinuclear theca, 
which is stabilised by disulfide bonds (Oko and Maravei. 1995). 
Located in the sperm head there is also the acrosome, a highly specialised Golgi-derived 
membrane-bound vesicle, which overlays the anterior of the spermatozoa nucleus and 
believed to have an important role in spermatozoa-zona binding (SZB) during fertilisation. 
The formation of the acrosome happens during early spermiogenesis (for further 
information see Yoshinaga and Toshimori. 2003). The acrosomal contents include a variety 
of hydrolytic enzymes, acid glycohydrolases, proteinases, phosphatases, esterases and aryl 
sulfatases (Yanagimachi. 1994;Tulsiani et al. 1998). 
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The spermatozoon flagellum is composed of four regions, the connecting piece, the 
midpiece, the principal piece and the end piece (Fawcett. 1965). The ultra-structure of the 
flagellum is critical for its function, to provide propulsion to the cell. The connecting piece 
joins the sperm head to the rest of the flagellum from which the axoneme extends along the 
length of the flagellum. The axoneme is a ring of nine microtubule doublets that surround a 
central doublet pair. Dynein arms project and link the microtubule doublets and are 
responsible for the motive propulsions generated by the flagellum (Fawcett. 1975b;Clermont 
et al. 1990). In the midpiece region, the axoneme is surrounded by a ring of nine outer dense 
fibres. Both structures are then enclosed in a mitochondrial sheath which is exclusive to the 
midpiece region. The annulus signals the termination of the midpiece and the start of the 
principle piece of the flagellum. From this point, two outer dense fibres are replaced with 
two longitudinal columns of fibrous sheath. Towards the end of the principle piece the 
fibrous sheath and longitudinal columns terminate leaving only the axoneme surrounded by 
plasma membrane to form the end piece region of the flagellum (Turner. 2006) (figure 1.2). 
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Figure 1.2: The mature human spermatozoa. 
Schematic representation of mature human spermatozoa and ultrastructure of the flagellum. OMDA: 
Outer microtubule doublets of the axoneme, PM: Plasma membrane, MS: Mitochondrial sheath, 
ODF: Outer dense fibres, RS: Radial spokes, DA: Dynein arms, CP: Central pair of microtubule 
doublets, TR: Transverse ribs, LC: Longitudinal columns. Figure adapted from (Turner. 2006). 
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1.3.3 Epididymal storage and transport 
Once spermatozoa are released into the lumen of seminiferous tubules the morphologically 
mature but functionally incompetent spermatozoa leave the testes and are transported into 
the epididymis (Cornwall. 2009). The epididymis which transports spermatozoa from the 
testes to the vas deferens is a single duct, composed of three anatomical regions: the caput, 
the corpus and the cauda. The movement of spermatozoa through the caput to cauda relies 
on smooth muscle contractions by the epididymal wall (Reid et al. 2011). Exposure to the 
complex environmental milieu initiates a rapid process of membrane remodelling and 
protein acquisition (Nikolopoulou et al. 1985;Haidl and Opper. 1997;Aitken et al. 2007;Jones 
et al. 2007;Cornwall. 2009). This produces progressively motile spermatozoa which have 
further gained the capacity for fertilisation (Bedford. 1963;Bedford. 1965;Horan and 
Bedford. 1972;Saling. 1982). 
1.3.4 Seminal components and ejaculation  
Spermatozoa are expelled from the male via the urethra in a process termed ejaculation. A 
minimal value from a typical fertile human male ejaculate is 1.5 ml in volume, containing 39 
million spermatozoa (Cooper et al. 2010). Spermatozoa are not the only component of the 
ejaculate, with estimates of spermatozoa only forming 1-5% of the total ejaculate volume 
(Mortimer. 1994). During ejaculation spermatozoa are mixed with seminal plasma secreted 
by the accessory sex glands which, together with spermatozoa forms a substance termed 
semen.  
There is incomplete mixing of these secretions leading to semen being a non-homogenous 
mixture. The initial 5% of semen volume is secretions from both the Cowper and Littre 
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glands. A further 15-30% of semen volume is derived from prostate secretions composing of 
acid phosphatase, citric acid, inositol, calcium, zinc and magnesium. Fructose is found in a 
small volume of secretion from the epididymis. The largest volume is secreted by the 
seminal vesicles, which secrete large amounts of fructose, ascorbic acid and prostaglandins 
(Owen and Katz. 2005).  
A full comprehensive review of seminal components has been undertaken by Owen & Katz. 
2005.  
1.4 The oocyte 
1.4.1 Oogenesis 
Like the production of the male gamete, female gametes must undergo stages of mitotic 
proliferation and meiotic division to create a haploid oocyte (figure 1.3). In comparison to 
spermatogenesis which occurs in continual cycles throughout adulthood, oogenesis is an 
episodic process, with stages of divisional arrest which can last for long periods of time. The 
stages of oogenesis are closely linked with development of the follicle, which will be 
discussed in section 1.4.2. 
In the embryonic gonads PCGs mitotically proliferate into oogonia, forming a synctium, a 
cluster of oogonium attached by their cell membranes. The cytoplasmic bridges are as a 
result of incomplete cytokinesis during cell division. It is believed that the formation of the 
synctium helps synchronise molecular signals initiating meiosis (Baltus et al. 2006). With the 
rapid rate of mitosis the number of oogonia peaks at week 20 of gestation, at approximately 
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6 million, however this then follows a period of oogonial atresia which continues throughout 
the female’s lifetime (Oktem and Oktay. 2008). 
As oogonia enter the first stages of meiosis I, they soon arrest at the prophase I stage 
(Miyazaki. 1995;Hassold and Hunt. 2001;Conti et al. 2002), which is fairly stable allowing for 
long periods of storage and development of the oocyte (Smith. 1989;Conti et al. 
2002;Voronina and Wessel. 2003). The regulation and maintenance of this meiotic arrest 
seems dependent on a mixture of phosphorylation of cyclin-dependant kinase I and 
anaphase-promoting complex mediation of cyclin B levels (Solc et al. 2010;Tripathi et al. 
2010). The immature female gametes are now termed primary oocytes and by birth only 1 
million remain (Oktem & Oktay. 2008). 
By the onset of puberty only 3000-4000 primary oocytes remain and resumption of oocyte 
meiosis occurs (Oktem and Oktay. 2008). Prior to ovulation as a result of the Luteinising 
hormone (LH) surge, the nuclear membrane surrounding the chromosomes breaks down 
and the oocyte resumes meiotic division (Neal and Baker. 1975;Lei et al. 2001) and 
completes meiosis I. The primary oocyte undergoes an asymmetric division, resulting in two 
structures, the secondary oocyte and first polar body, which although both haploid, are 
unequal in cytoplasmic content. The secondary oocyte progresses to metaphase II, where it 
arrests for a second time. The meiotic mechanisms have been recently reviewed (Brunet and 
Verlhac. 2011;Fabritius et al. 2011).  
The second arrest is maintained by inhibition of an anaphase promoting complex (APC), 
which in turn promotes the degradation of maturation promoting factors (MPC) (Tunquist 
and Maller. 2003). Upon fertilisation by a spermatozoon the oocyte is subjected to an influx 
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of Ca2+, this promotes the completion of meiosis before pronuclear formation (Machaca. 
2010). 
 
Figure 1.3: Oogenesis. 
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1.4.2 Folliculogenesis 
The immature oocyte is surrounded by specialised somatic cells within the female ovary in 
structures known as follicles. The follicles that are formed around the immature oocyte 
create an essential microenvironment critical to the growth and development of the oocyte. 
Primordial follicle  
The first follicles (the primordial follicles) can be identified at 15 weeks gestation and their 
formation is completed by 6 months (Baker. 1963;McGee and Hsueh. 2000;Maheshwari and 
Fowler. 2008). The primordial follicle contains a primary oocyte which is surrounded by 
squamous pre-granulosa cells, encapsulated by a basal membrane and surrounding stromal 
cells (figure 1.4).  
                                         
Figure 1.4: Primordial follicle. 
Image from (Johnson. 2007a). 
 
Primary oocytes can reside in primordial follicles for decades and a complex set of inhibitory 
signals maintain their dormant state. Studies in mice have shown that the loss of certain 
factors such as tumour suppressor tuberous sclerosis complex 1 (Tsc-1), phosphatase and 
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tensin homolog deleted on chromosome 10 (PTEN), Foxo3a, p27kip1 and Foxl2 leads to the 
resumption of follicle development (Castrillon et al. 2003;Rajareddy et al. 2007;Reddy et al. 
2008;Adhikari et al. 2010). Anti-Mullerian hormone (AMH), which is expressed from 
granulosa cells in growing follicles, also plays a role in suppressing follicle transition, once 
recruitment has been initiated, creating a steady continuous stream of follicle recruitment 
and development (Durlinger et al. 1999;Durlinger et al. 2002). 
Primary follicle  
The transition between primordial follicles and primary follicles appears reliant on a myriad 
of environmental factors secreted by the surrounding somatic cells (O'Brien et al. 2003). 
Recruitment seems independent from the gonadotropin, follicle stimulating hormone (FSH), 
as no FSH receptors have been found in primordial follicles (Oktay et al. 1997). Members of 
the TGF-β family, BMP4 and BMP7 expressed by the stromal and theca cells (Nilsson and 
Skinner. 2003;Lee et al. 2004), GDF9 (Dong et al. 1996;Carabatsos et al. 1998; Vitt et al. 
2000) and Figla (Soyal et al. 2000) expressed by the oocyte itself have been shown to be 
among the factors that play a critical role in primary follicle formation. Figla is also the 
transcription factor controlling zona pellucida protein expression and along with ZP3 has 
been shown to be expressed prior to follicle formation (Soyal et al. 2000;Tormala et al. 
2008). Other factors that promote follicle transition are further reviewed in (Oktem and 
Urman. 2010).  
As a result of exposure to these factors morphological changes occur within the primary 
follicle and the stroma cells begin to condense near the basal membrane to form a theca cell 
16 
 
layer. The granulosa cells begin proliferate and become cuboidal (Johnson. 2007a) (figure 
1.5).  
                             
Figure 1.5: Primary follicle. 
Image from (Johnson. 2007a). 
 
Secondary follicle 
As the surrounding granulosa cells proliferate, they create ever increasing layers around the 
oocyte. This signals the long progression of the follicle to the secondary follicle stage (figure 
1.6), which develops over a period of several months. The follicle and oocyte increase in size 
and there is increasing vascularisation, which results in the formation of follicular fluid 
(section 1.4.3). Like the primary follicle stage, development of the secondary follicle is reliant 
on factors such as members of the TGF-β family (BMP4, BMP7 and BMP17), GDF9 and 
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activins produced by the surrounding granulosa, theca and the oocyte itself (Oktem and 
Urman. 2010). Although secondary follicles express FSH receptors the role of FSH in follicle 
maturation is debated (Goldenberg et al. 1976;McGee et al. 1997;Oktay et al. 1998). 
Intimate connections form between the oocyte and the surrounding granulosa cells. The 
granulosa cells form a network of gap junctions. The junctions are composed of connexin 
proteins arranged in a hexameric configuration, providing not only an ability to 
communicate with the neighbouring cell but also an ability to exchange metabolites with 
each other. The gap junctions also extent through the zona pellucida and connects the 
granulosa cells with the oocyte (Oktem and Urman. 2010). A bi-directional communication 
appears to develop with an exchange of small ions, amino acids, metabolites and regulating 
factors, this is further reviewed in Gilchrist et al. 2004. 
 
 
Figure 1.6: Secondary follicle. 
Image from (Johnson. 2007a). 
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Tertiary follicle and Ovulation 
In order for follicles to progress and release their oocyte, a combination of signals selects for 
a dominant follicle. Only a follicle with the correct expression of FSH and LH receptors and 
FSH aromatase activity will result in follicle dominance and avoid follicle atresia. The factors 
involved in the selection of dominant follicles were reviewed by Oktem and Urman. 2010. 
The oocyte is released at the end of the follicular phase of the female menstrual cycle 
(approximately day 14). Prior to ovulation a surge of the gonadotropin, LH, results in 
increased oestrogen expression from the tertiary follicle via a positive feedback loop. LH 
activates a number of signalling cascades such as PKA, PI3K/AKT and RAS, which initiates the 
process of ovulation. In the final stages, oocyte meiosis resumes and cumulus expansion 
occurs (section 1.4.1). The follicle becomes increasingly vascularised, increasing the volume 
of follicular fluid accumulating within the follicle (figure 1.7).  
 
                            
Figure 1.7: Tertiary follicle. 
Image from (Johnson. 2007a). 
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The rapid follicle expansion results in the thinning of the peripheral rim of mural granulosa 
cells, membrane and theca cells and the remaining connective tissue is broken down by a 
number of proteases such as matrix metalloproteinases. This process forces the follicle to 
rupture (Johnson. 2007a;Richards and Pangas. 2010).  
1.4.3 Follicular fluid 
Follicular fluid forms a supportive microenvironment for oocytes during maturation; it 
reflects not only the secretory activities of the surrounding granulosa and cumulus cells 
(Nayudu et al. 1989;Fortune. 1994), but also oocyte quality (Andersen. 1993;Mendoza et al. 
1999;Lamb et al. 2010). 
The proportion of the follicle filled with follicular fluid appears to be species related, with 
larger animals such as human, bovine and porcine having larger accumulation. For instance 
in bovine, >95% of follicular volume is reportedly comprised of follicular fluid (Rodgers et al. 
2001). The mechanisms behind follicular fluid accumulation as of yet have not been fully 
elucidated, however it is hypothesised that follicular fluid is derived from the blood (van 
Wezel and Rodgers. 1996;Herrmann and Spanel-Borowski. 1998) and involves an osmotic 
gradient during early stages of folliculogenesis (Jiang et al. 2002;Clarke et al. 2006). In larger 
species theca capillaries form multilayers around follicles to increase the vascularisation and 
blood flow (Yamada et al. 1995). Differences in the vascularisation of the follicle have been 
associated with the dominance or subordinance of the follicle and oocyte quality (Huey et al. 
1999;Berisha and Schams. 2005;Acosta. 2007;Rodgers and Irving-Rodgers. 2010a). 
Researchers using transgenic mice have identified genes that exhibit abnormal follicular fluid 
accumulation. Mice null for Gdf9 (Dong et al. 1996), Fshb (Kumar et al. 1997), Fshr (Abel et 
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al. 2000) and Igf1 (Zhou et al. 1997) exhibit small defective follicles whereas αEsrl (Lubahn et 
al. 1993) and Cyp19A1 (Britt et al. 2000) null mice exhibit large cystic follicles. Further 
investigation is needed to establish whether these genes are important for overall follicle 
development or they are directly involved in the regulation of follicular fluid accumulation.  
There appears to be close relationship between follicular fluid formation and the granulosa 
cells. Abnormal basal granulosa cells and follicular basal lamina in bovine follicles exhibit 
different rates of antrum expansion (Rodgers and Irving-Rodgers. 2010b). It has been 
hypothesised that as a result of certain factors, granulosa and cumulus cell types within the 
follicle secrete osmotically active molecules or factors that facilitate fluid movement, 
resulting in the accumulation of follicular fluid (Rodgers and Irving-Rodgers. 2010a). 
Due to the complexity of follicular fluid, the complete composition profile has yet to be 
completed. One study however identified 69 proteins in human follicular fluid, the majority 
of which were blood plasma proteins. Follicular fluid also contains an array of steroids 
including progesterone, oestradiol and testosterone (Hanrieder et al. 2008). 
1.4.4 The cumulus oocyte complex (COC) 
At ovulation the secondary oocyte, which is arrested in metaphase of meiosis II, is released 
from the ovarian follicle into the peritoneal or bursal cavity surrounded by an elaborate 
structure consisting of the zona pellucida (ZP) and cumulus cells embedded in a viscous 
matrix, together they are termed the cumulus oocyte complex (COC) (figure 1.8). The COC is 
transferred into the ampullar region of the female reproductive tract via the infundibulum 
where it awaits possible fertilisation. 
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Figure 1.8: The cumulus oocyte complex (COC). 
 
1.4.5 The cumulus matrix  
Following the LH surge the cumulus cells surrounding the oocyte expand, and the 
components of the follicular fluid are incorporated into the COC matrix. Although not fully 
characterised, the viscous extracellular matrix appears to be mainly composed of hyaluronic 
acid, a polymer of repeating disaccharide units of N-acetyl-D-glucosamine and D-glucuronic 
acid (Laurent and Fraser. 1992;Harper. 1994) along with versican (Russell et al. 2003), 
dermatin sulphate proteoglycan (Camaioni et al. 1996) and inter-α-trypsin inhibitor (Chen et 
al. 1996;Nagyova et al. 2004). The gel viscosity is created as a result of the multimeric 
interactions between hyaluronic acid and complexes of pentraxin 3 and TNFAIP6 (Salustri et 
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al. 2004). After the COC is ovulated the links created between the oocyte and the 
surrounding cumulus cells, through the ZP matrix, during folliculogenesis are thought to be 
lost or at least greatly reduced (Gregory et al. 1994;Motta et al. 1994;Motta et al. 1995).  
1.4.6 The zona pellucida  
The zona pellucida (ZP) is an extracellular matrix that surrounds all vertebrate oocytes and 
remains around the early embryo. The ZP matrix in humans is composed of four individual 
glycoproteins (hZP1,hZP2, hZP3 and hZP4) (Lefievre et al. 2004) and they are involved in 
several important roles within fertilisation process. The ZP is thought to mediate 
spermatozoa binding in a species-specific manner, induce spermatozoa to undergo the 
acrosome reaction, be involved in the prevention of polyspermy and protect the zygote until 
implantation (Conner et al. 2005). 
1.4.7 Secondary structure of the zona pellucida proteins 
Although all four human zona glycoproteins have their own distinct structure, they share 
certain functional motifs which are conserved not only between themselves but also with 
their mammalian homologues (Rankin and Dean. 2000) (figure 1.9). 
ZP domain  
All ZP proteins share a conserved structural element, the ZP domain, which was first 
identified in mice by Bork and Sander (Bork and Sander. 1992). Since then the ZP domain has 
been found in hundreds of different eukaryotic proteins that have a wide range of structural 
architecture and function (Jovine et al. 2005). The ZP domain resides close the C-terminal 
end of the protein and consist of approximately 260 amino acids with 8 conserved cysteine 
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(Cys) residues (Wassarman et al. 2001). It is a bipartite structure consisting of two sub-
domains, ZP-N and ZP-C consisting of approximately 120-130 amino acids respectively with 
each sub-domain containing 4 conserved cysteine (Cys) residues (figure 1.10 a). The two sub-
domains are separated by a protease-sensitive linker (Jovine et al. 2004). The ZP-N motif has 
been implicated as the basic building block of the ZP filaments, whereas ZP-C has been 
suggested as the mediator between the protein interactions (Sasanami et al. 2006;Kanai et 
al. 2008). 
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Figure 1.9: Schematic representation of key structural motifs in human zona pellucida proteins. 
All zona proteins have an N-terminal signal peptide (SP), a C-terminal transmembrane domain (TM) which is preceded by a conserved furin cleavage 
site (FC) and a ZP domain (ZP). Human ZP1 and ZP4 also share an additional structural motif, a conserved trefoil domain (T). All protein sizes are given 
in the number of amino acid residues (aa) (Callabaut et al. 2007). Adapted from (Conner et al. 2005).  
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The conserved Cys residues form disulfide bonds within the ZP domain itself. The 
connectivity of the Cys residues within the ZP-N motif is identical (1-4, 2-3) in all ZP proteins, 
however differences exist in the connectivity of the Cys residues in ZP-C motif, taking either 
a type I or type II form. A type I ZP-C motif is found in ZP1, ZP2 and ZP4 proteins which have 
Cys-Cys connectivity of 5-6, 7-8, whereas a type II motif is found in ZP3 with bond between 
Cys 5-7 and 6-8. These disulfide bonds are thought to be crucial for the three dimensional 
folding of the proteins (Jovine et al. 2005) (figure 1.10 b, c).  
ZP-N repeats  
With the exception of hZP3, the other hZP proteins have N-terminal extensions formed of 
divergent copies of ZP-N domain, with hZP1 and hZP4 having one copy and hZP2 having 3. 
This has raised the debate whether the ZP proteins evolved around the common ZP-N motif 
(Callebaut et al. 2007).  
Transmembrane domain and furin cleavage site  
In addition, each ZP protein has an N-terminal signal peptide and a C-terminal 
transmembrane (TM) domain preceded by a conserved furin cleavage (FC) recognition 
sequence (RXK/RR) (Rankin and Dean. 2000). While it is generally accepted that the ZP 
proteins are cleaved at the FC site during proteolytic processing, some studies in mice have 
suggested that the FC site might not be essential for intracellular trafficking, post-
translational processing or secretion of the ZP proteins (Zhao et al. 2002).  
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Figure 1.10: The subunits and cysteine residues of the ZP domain. 
The ZP domain is bipartite structure composed of two motifs ZP-N and ZP-C. It also contains: an internal hydrophobic patch (IHP); an external 
hydrophobic patch (EHP) and a furin cleavage site (FC) (a). The formation of type I (ZP3 like) cysteine disulfide bonds (b). The formation of type II (ZP1, 
ZP2 and ZP4 like) cysteine disulfide bonds (c). Figure adapted from (Jovine et al. 2005).  
26
 
27 
 
Internal and external hydrophobic patches  
Two short hydrophobic motifs are also conserved, an internal hydrophobic patch (IHP) 
resides after the 4 conserved cysteines within the ZP-N region of the ZP domain and an 
external hydrophobic patch (EHP) which is located between the FC site and the TM domain. 
The EHP is conserved in all ZP domain-containing proteins (Jovine et al. 2004). Both the IHP 
and EHP are thought to be important in the proteolytic processing of ZP proteins (Jovine et 
al. 2003). 
Trefoil domain 
ZP1 and ZP4 contain an additional structural motif, a trefoil domain, which forms a three 
loop structure of approximately 40 residues and like the ZP domain has six conserved 
cysteine residues (Braun et al. 2009). 
1.4.8 3D structure of the zona pellucida  
Recent studies by Jovine et al., have attempted to elucidate the three dimensional structure 
of the ZP proteins. Crystal structures of both the mouse ZP3 (mZP3) ZP-N domain (Monne 
and Jovine. 2011) and full length chicken ZP3 (Han et al. 2010) established that both ZP-N 
and ZP-C form immunoglobulin (Ig) like folds, which consist of two β sheets that enclose a 
hydrophobic core (Halaby et al. 1999). 
The ZP-N can be defined as a new subtype of the Ig superfamily of proteins due to its 
characteristic E’-strand within an E’-F-G β sheet that extends from the hydrophobic core, in 
addition to two enclosed disulfide bonds that secure both sides of the β sandwich (Han et al. 
2010;Monne and Jovine. 2011).  
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Additional structural information can be found in their most recent review (Monne and 
Jovine. 2011).  
1.4.9 Secretion of the zona pellucida 
The secretion and formation of the ZP matrix appears to rely on the presence and possible 
interaction of the IHP and EHP (Jovine et al. 2004). The formation of the ZP matrix appears to 
happen outside of the oocyte with ZP proteins being secreted in a monomeric form. The IHP 
and EHP create a hydrophobic core, which is the key interaction between the ZP-N and ZP-C 
motifs of the ZP domain. The position of the EHP is important as it appears to be critical in 
correct secretion and preventing premature polymerisation within the oocyte (Jovine et al. 
2004;Han et al. 2010) (figure 1.11 a). Cleavage of the exposed FC site on the cell surface 
causes a conformational change separating the IHP and EHP and exposing the IHP (figure 
1.11 b), resulting in polymerisation events to form the ZP filaments (Monne and Jovine. 
2011) (figure 1.11 c).  
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Figure 1.11: Assembly model for zona pellucida proteins.  
The interaction between the IHP and the EHP avoids the premature polymerisation of ZP proteins (a). On the cell surface cleavage occurs causing a 
conformational change and exposure of IHP (b). This IHP exposure allows polymerisation of the ZP proteins into filaments (c). Internal hydrophobic 
patch (IHP); external hydrophobic patch (EHP); furin cleavage site (FC) and transmembrane domain (TM). (Jovine et al. 2005).  
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1.5 The spermatozoon’s journey to fertilisation 
1.5.1 Capacitation 
Ejaculated spermatozoa have to undergo a further and final maturation process, termed 
capacitation, before they are capable of fertilising the oocyte (Austin. 1951;Chang. 
1951;Austin. 1952). The process of capacitation is mediated by factors expressed by the 
female reproductive tract and it is a distinctive process of plasma membrane lipid 
remodelling, increases in intracellular pH and induction of signalling pathways within the 
spermatozoa (Visconti et al. 1995;Aitken et al. 1998;Baldi et al. 2000;Salicioni et al. 2007). 
The precise molecular mechanisms of capacitation have yet to be elucidated however some 
of the key molecular events are summarised in table 1.1 and for further information 
spermatozoa capacitation has been reviewed (Shivaji et al. 2007;Fraser 2010;Visconti et al. 
2011). 
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Key event Information Reference 
Cholesterol efflux  Substantial efflux of cholesterol from spermatozoa plasma membrane. 
 Caused by exposure to cholesterol sinks e.g. human follicular fluid. 
 Loss of cholesterol induces transmembrane signalling pathways. 
 Cholesterol efflux also creates an increased fluidity of the spermatozoa 
plasma membrane allowing movement of integral membrane proteins.  
(Davis. 1981;Langlais et al. 
1988;Martinez and Morros. 
1996; Visconti and Kopf. 
1998;Visconti et al. 1999) 
Bicarbonate ion influx  Influx disrupts and destabilises spermatozoon plasma membrane, 
rendering it more fusogenic.  
 This is due to activation of phospholipid scramblases.  
 It also activates signal transduction pathways which lead to an increase in 
tyrosine phosphorylation that can induce hyperactivated motility.  
(Visconti et al. 1995;Aitken et al. 
1998) 
(Gadella and Harrison. 
2000;Harrison and Gadella. 
2005) 
Loss of de-capacitation factors  The loss of factors acquired by spermatozoa from the epididymis and 
seminal components, which makes spermatozoa capable of fertilisation.  
 Factors such as HongrES1, DF glycoprotein and phosphatidylethanolamine 
binding protein 1. 
(Fraser. 1984;Fraser. 
1998;Gibbons et al. 2005;Ni et 
al. 2009) 
Protein and lipid raft 
remodelling and movement 
 Spermatozoa are transcriptionally inactive so rely on post-translational 
modifications to aid remodelling. 
(Nixon et al. 2009;Jones et al. 
2010) 
  Lipid raft movement may act as platforms for functional molecules to 
aggregate.  
 
Table 1.1: The key biochemical and molecular events that happen during sperm capacitation.  
Table modified from (Reid et al. 2011). 
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1.5.2 Sperm motility  
Motility is critical for the mammalian spermatozoon. Motility is achieved through the 
specialised structure the flagellum, however it is a process that is acquired under the 
regulation of many extrinsic and intrinsic factors (Turner. 2006). 
The motility pattern displayed by spermatozoa differs between ejaculated spermatozoa and 
spermatozoa that are recovered from the site of fertilisation (Katz and Vanagimachi. 
1980;Chevrier and Dacheux. 1987;Suarez and Osman. 1987). Freshly deposited spermatozoa 
within the female reproductive tract exhibit a symmetrical, low amplitude flagellar wave 
which gives spermatozoa a progressive trajectory when observed in aqueous medium (Katz 
and Vanagimachi. 1980;Suarez. 2008). It is believed that this enables spermatozoa to 
traverse the early anatomical regions of the female reproductive tract (Turner. 2006). 
However as spermatozoa progress to the site of fertilisation they exhibit an asymmetric, 
higher amplitude flagellar wave, which gives them a characteristic circular figure-of-eight 
movement when observed in aqueous medium (Yanagimachi. 1970;Yanagimachi. 1994). This 
pattern of motility is termed hyperactivation and although such spermatozoa exhibit 
characteristic movements in an aqueous environment, recent evidence suggests that within 
the viscous in vivo environment of the female reproductive tract (Smith et al. 2009) this 
hyperactivated movement allows spermatozoa to have a progressive trajectory through the 
oviduct and also facilitate the penetration of the COC (Ho and Suarez. 2001;Turner. 2006). 
The hyperactivated motility is observed to coincide with the completion of capacitation 
which may be important in vivo, although studies have demonstrated that they arise 
independently (Olds-Clarke. 1989;Marquez and Suarez. 2004). 
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Sperm motility appears to be regulated by a number of different signalling pathways (White 
and Aitken. 1989;Brokaw. 1991;Yanagimachi. 1994;Ho and Suarez. 2003;Wang et al. 2003). 
The two main signalling pathways have been identified as cyclic AMP (cAMP)/protein kinase 
A (PKA) and Ca2+ signalling. An influx of bicarbonate ions (HCO3
-) results in the cAMP-
dependent phosphorylation of downstream flagellar proteins such as tyrosine (Turner. 
2006). Extracellular Ca2+ signalling has been identified as regulating both activated and 
hyperactivated sperm motility patterns (Yanagimachi. 1994;Ho et al. 2002;Darszon et al. 
2006). Ca2+ influx is required for HCO3
- induction of ‘soluble’ adenylyl cyclase (sAC) which 
promotes the cAMP activation of PKA (Carlson et al. 2007). Calcium can also act as part of a 
positive feedback loop with cAMP stimulating calcium influx via cyclic nucleotide-gated Ca2+ 
or CatSper channels activation (Xia et al. 2007). The increase in [Ca2+]i observed in 
spermatozoa may also involve [Ca2+]i stores, however the mechanisms are not fully 
elucidated (Ho and Suarez. 2003). 
Although discussed briefly, the mechanisms and regulation of sperm motility are highly 
complex which far reaches beyond the scope of this thesis, however there are many reviews 
that provide further details (Ford. 2006;Turner. 2006;Bedu-Addo et al. 2008; Publicover et al. 
2008;Hung and Suarez. 2010). 
1.5.3 Sperm selection and migration  
Once deposited in the vagina of the female reproductive tract, spermatozoa must traverse 
multiple selective obstacles to reach the ovulated oocyte.  
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The cervix and cervical mucus 
The initial barrier that spermatozoa must penetrate is the cervix, a narrow structure which 
connects the vagina to the uterus. Numerous glands residing in the cervix produce a viscous 
secretion, cervical mucus. Cervical mucus is a highly viscoelastic gel composed of long 
hydrated glycoproteins called mucins (Brunelli et al. 2007). The physical, chemical and 
hydrodynamic properties of cervical mucus change in response to ovarian hormone changes 
through the female menstrual cycle. Outside the ovulatory phase of the cycle cervical mucus 
is thick and viscous, limiting the spermatozoon’s ability to penetrate. However during 
ovulation cervical mucus thins, becoming penetrable to only highly motile spermatozoa 
(Mortimer and Templeton. 1982;Katz et al. 1997). There is evidence to suggest that a protein 
acquired during the epididymal maturation of spermatozoa aids cervical mucus transit 
(Tollner et al. 2008). Studies in vivo have observed that spermatozoa lose lipid species after 
migration through cervical mucus (Feki et al. 2004), suggesting that cervical mucus may play 
a role in remodelling of sperm surface plasma membranes (Baldi et al. 2000). 
The utero-tubal junction (UTJ) 
The UTJ connects the uterus and the oviduct by intersecting the distal portion of the oviduct 
and it is another barrier to sperm migration. Like the cervix, the UTJ lumen has been found 
to contain mucus during the periovulatory period, inhibiting sperm migration into the 
oviduct (Jansen. 1980). In addition to physical barriers, studies using transgenic mice have 
shown that the process of sperm migration through the UTJ is biologically regulated. Mice 
spermatozoa lacking in Clgn, Ace, Adam1a, Adam2 or Adam3 cannot traverse the UTJ, even 
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though motility is not impaired (Cho et al. 1998;Hagaman et al. 1998;Ikawa et al. 
2001;Nishimura et al. 2004;Yamaguchi et al. 2009).  
Interactions with the oviduct  
Interactions between both male and female gametes and oviductal epithelial cells and their 
products play an important role in fertilisation.  
Spermatozoa can bind to cells in the isthmus region of the oviduct, suppressing capacitation 
for approximately 24 hours (Dobrinski et al. 1997;Murray and Smith. 1997;Connolly. 2011). 
Prior to ovulation spermatozoa are released from the isthmus allowing progression towards 
the site of fertilisation within the ampulla region of the oviduct. The mechanisms behind this 
release are not fully elucidated; however capacitation of the spermatozoa could promote 
changes within the plasma membrane of spermatozoa, causing them to lose their binding 
ability (Ignotz et al. 2001). Induction of the hyperactivated motility pattern may also 
facilitate spermatozoa release (Demott and Suarez. 1992). Recent studies show that 
interaction between human spermatozoa and cells of the female tract induces Ca2+ signalling 
in both cell types (Connolly. 2011).  
Multiple studies have observed gametes and early embryos modifying the transcriptomic 
and proteomic expression profile of the oviduct (Ellington et al. 1993;Thomas et al. 1995;Lee 
et al. 2002;Bauersachs et al. 2003;Long et al. 2003;Fazeli et al. 2004;Georgiou et al. 2005;Das 
et al. 2006;Sostaric et al. 2006;Mack et al. 2006;Georgiou et al. 2007;Kapelnikov et al. 
2008;Seytanoglu et al. 2008;Kolle et al. 2010). Spermatozoa exposure in the oviduct of pigs 
causes an up-regulation in the synthesis of 19 oviductal proteins (Georgiou et al. 2007) and 
58 genes have been found to be up-regulated in the mouse (Fazeli et al. 2004). These studies 
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demonstrate the ability of spermatozoa to create their own microenvironments within the 
oviduct, which potentially supports spermatozoa maturation, viability and function 
(reviewed by Holt and Fazeli. 2010). 
Chemotaxis  
Sperm migration may also rely on chemotaxis as a result of exposure to both follicular fluid 
and the COC itself (Cohen-Dayag et al. 1995;Sun et al. 2005;Oren-Benaroya et al. 2008). 
Progesterone has been observed to elicit a chemotactic effect in spermatozoa (Oren-
Benaroya et al. 2008). An olfactory receptor (OR1D2) found on spermatozoa has also been 
implied to play a functional role in sperm migration when exposed to bourgeonal in vitro, 
however the in vivo ligand for OR1D2 has not yet been found (Spehr et al. 2003).  
1.5.4 Calcium (Ca2+) signalling in spermatozoa  
Calcium (Ca2+) is a common signalling molecule important in many cellular processes. The 
regulation of Ca2+ entry into the cytoplasm of the cell initiates the transduction of a series of 
signalling cascades (figure 1.12 a), resulting in Ca2+ and its associated secondary messengers 
activating functional proteins. Ca2+ signalling is known to play a crucial role in sperm function 
involving many Ca2+ channels and pumps and has been reviewed (Jimenez-Gonzalez et al. 
2006;Publicover et al. 2007;Bedu-Addo et al.2008) (figure 1.12 b).  
Ca2+ signalling is reliant on the influx of Ca2+ from both extracellular and intracellular sources 
into the cytoplasm of the spermatozoa. The levels of Ca2+ in the cytoplasm are purposely 
maintained at a lower concentration than either of its Ca2+ sources (Publicover et al. 2007). 
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Figure 1.12: Spermatozoa Ca2+signalling. 
(a) Key routes and molecular cascades in spermatozoa (Image adapted from Connolly. 2011). (b) Summary of identified calcium channels (rectangles) 
and pumps (circles) and their location within the spermatozoa (Image from Bedu-Addo et al. 2008). 
37
 
38 
 
Rises in the concentration of extracellular Ca2+ increases the membrane potential of the 
plasma membrane, causing the opening of voltage-operated Ca2+ channels (VOCCs) allowing 
an influx of Ca2+ into the cytoplasm (Arnoult et al 1996;Jimenez-Gonzalez 2006). 
Spermatozoa contain a range of VOCCs, including both L (long lasting) and T (transient) 
channel types (Goodwin et al. 2000;Jagannathan et al. 2002;Park et al. 2003). As a divalent 
cation, Ca2+ can bind directly to exposed negative and uncharged oxygen atoms on carbonyl 
groups of peptides, causing a conformational change that can in turn alter the protein 
function. 
Binding of specific ligands to G-coupled membrane receptors results in a phosphoinositide 
signalling cascade producing the secondary messengers inositol 1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG) (Putney. 2001). IP3 binds to a receptor (IP3R) which is located on an 
intracellular store of Ca2+. In somatic cells the endoplasmic reticulum and the golgi body act 
as internal Ca2+ stores, however spermatozoa lack these membranous organelles. Currently 
two intracellular Ca2+ stores have been identified in spermatozoa, the acrosome and the 
redundant nuclear envelope (RNE). IP3R can be detected in both the acrosome and RNE 
(Bedu-Addo et al. 2008). Binding of IP3 to the IP3R causes Ca
2+ to be released from the 
intracellular Ca2+ stores, allowing Ca2+ to act on other proteins. The process of Ca2+ release 
from intracellular stores appears to be under the control of Ca2+ itself with IP3R activity being 
inhibited by high levels of Ca2+ (Marchant and Parker. 2000). Ryanodine receptors (RYRs) 
have also been found to empty intracellular Ca2+ stores and like IP3R are also controlled by 
Ca2+ in addition to ATP and cyclic ADP (cADP) (Marks. 1997). The intracellular stores can 
signal to store-operated Ca2+ channels (SOCC) located on the plasma membrane, that open 
when the [Ca2+]i stores are depleted (Berridge et al. 2003). 
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In addition to mechanisms controlling Ca2+ influx into spermatozoa, there are also 
mechanisms controlling Ca2+ removal. This process is essential as prolonged exposure to high 
Ca2+ concentration levels can result in cell death. The removal of Ca2+ depends on ATP-
dependent PMCA and SERCA pumps, which transports Ca2+ from the cytoplasm back into the 
extracellular fluid and pumps cytoplasmic Ca2+ back into [Ca2+]i stores, respectively. The NCX 
exchanger, found in the plasma membrane can transport Ca2+ out into the extracellular fluid 
(Berridge et al. 2003).  
1.6 Fertilisation  
1.6 1 Spermatozoa penetration of cumulus 
For successful mammalian fertilisation, spermatozoa must penetrate through cumulus 
matrix in order to reach the oocyte (Myles and Primakoff. 1997;Kim et al. 2008). As the 
cumulus cells are embedded in an extracellular viscous matrix, comprised mostly of 
hyaluronic acid, it was believed that the action of sperm hyaluronidase enabled spermatozoa 
to penetrate the cumulus matrix (Kim et al. 2008). However knockout experiments involving 
two key hyaluronidases identified on spermatozoa, SPAM1 and HYAL5, showed that null 
mice were fertile and only SPAM1-null mice showed slightly delayed cumulus matrix 
penetration (Lin et al. 1994;Baba et al. 2002;Kim et al. 2005;Kimura et al. 2009). A 
hyaluronidase inhibitor, apigenin also showed no effect on sperm penetration through the 
cumulus matrix (Kang et al. 2010). Double-knockout mice lacking the serine proteases 
Acrosin and Tesp5 were unable to traverse the cumulus matrix, suggesting that the joint 
activity of both Acrosin and Tesp5 seems to be essential for cumulus penetration, at least in 
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vitro. However normal phenotype was partially restored in vitro with exposure to uterine 
fluid (Kawano et al. 2010). 
1.6.2 Acrosome reaction (AR) 
The exocytosis of the contents of the spermatozoon acrosome is an important pre-requisite 
for fertilisation, allowing spermatozoa to penetrate through the ZP matrix. The induction of 
AR only occurs in capacitated spermatozoa (Saling and Storey. 1979;Yanagimachi. 1994). The 
release of acrosomal contents occurs as a result of the outer acrosomal membrane fusing at 
multiple points with the spermatozoon outer plasma membrane, exposing the inner 
acrosomal membrane (Zanetti and Mayorga. 2009). Experiments using murine spermatozoa 
with an acrosome labelled with a GFP reporter indicated that the AR is a gradual process 
(figure 1.13), with some acrosomal components such as acrin 1 and acrin 2 remaining 
attached to the membrane for 15 minutes after AR induction (Nakanishi et al. 
1999;Nakanishi et al. 2001). 
The in vivo stimulant of spermatozoa AR is still not fully elucidated. The ZP has long been 
thought to have a physiological role in the stimulation of AR as in vitro studies showed that 
solubilised zona induce the AR (Florman and Storey. 1982;Cherr et al. 1986;Bailey and 
Storey. 1994;Chiu et al. 2008a;). However there are reports that intact ZP does not induce 
spermatozoa AR (Baibakov et al. 2007). In comparison to the mouse, where only mZP3 
appears to induce the spermatozoa AR, three hZPs (hZP1, hZP3 and hZP4) appear to induce 
the AR (reviewed Gupta and Bhandari. 2011). Both progesterone and 17 α OH-progesterone 
from human cumulus and follicular fluid have been identified as AR inducers (Osman et al. 
1989;Garcia and Meizel. 1999;Patrat et al. 2000). There is also evidence to suggest that in 
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vivo, the cumulus oophorus is the physiological inducer of the mammalian spermatozoa AR 
(Bedford et al. 2004;Jin et al. 2011). In vitro AR can be induced by ionophores which 
exchange Ca2+ for alternate ions, such as H+ (Florman. 1994). 
Both ZP and progesterone induced AR induction causes a vast signal cascade mediated by an 
elevation of [Ca2+]i, and have been extensively reviewed (Abou-Haila and Tulsiani. 
2000;Kirkman-Brown et al. 2002;Gupta and Bhandari. 2011). Although initial receptors and 
responses differ, the subsequent signals employ common components. The influx of Ca2+ 
produces a multiphasic response with an initial transient phase that results in plasma 
membrane depolarisation which activates voltage-operated calcium channels (VOCCs), 
although it is believed that progesterone-induced AR is not solely reliant on VOCCs (Thomas 
and Meizel. 1989;Foresta et al. 1993;Aitken et al. 1996). This results in multiple downstream 
activation, resulting in the emptying of [Ca2+]i stores (O'Toole et al. 2000). The resulting 
increase in Ca2+ and elevated pH depolymerises the F-actin between the plasma and outer 
acrosomal membranes in addition to activating phospholipase A2 which cleaves fatty acids 
from phospholipids, which promotes the fusion of membranes at multiple sites resulting in 
vesiculation (Tulsiani et al. 1998;Abou-Haila and Tulsiani. 2000).  
There is some evidence to suggest that the AR is stimulated by purely a mechanical force 
and requires no biological inducer. A study by Baibakov et al. 2007 showed that mouse 
spermatozoa penetrating 1.2 µM polycarbonate filters, in the absence of known AR inducers 
(such as ZP or progesterone) induced the AR in 98 ± 5.8% of the sperm population, however 
this fell to 10-11% when spermatozoa penetrated polycarbonate filters with a larger pore 
size of ≥ 5 µM.  
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Figure 1.13: Morphological changes during human sperm acrosomal exocytosis.  
Spermatozoa acrosomal exocytosis induced by calcium ionophore A22187 incubated for 10 min. Images (a) to (d) show the gradual vesiculatated 
acrosome, exposing the inner plasma membrane. Acrosomal exocytosis is restricted to the anterior part of the equatorial segment. (ES) equatorial 
segment, (N) nucleus, (A) acrosomal contents, (IM) inner plasma membrane, (OM) outer plasma membrane, (PM) plasma membrane, (HV) hybrid 
vesicle. Bars represent 500 nm, images taken from (Zanetti and Mayorga. 2009). 
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1.6.3 Spermatozoa-zona binding and penetration 
In order to fertilise the oocyte, spermatozoa must bind and penetrate the ZP matrix. The 
mechanisms behind this have not been fully characterised.  
There is evidence from using a combination of both native hZP3 and hZP4 (Chiu et al. 
2008a;Chiu et al. 2008b) and recombinant human zona (rhZP) proteins that all four, rhZP1 
(Ganguly et al. 2010), rhZP2 (Chirinos et al. 2011), rhZP3 and rhZP4 (Chakravarty et al. 
2005;Chakravarty et al. 2008) exhibit spermatozoa binding. However the exact interactions 
and their overall importance to fertilisation have yet to be elucidated. There has been 
research for many decades looking for the primary zona receptor on spermatozoa, with 
multiple candidates being put forward, however the true receptor remains elusive. This is 
further discussed within chapter 4.  
Spermatozoa zona penetration may be due to mechanical force generated by flagellar 
motility and/or dependent on proteolytic hydrolysis by enzymes originating from the 
acrosome (Yanagimachi. 1994). A number of proteolytic enzymes have been suggested as 
playing a key role in ZP penetration such as Acrosin and Tesp5, however knockout mouse 
experiments showed that ZP penetration still occurred, albeit slightly delayed (Baba et al. 
1994;Adham et al. 1997;Yamashita et al. 2008). In the case of Tesp5, normal phenotype can 
be rescued with exposure to uterine fluids.  
Other proteins have also been highlighted as important players in ZP penetration. 
Experiments blocking PSMD4, an essential subunit of a proteasomal 19S complex important 
in proteasome substrate recognition, show defective ZP penetration with no effect on ZP 
binding (Yi et al. 2010). DKKL1-null mice exhibit defective ZP penetration in vitro, however it 
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appears that in vivo they are completely fertile, whether this is as a result of phenotype 
rescue by in vivo conditions is still under investigation (Kohn et al. 2010). 
1.6.4 Sperm-oocyte fusion  
Only acrosome reacted spermatozoa can penetrate the ZP matrix and fuse with the oocyte 
plasma membrane (Bedford 1968;Stein et al. 2004). Although the exact mechanisms behind 
sperm-oocyte fusion are still not fully elucidated there has been identification of a number 
of key molecules involved in the process. Both an Ig superfamily, type 1 membrane protein, 
Izumo1 identified on spermatozoa and a tetraspanin Cd9 identified on the oocyte plasma 
membrane, have been found to be essential in sperm-oocyte fusion (Kaji et al. 2000;Le et al. 
2000;Miyado et al. 2000;Inoue et al. 2005). However no direct interaction between the two 
molecules has been found, potentially implying that the process involves some sort of 
multimeric protein interaction or a number of distinct receptors.  
1.6.5 Prevention of polyspermy 
The successful fusion of the sperm and oocyte plasma membranes initiates the most 
important event in oocyte activation, the release of intracellular calcium [Ca2+]i. This initial 
increase in [Ca2+]i triggers cortical granule exocytosis, which is key in preventing the 
occurrence of polyspermy (Abbott and Ducibella. 2001). 
Polyspermy is an abnormal phenomenon where more than one spermatozoon fertilises the 
oocyte, introducing more than the desired haploid set of chromosomes. Polyspermy in 
humans usually results in embryo lethality; although there have been reports of both 
tetraploid and triploid infants, however they are born with severe abnormalities which result 
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in an early infant death (Sherard et al. 1986;Roberts et al. 1996;Dean et al. 1997;Hasegawa 
et al. 1999).  
Cortical granules reside beneath the oocyte plasma membrane (Longo. 1985) and exocytosis 
of their contents in mature oocytes is dependent of the rise in [Ca2+]i and calcium dependent 
proteins (Abbott and Ducibella. 2001). The mammalian cortical granule contents which 
include proteinases, ovoperoxidase and N-acetylglucosaminidase (reviewed by Sun. 2003) 
initiates cleavage of ZP2 in the second ZP-N repeat which causes conformational change 
within the ZP matrix (Monne and Jovine. 2011). This prevents further spermatozoa unable to 
bind and penetrate the ZP, although the identity of the exact molecule that catalyses these 
changes remains unidentified (Moller and Wassarman. 1989;Familiari et al. 2008;Papi et al. 
2010). 
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1.7 Research aims 
This study aims to take a multidirectional approach to investigate the interactions between 
human spermatozoa and the ovulatory components including follicular fluid, the COC and 
the ZP, addressing the hypothesis that sperm function is altered by the ovulatory 
components they encounter, as they approach the oocyte in the female reproductive tract. 
Since these modulatory effects would be crucial to fertilisation success we predict that 
follicular fluid and cumulus cells from patients undergoing ART treatment would differ in 
their ability to induce these changes according to the treatment outcome of the patient. The 
modulation of sperm motility parameters caused by cumulus cells and spermatozoa Ca2+ 
signalling induced by follicular fluid will be studied.   
In addition the development of novel experimental procedures designed to further our 
understanding of the interactions of spermatozoa with the ZP will be undertaken, utilising 
both recombinant and native ZP in SPR technology and also examining a novel in vitro 
oogenesis model via hESC differentiation.   
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CHAPTER 2 
Effect of the cumulus oophorus and follicular fluid on 
spermatozoa 
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2.1 Introduction 
At the moment of ovulation the contents of the ovarian follicle, comprising of the 
cumulus oocyte complex (COC) and follicular fluid, are released into the female 
reproductive tract (Harper. 1994). The milieu created by these follicular components at 
the time of fertilisation may be critical in the regulation of spermatozoa activity. 
Although debated (Gur and Breitbart. 2008), spermatozoa are generally regarded as 
transcriptionally and translationally inactive, due to the absence of ribosomes and 
endoplasmic reticulum, in addition to having highly condensed nuclear DNA. With this 
lack of de novo protein synthesis, spermatozoa may be sensitive to post translational 
modifications such as phosphorylation (Visconti and Kopf. 1998), nitrosylation (Lefievre 
et al. 2009) and carbonylation (El-Taieb et al. 2009), initiated by environmental factors.  
Both the COC and follicular fluid are a major source of potential sperm modulators and 
are known sources of steroids, particularly the steroid hormone progesterone (Osman 
et al. 1989;Bar-Ami 1994;Wen et al. 2010). Progesterone has been shown to have an 
effect on sperm motility by increasing the levels of intracellular Ca2+ ([Ca2+]i) (Blackmore 
et al. 1990;Harper et al. 2004;Giretti and Simoncini. 2008). Such increases in [Ca2+]i are 
known to initiate a hyperactivated motility pattern (Marquez and Suarez. 2007), a 
vigorous ‘whiplash’ effect characterised by a high amplitude, asymmetrical flagellar 
bending which is thought to aid penetration through the oocyte vestments (Suarez. 
2008). Progesterone stimulation has also been seen to cause sperm populations to 
undergo the acrosome reaction (AR), which is also linked to a rapid elevation in [Ca2+]i 
(Harper et al. 2006). Some evidence suggests that progesterone may have a directional 
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chemotactic effect on spermatozoa motility (Teves et al. 2006) although this is not 
without rebuttal (Jaiswal et al. 1999).  
Nitric oxide (NO) is another key molecule secreted by cumulus cells and found in 
follicular fluid (Machado-Oliveira et al. 2008;Vignini et al. 2008;Zhao et al. 2010). Due to 
its uncharged nature and diffusible properties NO can act as an effective intracellular 
and extracellular biological messenger (Lancaster. 1997). As with progesterone, NO has 
been identified as a modulator of sperm motility (Lewis et al. 1996). In addition to 
protein nitrosylation (Lefievre et al. 2007), NO may also have a role in the final steps of 
sperm maturation, capacitation and induction of AR (Herrero et al. 1999). 
Isoforms of lipocalin glycoproteins have been identified in both follicular fluid and the 
cumulus oophorous; Glycodelin F, identified from follicular fluid (Chiu et al. 2003b) and 
Glycodelin C which is converted from endogenous Glycodelin A and F by the cumulus 
cells (Chiu et al. 2007). The proteins have the same core and only differ in their 
glycosylation pattern (Yeung et al. 2006). Glycodelin F has been shown to inhibit 
spermatozoa zona binding (Chiu et al. 2005) and the progesterone-induced acrosome 
reaction (Chiu et al. 2003a). In contrast, Glycodelin-C appears to promote spermatozoa-
zona binding (Chiu et al 2007).  
Although there have been a handful of studies, the full proteomes and steroid 
composition of cumulus oophorus and follicular fluid are as yet uncertain (Memili et al. 
2007;Hanrieder et al. 2008;Jarkovska et al. 2010). 
There are factors secreted by cumulus cells and/or present in follicular fluid that appear 
to have an active role in fertilisation success. Studies using animal models in vitro have 
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shown that, although spermatozoa are capable of fertilising the oocyte in the absence of 
the cumulus oophorus layer, there are decreased levels of spermatozoa/oocyte 
interaction and lower fertilisation rates (Mattioli et al. 1988). The quality of the resultant 
embryos is also affected with reduced cleavage rates (Cross and Brinster. 1970) and 
early embryo development is slowed (Eyestone et al. 1987;Goto et al. 1988). 
Glucocorticoid production has been highlighted as a further marker for fertilisation 
success. Decreased activity in granulosa cells of 11β hydroxysteroid dehydrogenase 
(HSD11β) enzymes, which catalyse the conversion of steroid hormones from ‘inert’ 
cortisone to ‘active’ cortisol or vice versa, and/or increased cortisol:cortisone ratios in 
follicular fluid have been associated with improved pregnancy outcomes in patients 
undergoing ART (Michael and Papageorghiou. 2008). The production of steroids has 
been shown to be important for successful fertilisation, indicating that higher levels of 
certain steroid hormone levels in follicular fluid relate to fertilisation success in patients 
undergoing ART (Andersen. 1993;Mendoza et al. 1999;Lamb et al. 2010) (figure 2.1). 
These studies however focus on oocyte quality and ignore the potential effects these 
factors could have on sperm function and their fertilising ability.  
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Figure 2.1: Steroidogenic pathway. 
Overview of the major steroidogenic pathway. Conversion enzymes are indicated by blue text 
and steroid products indicated by blue shaded boxes (Holt and Hanley. 2007). 
 
To assess the physiological effects of products exposed to spermatozoa it is important to 
select the ‘correct’ sperm population. In vivo the population containing the fertilising 
spermatozoa are selected through viscous barriers within the female reproductive tract. 
The cervical mucus, which spermatozoa have to penetrate, exhibits a viscoelastic 
property, contributed by the protein Mucin (Carlstedt and Sheehan. 1984) and has been 
shown to preferentially select for spermatozoa which have a ‘normal’ morphology and 
progressive motility (Hanson and Overstreet. 1981;Katz et al. 1997). Spermatozoa in 
viscous mediums have been shown to affect flagellar bending and sperm trajectory 
(Smith et al. 2009). There is also preliminary unpublished data from our laboratory that 
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shows that penetration through a viscous medium may not only select for progressive 
spermatozoa, but select for spermatozoa with lower levels of DNA damage (data not 
shown). There appears a moderate negative correlation between sperm motility and 
chromatin structure, with sperm populations that exhibit higher percentages of motile 
cells having lower levels of DNA fragmentation (Giwercman et al. 2003). 
There appears to be a complex combination of signals and interaction between 
spermatozoa and their environment. Many of the molecular mechanisms involved and 
their effects on spermatozoa are currently unknown. Whether these factors and their 
ability to elicit the ‘correct’ response in spermatozoa are important for a pregnancy 
positive outcome deserves investigation. The work in this chapter looks at the selection 
of motile spermatozoa through a viscous medium and effect of cumulus cells and 
follicular fluid collected from patients undergoing assisted reproductive treatment, on 
spermatozoa motility and [Ca2+]i influx and whether the results relate to pregnancy 
outcome.  
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2.2 Aims 
 To develop a physiologically based sperm selection method and compare 
different sperm preparation techniques. 
 To identify any effects on sperm motility exerted by native human cumulus cells. 
 To establish the effects of human follicular fluid on spermatozoa [Ca2+]i 
responses. 
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2.3 Materials 
2.3.1 Cell Culture reagents 
Product Name Company Product Number 
Bovine Serum Albumin (BSA) Millipore, Watford, UK 82-002-4 
Dimethyl sulfoxide (DMSO) Sigma, Dorset, UK. D4540 
Dulbecco’s Modified Eagle/F-12 Medium 
(DMEM/F-12) 
Invitrogen, Paisley, UK. 21041-033 
Fetal Bovine Serum (FBS) Biosera, Ringmer, UK. S181X 
Non Essential Amino Acids (NEAA) Invitrogen, Paisley, UK 11140-035 
Penicillin/Streptomycin Invitrogen, Paisley, UK. 15140-122 
Supplemented Earle’s Balanced Salt Solution 
(sEBSS) 
Geneflow, Fradley, UK. 06-2010-03-1B 
 
2.3.2 Chemicals 
Product Name Company Product Number 
Agarose Bioline, London, UK. 41025 
Deoxynucleoside triphosphates (dNTPs) Promega, Southampton, UK C1141 
Ethidium bromide Sigma, Dorset, UK. 160539 
Ethylenediaminetetraacetic acid disodium 
salt dehydrate (EDTA) 
Sigma, Dorset, UK E5134 
Glacial acetic acid Fisher Scientific, 
Loughborough, UK 
A/0400/PB17 
Glucose Sigma, Dorset, UK G7528 
Methylcellulose 4000 Sigma, Dorset, UK M0512 
N-(2-Hydroxyethyl)piperazine-N’-(2-
ethanesulfonic acid) (HEPES) 
MP Biochemical, Ohio, USA l 194726 
Percoll Sigma, Dorset, UK P1644 
Pluronic F-127 *20% solution in DMSO Invitrogen, Paisley, UK P3000MP 
Poly D lysine solution Sigma, Dorset, UK. P8920 
55 
 
Product Name Company Product Number 
Potassium chloride MP Biochemical, Ohio, USA l 194726 
Progesterone  Sigma, Dorset, UK. P0130 
Sodium chloride Sigma, Dorset, UK. S9888 
Tris(hydroxymethyl)aminomethane Sigma, Dorset, UK 25285-9 
 
2.3.3 Commercial Kits 
Product Name Company Product Number 
Sensiscript Reverse Transcriptase (RT) kit Qiagen, Crawley, UK. 205211 
Total RNA purification kit Norgen Bioteck Corp 17200 
 
2.3.4 DNA and Protein ladders 
Product Name Company Product 
Number 
1Kb DNA Step Ladder Promega, Southampton, UK. G6941 
25bp DNA Step Ladder Promega, Southampton, UK. G4511 
 
2.3.5 Dyes 
Product Name Company Product number 
Calcium Green-1 AM Invitrogen, Paisley, UK C3012 
6X Blue/Orange loading dye Promega, Southampton, UK. G1881 
 
2.3.6 Enzymes 
Product Name Company Product 
Number 
RNase Inhibitor Bioline, London, UK. 65027 
Red Taq DNA Polymerase Bioline, London, UK 21038 
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2.4 Methods 
2.4.1 Human Spermatozoa preparation 
Human sperm donors were recruited and gave their informed consented at the Assisted 
Conception Unit (ACU), Birmingham Women’s Hospital (HFEA Centre 0119) in 
accordance with the Human Fertilization and Embryology Authority code of practice 
(The HFEA 2011). The research was reviewed and approved by the Local Ethical Panel 
(South Birmingham LREC 2003/239). Semen samples were obtained from healthy donors 
via masturbation after 2-3 days of sexual abstinence. Semen was then allowed to liquify 
for 30 min at 37°C before preparation.  
Dependent on the experimental design, spermatozoa were prepared using either one or 
all of the following sperm preparation techniques.  
Percoll Density Gradient Centrifugation 
Percoll was prepared into a 100% isotonic (285-300 mOsm/kg) solution by dilution with 
10 X M medium (1.37 M NaCl, 25 mM KCl, 200 mM N-(2-hydroxyethyl)piperazine-N’-(2-
ethanesulfonic acid) (HEPES), 100 mM glucose). Percoll fractions of 90% and 45% were 
prepared by diluting 100% Percoll with 1 X M medium. Liquefied semen (1 ml) was 
layered over a 90% and 45% gradient (1 ml of each) and centrifuged at 2000 x g for 20 
min, the spermatozoa pellet was resuspended and left to capacitate in sEBBS + 0.3% 
(w/v) BSA for a minimum of 3 h and maximum of 4 h, at 37°C, 6% CO2. 
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The Direct Swim-up Method 
Three hundred microlitre aliquots of liquefied semen were underlaid beneath 1 ml 
sEBBS + 0.3% (w/v) BSA in round bottomed tubes. Tubes were inclined at a 45° angle 
and incubated for 1 h at 37°C, 6% CO2. The upper 0.8 ml of media, containing highly 
motile spermatozoa, was then collected, and set aside for the spermatozoa to 
capacitate in sEBBS + 0.3% (w/v) BSA for a minimum of 3 h and of maximum 4 h, at 37°C, 
6% CO2. 
Modified Swim-up Method 
These experiments were designed to mimic the selective viscous physiological 
environment of the female reproductive tract. Three hundred microlitre of 1% (w/v) 
methylcellulose 4000 in sEBBS + 0.3% (w/v) BSA, which had a viscosity of 140 centipoise 
(cP) was aliquoted into round bottomed tubes. Three hundred microlitre of semen 
sample was underlaid beneath the methylcellulose. The methylcellulose layer was then 
overlaid with 250 µl of sEBSS + 0.3% (w/v) BSA. Multiple tubes were inclined at a 45° 
angle and incubated for 1 h at 37°C, 6% CO2. Penetrating spermatozoa were collected, 
pooled and left to capacitate in sEBBS + 0.3% (w/v) BSA for a minimum of 3 h and 
maximum of 4 h, at 37°C, 6% CO2 (figure 2.2). 
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Figure 2.2: Modified swim-up sperm preparation method. 
 
2.4.2 Spermatozoa preparation technique comparison  
For comparison between sperm preparation techniques, each sample was prepared 
using all three preparation techniques. The motility of the spermatozoa was assessed 
both before and after preparation. 
Analysis of motility 
Sperm motility was assessed using Computer Aided Sperm Analysis (CASA) software on a 
Hamilton-Thorne IVOS Version 10.9i. The CASA equipment was operated using the 
standard setup parameters (37°C working temperature; cell depth 20 µm; frame rate 60 
Hz; average path velocity low cutoff 5 µm/s and high cutoff 25 µm/s) (Björndahl et al. 
2006). Each assessment of motility was an average of 10 fields of view per chamber with 
two chambers used per treatment to obtain a reliable evaluation of sperm motility. The 
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percentage of motile and progressive sperm was recorded. Statistical analysis (one-way 
analysis of variance (ANOVA)) was completed using SPSS 14.0.  
2.4.3 Human Cumulus Cell, Follicular Fluid and Granulosa cell preparation 
Patients undergoing either in vitro fertilisation (IVF) or intracytoplasmic sperm injection 
(ICSI) treatment were recruited and gave their informed consent at the Assisted 
Conception Unit (ACU), Birmingham Women’s Hospital (HFEA Centre 0119) in 
accordance with the Human Fertilization and Embryology Authority code of practice 
(Ethical approval number 2003/239). The patients had been treated hormonally to 
induce multiple follicle development prior to oocyte retrieval; briefly the female cycle 
was down regulated with Buserelin acentate, followed by long protocol stimulation with 
urinary follicle stimulating hormone (FSH). A transvaginal ultrasound-guided puncture 
was used to aspirate the follicles recovering the cumulus oocyte complexes (COC) and 
follicular fluid. In some cases a ‘flushing’ medium, containing Hartmann’s solution with 
heparin was used to aspirate the follicle. Samples of follicular fluid from individual 
follicles were separated and pooled depending on whether a “flushing” medium was 
used.  
Preparation of Cumulus cells 
The cumulus cells were removed from the COC by exposure to hyaluronidase, either 
before ICSI was performed or post-fertilisation of the oocyte in IVF. The cells collected 
were centrifuged at 600 x g for 10 min, the cell pellet was resuspended in Dulbecco’s 
modified Eagle’s medium F-12 (DMEM/F-12) supplemented with 10% (v/v) FBS, 1% (v/v) 
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NEAA and 100 IU/ml (each) Penicillin and Streptomycin and incubated at 37°C, 6% CO2. 
Cumulus cultures were kept for a maximum of 3 days. 
Preparation of Follicular Fluid 
Only recovered follicular fluid from follicles not “flushed” was used, to avoid “flushing” 
medium contamination. Follicular fluid was centrifuged at 3500 x g for 30 min to remove 
any cell debris. The supernatant was then aliquoted and frozen at -20°C until required.  
Preparation of Granulosa Cells 
Mural granulosa cells dislodged from the follicles by the aspiration process were 
collected from the follicular fluid by centrifugation. The cell pellet was layered over a 
90%/45% Percoll density gradient and centrifuged at 2000 x g for 20 min to allow 
separation of granulosa cells from red blood cells. The granulosa cells were collected 
and further centrifuged at 600 x g for 10 min to remove Percoll contamination. The cell 
pellet was resuspended in Dulbecco’s modified Eagle’s medium F-12 (DMEM/F-12) 
supplemented with 10% (v/v) FBS, 1% (v/v) NEAA and 100 IU/ml (each) Penicillin and 
Streptomycin and incubated at 37°C, 6% CO2, cells were in culture for a maximum of 3 
days. 
2.4.4 Immortalised Human Granulosa cell line (COV434) cell culture. 
An immortalised human granulosa cell line (COV434) (derived from a primary human 
granulosa cell tumour) was donated by Dr. P.I.Schrier of the Department of Oncology, 
University of Leiden, Netherlands (van den Berg-Bakker et al. 1993). The granulosa cells 
were cultured in Dulbecco’s modified Eagle’s medium F-12 (DMEM/F-12) supplemented 
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with 10% (v/v) FBS, 1% (v/v) NEAA and 100 IU/ml (each) Penicillin and Streptomycin and 
incubated at 37°C, 6% CO2 (Zhang et al. 2000). Culture media was replaced every 3-4 
days.  
Once the COV434 cells were confluent they were subcultured. Cell scrapers were used 
to dislodge the COV434 cells from the culture flask and cells were recovered in complete 
growth medium and centrifuged for 5 min at 500 x g. Cells were resuspended in culture 
medium at a typical subcultivation ratio of 1:3.  
For storage, frozen aliquots of COV434 cells in cryoprotectant medium (90% (v/v) FBS, 
10% (v/v) DMSO) were stored in liquid nitrogen. When required, frozen aliquots of 
COV434 cells were thawed in a 37°C water-bath and slowly mixed with complete growth 
medium in order to avoid osmotic shock. Cells were then centrifuged for 5 min at 500 x 
g, then seeded in an appropriate volume of culture medium.  
2.4.5 Investigation of the interaction between Spermatozoa and Cumulus cells 
After preparing semen by the modified swim-up technique (section 2.4.1) selected and 
capacitated spermatozoa were split into 300 µl aliquots and placed in round bottomed 
tubes. Layers of 300 µl 1% (w/v) methylcellulose 4000 in sEBSS + 0.3% (w/v) BSA 
containing suspensions of either native human cumulus cell, COV434 cells or cell-less 
controls were pipetted over the spermatozoa. The methylcellulose layer was then 
overlaid with 250 µl of sEBSS. + 0.3% (w/v) BSA, (figure 2.3). Tubes were inclined at a 45° 
angle and incubated for 1 h at 37°C, 6% CO2. Penetrating spermatozoa were collected 
and analysed. 
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Figure 2.3: Cartoon illustrating the spermatozoa and cumulus cell interaction swim-up 
experiment. 
 
Analysis of motility 
Sperm motility parameters (see table 2.1) were assessed using Computer Aided Sperm 
Analysis (CASA) software on a Hamilton-Thorne IVOS Version 10.9i. The CASA equipment 
was operated using the standard setup parameters (37°C working temperature; cell 
depth 20 µm; frame rate 60 Hz; average path velocity low cutoff 5 µm/s and high cutoff 
25 µm/s) (Björndahl et al. 2006). Each assessment of motility was an average of 10 fields 
of view per chamber with two chambers used per treatment to obtain a reliable 
evaluation of sperm motility.  
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Sperm motility parameters were normalised to sperm motility parameters from control 
experiments containing no cumulus cells (expressed as percentage change (Δ%)). 
Statistical analysis (student’s independent t-test) was completed using SPSS 14.0.  
Motility parameter Abbreviation Unit Definition 
Straight line velocity VSL µm/s The total straight line distance travelled, 
measured from the first to the last point 
of trajectory. 
 
Average path velocity VAP µm/s The distance travelled in the average 
direction of movement. 
  
Curvilinear velocity VCL µm/s The distance that the head of the sperm 
travels. 
 
Lateral head 
displacement 
ALH µm The width of the lateral movement of 
the head, calculated as the total width 
of the head trajectory 
 
Beat cross frequency BCF Hz The number of times the sperm head 
crosses the direction of movement, 
which is related to the development of 
another flagellar wave. 
 
Table 2.1: CASA motility parameters.  
(Mortimer. 2000b) 
 
2.4.6 Analysis of Steroidogenic enzyme gene expression. 
Total RNA was extracted from a number of donated cumulus cell samples using the 
Total RNA purification kit in accordance to the manufacturers’ protocol, once extracted 
RNA was stored at -80°C.  
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Reverse transcription was carried out with Sensiscript Reverse Transcriptase (RT) kit 
according to manufacturers’ protocol. Briefly reactions contained; 1 µM oligo-dT primer, 
1 X buffer, 0.5 mM (each) dNTPs , 10 U RNase inhibitor, 1 µl Sensiscript Reverse 
Transcriptase enzyme and 50 ng of RNA template. Reactions were incubated at 37°C for 
1 h, and then stored at -20°C. 
Primers were designed to screen for expression of steroidogenic enzymes, using the 
NCBI Primer-BLAST online tool. Primers used in PCR amplifications were obtained from 
Eurogentec, Southampton, UK. Oligonucleotide sequences are indicated in table 2.2.  
PCR reactions contained 1 U Taq DNA polymerase, 0.5 µM (each) appropriate reverse 
and forward primers, 0.5 mM (each) dNTPs, 2 mM MgCl2 and 2 µl of RT Sensiscript 
reaction. Each PCR reaction had a corresponding negative water control to ensure no 
contamination was present. Reactions were performed under the following conditions: 
95°C, 2 min; 35 cycles of 95°C, 30 s; 52°C, 30 s; 72°C, 1 min and one cycle of 72°C, 5 min.  
Primer Oligonucleotide sequence (5’-3’) 
GAPDH - Forward CAATGACCCCTTCATTGACC 
GAPDH - Reverse TTGATTTTGGAGGGATCTCG 
CYP19 - Forward TCACTGGCCTTTTTCTCTTGGT 
CYP19- Reverse GGGTCCAATTCCCATGCA 
CYP17 - Forward CATGCTGGACACACTGATGC 
CYP17 - Reverse GGGTTGTATCTCTAAATCTGTG 
3β HSD - Forward GTGTGCCAGTCTTCATCTAC 
3β HSD - Reverse CAGGGTTAAAGGAAGGCTCC 
HSD11B2 - Forward CTGGCTGCTTCAAGACAGAGT 
HSD11B2 - Reverse AGGCAGGTAGTAGTGGATGAA 
 
Table 2.2: Steriodogenic enzyme oligonucleotide sequences.  
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2.4.7 Agarose gel electrophoresis.  
Dependent on the expected size of the PCR product, agarose gels were prepared at 
various concentrations from 1% to 2.5% (w/v) agarose (table 2.3) in 1 X TAE buffer (0.04 
M tris-acetate, 0.001 M EDTA) supplemented with 0.5 µg/ml ethidium bromide. Five 
microlitres of an appropriate DNA ladder and 20 µl of PCR product were loaded. Gels 
were visualised using a UV-Transilluminator.  
Amount of agarose 
in gel (%) 
Range of separation of  
linear DNA (Kb) 
1.0 3 – 0.1 
2.0 6 – 0.4 
 
Table 2.3: DNA separation of different (w/v) percentages agarose gels.  
(Maniatis et al. 1982). 
 
2.4.8 Single Cell Imaging. 
After preparing semen by direct swim-up technique (section 2.4.1), capacitated 
spermatozoa at 6 million cells/ml were labelled with Calcium Green-1 AM, diluted in 
Pluronic F-127 *20% solution in DMSO, to a final concentration of 7.5 M and incubated 
for 45 min at 37°C, 6% CO2. After incubation approximately 100 µl of labelled 
spermatozoa were introduced into a purpose-built, perfusable, imaging chamber. 
Chambers were then incubated at 37°C, 6% CO2 for 5-10 min, to allow spermatozoa to 
become fully immobilised to the lower surface of the imaging chamber, a 0.01% (v/v) 
poly-D-lysine coated coverslip.  
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The chamber was placed on the stage of the imaging system (Cairn Imaging System – in 
brief comprising Nikon TE3000 with LED excitation controlled by Cairn Optomorph 
software) and perfused with sEBSS + 0.3% (w/v) of BSA for 5 min at the standard 
perfusion rate (0.4 ml/min) to remove all traces of extracellular dye. Cells were imaged 
using an x40 Plan Fl objective. Experiments were carried out at room temperature. 
Experiments consisted of an initial 5 min control perfusion of sEBSS + 0.3% (w/v) BSA 
followed by sequential repeats of exposure to follicular fluid for 50 s followed by either 
5 or 10 min control perfusion with sEBSS + 0.3% (w/v) BSA. Experiments were ended 
with a final exposure of 3.2 µM progesterone diluted in sEBSS supplemented with 0.3% 
(w/v) BSA. Images were captured at intervals of 2.5 s. Follicular fluid samples from a 
variety of patients were used at different concentrations (see table 2.4). 
Exposure 
number 
Donor number Dilution 
(v/v) 
Pregnancy 
outcome 
Procedure Reason for 
infertility 
1 119ECF04 10% Positive IVF Unexplained 
2 119ECF08 10% Negative IVF Age related factors  
3 119ECF25 10% Positive ICSI Male infertility 
4 119ECF21 10% Negative ICSI Endometriosis 
5 119ECF04 10% Positive IVF Unexplained 
6 119ECF04 50% Positive IVF Unexplained 
7 119ECF25 10% Positive ICSI Male infertility 
8 119ECF25 50% Positive ICSI Male infertility 
 
Table 2.4: Human follicular fluid samples used in imaging experiments. 
Human follicular fluid was diluted to the desired concentration in sEBSS + 0.3% (w/v) BSA. 
Donors were assigned an individual code, ensuring anonymity. Information regarding their 
clinical diagnosis and pregnancy outcome was taken from their clinical medical records.  
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2.4.9 Data processing and analysis. 
Data was processed offline using Image ProPlus 7.0 software. A region of interest was 
manually drawn around the head of each spermatozoon in the field of view. For each 
cell the average intensity within the head was obtained for every image in the series and 
plotted against time. Data from cells that moved significantly during the experiment 
were not included in analysis.  
Raw intensity values were imported into Microsoft Excel and normalised using the 
equation: 
R = [(F - F rest)/F rest] x 100% 
R is normalised fluorescence intensity, F is Fluorescence intensity at time t and F rest is 
the mean of at least 20 determinations of F taken during the control period. 
At each time point the normalised fluorescence intensity values (R) for each cell were 
compiled to generate average normalised head fluorescence (Rtot). The total series of 
Rtot were then plotted to give the mean normalised response of head fluorescent 
intensity for that experiment. 
To assess if cells were exhibiting a significant [Ca2+]i response to the follicular fluid and 
progesterone treatments Microsoft Excel was used to calculate the mean and 95% 
confidence interval of fluorescent intensity for 20 images during the control periods 
taken prior to individual treatments (C ± c) and 20 images during exposure to treatments 
(T ± t) (figure 2.4) . An increase in fluorescence was considered significant if, 
T - t > C + c 
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Where ‘T’ and ‘t’ are the mean and 95% confidence interval for the treatment periods 
and ‘C’ and ‘c’ the mean and 95% confidence interval for the control period. Cells were 
categorised as either a responder or non-responder. Data from each experiment was 
pooled to calculate the frequency of each response to the different treatments and 
expressed as mean ± SEM. SPSS 14.0 was used to analyse for statistical significance.  
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Figure 2.4: Assessment of sperm responses to treatments. 
To analyse spermatozoa for statistically significant [Ca2+]i responses upon exposure to human follicular fluid and progesterone, normalised 
fluorescence values (Δ Fluorescence (%)) during response periods (50 s) were compared to responses during control periods (50 s) prior to treatment 
exposure.  
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2.5 Results  
2.5.1 Modified swim-up method viability  
To assess the ability of the modified swim up to select motile and progressive spermatozoa 
in comparison to more established sperm preparation techniques: Percoll density 
centrifugation and aqueous direct swim-up, data was collected and CASA analysed from 16 
sperm donors. The percentage of motile and progressively motile sperm in raw semen 
samples was assessed using CASA (section 2.4.2). Samples were then split equally and 
prepared using the three sperm preparation methods (section 2.4.1) and again analysed by 
CASA to determine the percentage of motile and progressive spermatozoa present.  
All three preparation methods effectively selected motile and progressive sperm populations 
from raw semen, increasing the percentage of motile spermatozoa by 5-8% and progressive 
spermatozoa by 13-15% dependent on preparation method. No statistical difference in the 
percentage of motile and progressive spermatozoa was found between the three 
preparation methods (figure 2.5). 
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Figure 2.5: Mean (%) of motile and progressive spermatozoa recovered after different sperm preparation techniques.  
The motile and progressive percentages (%) of spermatozoa were recorded by CASA before and after spermatozoa preparation. Samples were equally 
split between the three preparation techniques. Bars represent the mean (%) ± SEM, n = 16.   
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2.5.2 Modulation of sperm motility by native cumulus  
To investigate whether cumulus cells play an active role in the modulation of sperm motility, 
the modified swim-up technique was utilised to facilitate an interaction between human 
spermatozoa with either: cumulus cells removed from pre-fertilisation COCs from patients 
undergoing ICSI treatment; cumulus cells removed from post-fertilisation COCs from 
patients undergoing IVF treatment; or an immortalised human granulosa cell line (COV434). 
Cumulus cells were suspended in a 1% methylcellulose layer which allowed spermatozoa to 
interact in a more physiological viscous environment (section 2.4.5). Motility parameters 
were analysed using CASA (section 2.4.2). 
The data presented by cell type (IVF cumulus; ICSI cumulus; COV434 cells) shows that after 
exposure to different cumulus cell types the straight line velocity (VSL), the straight line 
distance between the first and last points of spermatozoa trajectory, and the average path 
velocity (VAP), the distance the spermatozoa has travelled in the average direction of 
movement, both decrease, with no statistical difference between cell types (P>0.05) (figure 
2.6 a, 2.7 a). The curvilinear velocity (VCL), the total distance that the spermatozoa covers, 
the highest of the three sperm velocity values, increases, but again shows no statistical 
difference between cell type (P>0.05) (figure 2.8 a). The amplitude of lateral head 
displacement (ALH), the total width of the lateral movement of the spermatozoa head 
trajectory, increases, but no statistical difference could be identified between cell types 
(P>0.05) (figure 2.9 a). Finally beat cross frequency (BCF), the number of times the sperm 
head crosses the direction movement which is related to the formation of the flagellar wave, 
73 
 
decreases, but no statistical difference could be identified between cell types (P>0.05) 
(figure 2.10 a). 
Data was also separated according to the cumulus cell donors’ fertility treatment outcome. 
This identified some interesting trends. VSL values for spermatozoa exposed to cumulus 
from donors that had a pregnancy-positive outcome increased with a mean percentage 
change (Δ%) of 4.7 ± 6.5% as compared to cumulus with a pregnancy-negative outcome that 
decreased by 7.7 ± 3.3%. Statistical analysis identified no significant difference, however the 
P value was 0.086 (figure 2.6 b). As with the case of VSL, VAP showed a clear difference 
between spermatozoa exposed to cumulus from donors with either a pregnancy-positive or 
pregnancy-negative outcome. In the presence of pregnancy-positive cumulus cells 
spermatozoa VAP values increased by 10.1 ± 6.9%, whereas with pregnancy-negative 
cumulus VAP values decreased by 4.9 ± 3.5%. Again statistical analysis showed no significant 
difference, however the P value was 0.054 (figure 2.7 b). Spermatozoa that were exposed to 
pregnancy-positive and pregnancy-negative cumulus cells, are found to have increased levels 
of VCL, 22.3 ± 9.7%, 5.8 ± 6.7% (respectively). However the large standard error of the data 
made it hard to determine accurate trends, with no statistical significance being identified 
(P>0.05) (figure 2.8 b). Cumulus cells from both pregnancy-positive and pregnancy negative 
groups caused a similar increase in spermatozoa ALH values with and no differential effect 
between pregnancy-positive cumulus (68.1 ± 30.9%) and pregnancy-negative cumulus (63.9 
± 37.0%) (figure 2.9 b). Finally spermatozoa BCF decreased when exposed to cumulus cells 
from both patient groups. However spermatozoa exposed to pregnancy-positive cumulus 
had a much smaller decrease (4.2 ± 2.0%) as compared to that of BCF from spermatozoa 
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exposed to pregnancy-negative cumulus (13.9 ± 1.6%), which exhibits an almost statistically 
different significance (P = 0.06) (figure 2.10 b). 
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Figure 2.6: Mean percentage change (Δ%) of spermatozoa straight line velocity (VSL) after cumulus interaction. 
Bars represent the mean percentage change from prepared spermatozoa (Δ%) of VSL values after interaction with either native human cumulus or an 
immortalised granulosa (COV434) cell line suspended in 1% methylcellulose made with sEBSS + 0.3% (w/v) BSA. Samples were analysed using CASA 
and normalised to cell-free controls. Errors bars represent SEM. (a) Shows data separated by assisted reproductive technique (IVF or ICSI) in addition 
to COV434 cell line (b) Shows data separated by pregnancy outcome of cumulus cell donors. 
 IVF ICSI COV434   Positive Negative 
N number 4 11 8  N number 4 11 
Mean VSL (Δ%) ± SEM -3.4 ± 10.6 -4.8 ± 2.7 -5.8 ± 6.1  Mean VSL (Δ%) ± SEM 4.7 ± 6.5 -7.7 ± 3.3 
Table 2.5: Summary data for figure 2.6. 
75
 
76 
 
 
Figure 2.7: Mean percentage change (Δ%) of spermatozoa average path velocity (VAP) after cumulus interaction. 
Bars represent the mean percentage change from prepared spermatozoa (Δ%) of VAP values after interaction with either native human cumulus or an 
immortalised granulosa (COV434) cell line suspended in 1% methylcellulose made with sEBSS + 0.3% (w/v) BSA. Samples were analysed using CASA 
and normalised to cell-free controls. Errors bars represent SEM. (a) Shows data separated by assisted reproductive technique (IVF or ICSI) in addition 
to COV434 cell line (b) Shows data separated by pregnancy outcome of cumulus cell donors. 
 IVF ICSI COV434   Positive Negative 
N number 4 11 8  N number 4 11 
Mean VAP (Δ%) ± SEM -1.2 ± 10.1 -0.8 ± 3.5 -3.0 ± 6.2  Mean VAP (Δ%) ± SEM 10.1 ± 6.9 -4.9 ± 3.5 
Table 2.6: Summary data for figure 2.7. 
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Figure 2.8: Mean percentage change (Δ%) of spermatozoa curvilinear velocity (VCL) after cumulus interaction. 
Bars represent the mean percentage change from prepared spermatozoa (Δ%) of VCL values after interaction with either native human cumulus or an 
immortalised granulosa (COV434) cell line suspended in 1% methylcellulose made with sEBSS + 0.3% (w/v) BSA. Samples were analysed using CASA 
and normalised to cell-free controls. Errors bars represent SEM. (a) Shows data separated by assisted reproductive technique (IVF or ICSI) in addition 
to COV434 cell line (b) Shows data separated by pregnancy outcome of cumulus cell donors. 
 IVF ICSI COV434   Positive Negative 
N number 4 11 8  N number 4 11 
Mean VCL (Δ%) ± SEM 6.6 ± 9.5 11.5 ± 7.2 10.7 ± 8.8  Mean VCL (Δ%) ± SEM 22.3 ± 9.7 5.8 ± 6.7 
Table 2.7: Summary data for figure 2.8. 
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Figure 2.9: Mean percentage change (Δ%) of spermatozoa amplitude of lateral head displacement (ALH) after cumulus interaction. 
Bars represent the mean percentage change from prepared spermatozoa (Δ%) of ALH values after interaction with either native human cumulus or an 
immortalised granulosa (COV434) cell line suspended in 1% methylcellulose made with sEBSS + 0.3% (w/v) BSA. Samples were analysed using CASA 
and normalised to cell-free controls. Errors bars represent SEM. (a) Shows data separated by assisted reproductive technique (IVF or ICSI) in addition 
to COV434 cell line (b) Shows data separated by pregnancy outcome of cumulus cell donors. 
 IVF ICSI COV434   Positive Negative 
N number 4 11 8  N number 4 11 
Mean ALH (Δ%) ± SEM 42.0 ± 9.3 73.4 ± 37.6 53.8 ± 29.6  Mean ALH (Δ%) ± SEM 68.1 ± 30.9 63.9 ± 37.0 
Table 2.8: Summary data for figure 2.9. 
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Figure 2.10: Mean percentage change (Δ%) of spermatozoa beat cross frequency (BCF) after cumulus interaction. 
Bars represent the mean percentage change from prepared spermatozoa (Δ%) of BCF values after interaction with either native human cumulus or an 
immortalised granulosa (COV434) cell line suspended in 1% methylcellulose made with sEBSS + 0.3% (w/v) BSA. Samples were analysed using CASA 
and normalised to cell-free controls. Errors bars represent SEM. (a) Shows data separated by assisted reproductive technique (IVF or ICSI) in addition 
to COV434 cell line (b) Shows data separated by pregnancy outcome of cumulus cell donors. 
 IVF ICSI COV434   Positive Negative 
N number 4 11 8  N number 4 11 
Mean BCF (Δ%) ± SEM -10.6 ± 2.9 -11.6 ± 2.1 -4.3 ± 8.1  Mean BCF (Δ%) ± SEM -4.2 ± 2.0 -13.9 ± 1.6 
Table 2.9: Summary data for figure 2.10. 
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2.5.3 Expression of steroidogenic enzymes in cumulus cells 
Cumulus cells from ICSI and IVF patients (section 2.4.3) were analysed for expression of 
enzymes involved in steroidogenesis and to see if expression of the conversion enzyme 
HSD11β related to pregnancy outcome as previously reported (Michael et al. 1993). RT-PCR 
(section 2.4.6) identified expression of 3β-HSD and CYP19 in all samples, while CYP17 was 
not detected at all. HSD11β2 expression was found in all samples tested except patient: IVF 
#4, which was the only sample that came from a patient with positive pregnancy outcome 
(figure 2.11). 
Expression was also tested in the mural granulosa cells, dislodged from the follicle during the 
oocyte aspiration procedure (section 2.4.3). As with the cumulus cells, 3β-HSD and CYP19 
were expressed in all samples, however unlike cumulus cell samples there was a positive 
result for CYP17 expression. HSD11β2 was also present in all samples. All mural granulosa 
cell samples were recovered from patients with a negative pregnancy outcome (figure 2.11). 
.
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Figure 2.11: Expression of steroidogenic enzyme genes in human cumulus and granulosa 
cells. 
Cells donated by patients undergoing either IVF or ICSI treatment are indicated by individual 
anonymised sample numbers. Shown are PCR products separated by gel electrophoresis, 
performed on the following genes: Positive RT-PCR control GAPDH; 3β HSD; CYP17; CYP19 
and HSD11β2.  
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2.5.4 Sperm calcium response to human follicular fluid 
Single cell [Ca2+]i imaging was used to investigate if follicular fluid from patients undergoing 
ART could generate a Ca2+ response in spermatozoa.  
Immobilised spermatozoa were exposed by constant perfusion to sequential repeats of 
either 5-10 min control periods of sEBSS + 0.3% (w/v) BSA followed by 50 s exposure to 
follicular fluid samples. The follicular fluid samples used in these experiments were selected 
based on patients’ ART procedure and their treatment outcome. The two follicular fluid 
samples from patients with a pregnancy-positive outcome were exposed to spermatozoa at 
two differing dilutions (10% and 50% (v/v)). As a positive control spermatozoa were exposed 
to 3.2 µM progesterone (Kirkman-Brown et al. 2000). In total 206 cells over 3 replicate 
experiments were individually analysed for increases in [Ca2+]i.  
Spermatozoa had a significant increase in [Ca2+]i upon exposure to human follicular and 
progesterone This can be seen on an individual single cell level in single cellular normalised 
fluorescent intensity traces and pseudocolour images (figure 2.12, figure 2.13) as well as a 
universal population level by analysis of the mean normalised fluorescent intensity values 
(Rtot) of 206 spermatozoa cells over 3 individual replicate experiments (figure 2.14). 
The mean percentage of the sperm population responses to the different follicular fluid 
samples showed a high population response ranging from 88.5 ± 7.9% to 98.4 ± 1.7% (figure 
2.15), with no statistical difference identified between population responses to different 
follicular fluid samples. Progesterone however, initiated a mean population response of only 
85.3 ± 4.1% and when compared to the follicular fluid population responses to all three 
IVFPos applications it showed a statistically significant difference: IVFPos 10% (v/v) 1st 
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application (P = 0.039); IVFPos 10% (v/v) 2nd application (P = 0.042); IVFPos 50% (v/v) (P = 
0.039). A significant difference was also identified between the progesterone and ICSIPos 50% 
(v/v) (P = 0.039). The initial application of ICSIPos 10% (v/v) was almost significant with a P 
value of 0.058 (figure 2.15). 
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Figure 2.12: Single cell traces of human follicular fluid and progesterone induced [Ca2+]i responses in spermatozoa. 
Representative single cell traces of 8 cells from an individual experiment. Treatment bar gives a schematic representation of time periods when cells 
were exposed via constant perfusion to a sequential exposure of different preparations of human follicular fluid and 3.2 µM progesterone, all 
separated by control periods of sEBSS + 0.3% (w/v) BSA for either 5 or 10 min. 
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Figure 2.13: Series of representative pseudo-colour images of two spermatozoa undergoing a Ca2+ response to follicular fluid. 
High [Ca2+]i (indicated by warm colours) was observed when spermatozoa were exposed to human follicular fluid (IVF
Pos 10% (v/v)1st application) 
(labelled with Calcium Green-1AM). Numbers show time in seconds (s) after perfusion was initiated.  
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Figure 2.14: Mean response (Rtot) trace of Human follicular fluid and Progesterone induced [Ca
2+]i response in spermatozoa. 
Mean response (Rtot) trace of normalised Δ fluorescence (%) in 206 spermatozoa cells over 3 replicate experiments. Treatment bar gives a schematic 
representation of time periods when cells were exposed via constant perfusion to a sequential exposure of different preparations of human follicular 
fluid and 3.2 µM progesterone, all separated by control periods of sEBSS + 0.3% (w/v) BSA for either 5 or 10 min. Error bars represent ± SEM. 
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Figure 2.15: Mean percentage (%) of sperm population that elicit a significant [Ca2+]i response upon exposure to different follicular 
fluid preparations and 3.2 µM progesterone. 
Rtot values from 3 replicate experiments analysing 206 cells. Asterisk denotes statistical significant (P<0.05) when compared to 
a IVFPos 10% (v/v) 1st 
application; b IVFPos 10% (v/v) 2nd application; c IVF
Pos 50% (v/v), d ICSIPos 10% (v/v). Error bars represent ± SEM. 
 IVF
Pos 
10% 
(v/v) #1 
IVF
Neg 
10% (v/v) 
ICSI
Pos
 10% 
(v/v) #1 
ICSI
Neg
 
10% (v/v) 
IVF
Pos 
10% 
(v/v) #2 
IVF
Pos 
50% (v/v)  
ICSI
Pos
 10% 
(v/v) #2 
ICSI
Pos
 
50% (v/v)  
Progesterone
3.2 µM 
N number 3 3 3 3 3 3 3 3 3 
Number of cells 206 206 206 206 206 206 206 206 206 
Mean population 
response (%) ± SEM 
 
98.0 ± 1.1 
 
89.3 ± 8.3 
 
96.2 ± 0.8 
 
96.0 ± 3.3 
 
97.8 ± 1.1 
 
98.4 ± 1.7 
 
88.5 ± 7.9 
 
98.0 ± 1.1 
 
85.3 ± 4.1 
Table 2.10: Summary data for figure 2.15. 
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2.5.5 Peak kinetics of [Ca2+]i in response to human follicular fluid 
To identify significant variations in [Ca2+]i when spermatozoa were exposed to multiple 
human follicular fluid samples, the mean normalised fluorescent intensities (Rtot) of peaks 
initiated by follicular fluid samples from patients undergoing different assisted reproduction 
procedures and with different pregnancy outcomes were aligned by the initiation of the 
rising phase and compared. 
Initial exposure to follicular fluid from an IVFPos patient initiated a maximum peak of 20.1 ± 
2.3% which had a duration of approximately 140 s. The peak had a distinctive shoulder on 
the descent and the proceeding control perfusion saw responses stay above that of the 
initial fluorescent intensity baseline (figure 2.16). As this was different to subsequent peaks 
caused by other patient samples, it had to be established if the peak was patient specific. 
The same follicular fluid sample was perfused for a second time period; this peak was more 
like the subsequent peaks after the initial exposure (figure 2.17). The peak had a slightly 
decreased maximum height, 17.6 ± 1.0% with duration of approximately 90 s. Intensity 
values returned to pre-exposure values. The same sample was also applied to spermatozoa 
at a higher concentration (50% (v/v)) and initiated a higher maximum peak (32 ± 2.9%) 
compared to the 10% (v/v) dilutions. The duration of the peak was similar at approximately 
100 s and intensity values returned to pre-stimulation baseline levels (figure 2.16). However 
what was very notable was that the peak gained a very clear two phase appearance, with an 
initial rise to a much higher level, looking like a spike, then dropping after approximately 25 
s, after which the peak had similar kinetics of decay when compared to the other peaks. 
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Data was compared to establish if there were any differences in the peaks generated by 
samples from patients with positive or negative pregnancy outcomes. When peaks were 
aligned there was no significant difference noted between responses. All had similar 
maximum peak heights (IVFNeg 10% (v/v) : 20.1 ± 4.2%; ICSIPos 10% (v/v) 1st application: 19.4 ± 
1.4%; ICSINeg 10% (v/v): 19.3 ± 2.4%; IVFPos 10% (v/v) 2nd application: 20.4 ± 2.7%) and peak 
durations (IVFNeg 10% (v/v): 37 s; ICSIPos 10% (v/v) 1st application: 36 s; ICSINeg 10% (v/v): 40 s; 
IVFPos 10% (v/v) 2nd application: 37 s) and intensity levels returned to pre-stimulation 
baseline values (figure 2.17). 
In collaboration with Dr. Angela Taylor and Dr. Wiebke Arlt (University of Birmingham), we 
were able to quantify the concentration of progesterone from a number of human follicular 
fluid samples (table 2.11). This allowed direct comparison of responses generated by 
follicular fluid samples to those from 3.2 µM progesterone. Spermatozoa exposed to 
progesterone and follicular fluid had a similar peak duration (35 s), however the maximum 
peak height of follicular fluid samples containing 0.4 µM (IVFPos 10% (v/v) 1st application) and 
2.2 µM (IVFPos 50% (v/v)) was significantly larger when compared to that of 3.2 µM 
progesterone (max height 8.7 ± 2.0%). The progesterone-induced peak also exhibited a 
much shallower decent (figure 2.18). 
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Figure 2.16: Peak alignment of mean response (Rtot) trace of normalised Δ fluorescence (%) from spermatozoa exposed to multiple 
applications of human follicular fluid from an IVF patient with a positive pregnancy outcome. 
Peaks aligned are IVFPos 10% (v/v) 1st application,  IVFPos 10% (v/v) 2nd application and IVFPos 50% (v/v) and are aligned from time 0, the initiation of the 
peak. Cells were exposed to follicular fluid samples for 50 s, followed by either a 5 or 10 min control perfusion of sEBSS + 0.3% (w/v) BSA. Rtot were 
analysed from 206 cells over 3 replicate experiments. 
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Figure 2.17: Peak alignment of mean response (Rtot) trace of normalised Δ fluorescence (%) from spermatozoa exposed to human 
follicular fluid from IVF and ICSI patients with positive and negative pregnancy outcomes. 
Peaks aligned are IVFNeg 10% (v/v), ICSINeg 10% (v/v), ICSIPos 10% (v/v)1st application and IVFPos 10% (v/v) 2nd application. Peaks are aligned from the 
initiation of the peak (time 0). Cells were exposed to follicular fluid treatments for 50 s, followed by either a 5 min control perfusion of sEBSS + 0.3% 
(w/v) BSA. Rtot were analysed from 206 cells over 3 replicate experiments. 
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Donor number Dilution (v/v) Final progesterone concentration (µM) 
119ECF04 10% 0.4 
119ECF08 10% 1.7 
119ECF21 10% 1.7 
119ECF25 10% 1.4 
119ECF04 50% 2.2 
119ECF25 50% 6.9 
 
Table 2.11: Progesterone concentrations of human follicular fluid samples used in 
experiments.  
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Figure 2.18: Peak alignment of mean response (Rtot) trace of normalised Δ fluorescence (%) from spermatozoa exposed to human 
follicular fluid from IVFPos and a positive responsive control 3.2 µM Progesterone. 
Peaks aligned are IVFPos 50% (v/v), IVFPos 10% (v/v) 2nd application and Progesterone (3.2 µM). Peaks are aligned from the initiation of the peak (time 
0). Cells were exposed to follicular fluid treatments for 50 s, followed by either a 5 min control perfusion of sEBSS + 0.3% (w/v) BSA. Rtot were analysed 
from 206 cells over 3 replicate experiments. 
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2.6 Discussion 
When investigating the interactions between spermatozoa and cumulus cells it is important 
to select the ‘correct’ population containing the fertilising spermatozoon. As mentioned 
previously, traditional sperm preparations select based on either normal morphology 
(density centrifugation) or motility through an aqueous environment (direct swim-up); 
neither method represents the physiological barriers spermatozoa meet in vivo (Henkel and 
Schill. 2003). In vivo spermatozoa are selected by their ability to penetrate through the 
viscous barriers of the female reproductive tract: the cervix (Karni et al. 1971;Wolf et al. 
1977); oviductal fluid (Jansen. 1980) and the cumulus cell and hyaluronic acid matrix that 
surrounds the oocyte (Dandekar et al. 1992).  
Ivic et al demonstrated that the viscosity of 1% methylcellulose 4000 was comparable to that 
of human cervical mucus (Ivic et al. 2002) and our laboratory’s assessment of its viscosity 
was approximately 140 centipoise, a measurement of dynamic viscosity. Although the 
viscosity measurements of 1% methylcellulose 4000 is lower than the values of Wolf et al 
measurement of human cervical mucus (approximately 180-520 cp dependent on time in 
menstrual cycle) (Wolf et al. 1977), methylcellulose does provides a more accurate 
physiological selection than an aqueous medium. Data showed (figure 2.5) that the 
percentage of motile and progressive spermatozoa effectively selected from seminal plasma 
by the methylcellulose swim-up technique was comparable to the two traditional 
preparation techniques. Notably both the direct swim-up and modified swim-up sperm 
preparation methods, which select spermatozoa based on progressive motility, do not 
recover a population that is completely motile which could be due to recovery of the lower 
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layer of immotile spermatozoa. Seminal plasma must be removed effectively as it contains 
factors that inhibit the fertilisation ability of spermatozoa in addition to inhibiting 
capacitation (Rogers et al. 1983;Mortimer. 2000a).  
The modified methylcellulose method was used to assess the interaction between sperm 
and cumulus cells recovered from patients undergoing ART treatment (figure 2.3). Analyses 
indicated that there was no effect on sperm motility parameters regardless of whether 
spermatozoa were exposed to cumulus cells stripped from the oocytes of ICSI patients prior 
to fertilisation or post-fertilisation cumulus cells from IVF patients (figures 2.6-2.10 a). 
However there were different effects on the three sperm velocity values VSL, VAP and VCL in 
addition to BCF, when spermatozoa were exposed to pregnancy-positive and pregnancy-
negative cumulus cells (figures 2.6-2.10 b). This may imply altered cumulus cell-receptor 
expression or factor secretion in women who have a successful pregnancy outcome. One can 
only hypothesise about the physiological role of increases in sperm velocity caused by 
pregnancy-positive cumulus but it could facilitate COC or ZP penetration. 
Cumulus cells have previously been shown to elicit effects on motility parameters of 
spermatozoa, potentially initiating sperm hyperactivation. Increases in curvilinear velocity 
and amplitude of lateral head displacement and decreases in beat cross frequency of 
spermatozoa have been shown when exposed to both cumulus cell conditioned medium and 
cumulus cells. The effects were not as great in comparison to this study, even with a longer 
interaction time of 24 h, however whether this was related to their use of a different sperm 
preparation method (direct swim-up) not selecting the same spermatozoa population would 
require further investigation (Fetterolf et al. 1994). There is evidence however to suggest 
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that in vivo hyperactivation is induced much earlier in sperm migration through the female 
reproductive tract and before interaction with the COC (Cooper. 1979;Overstreet and 
Cooper. 1979;Suarez and Osman. 1987). However after decades of investigation since the 
first report the physiological triggers of hyperactivation are still not identified, reviewed in 
(Suarez. 2008).  
This study offers interesting results that warrant further investigation. Although CASA is 
useful for assessing sperm motility it is not without limitations. Curvature values can being 
skewed by spermatozoa sticking to the glass slides (Suarez. 2008) and if BCF is faster than 
the rate of image acquisition results can be underestimated (Mortimer and Swan. 1999). 
Chamber depth has also been known to affect the assessment of sperm motility (Le et al. 
1992), and future experiments could use 50 µm chambers which would provide a better 
assessment of spermatozoa with wide ALH and non-progressive trajectories (Kay and 
Robertson. 1998). As previously mentioned a viscous medium has been shown to alter 
flagellum bending (Smith et al. 2009) so further investigations should focus on high speed 
acquisition experiments, analysing sperm motility in a viscous medium.  
Mural granulosa cells dislodged during the aspiration process of oocyte collection exhibited 
expression of the cytochrome P450 enzyme, CYP17 unlike cumulus cells (figure 2.11). This 
enzyme is essential in the synthesis of dehydroepiandrosterone (DHEA) a precursor molecule 
of testosterone and oestradiol (figure 2.1). This correlates with a previous report, that 
although CYP17 expression is nil in cumulus and granulosa cells, it is highly expressed in the 
theca cells of the follicle suggesting that the aspiration process may have disrupted not only 
the mural granulosa cells, but also the underlying theca cells (Patel et al. 2010).  
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The expression profile of cumulus cells was negative for CYP17, limiting steroidogenic 
synthesis to the progesterone side of the pathway (figure 2.19). This is in line with studies 
that show that after ovulation cumulus cells continue to synthesise and secrete 
progesterone (Baltes et al. 1998). Lower activities of the conversion enzymes, HSD11β1 and 
2, which interconvert ‘active’ cortisol to ‘inert’ cortisone, have been associated with positive 
pregnancy outcomes for patients undergoing ART (Michael et al. 1995). Expression of 
steroidogenic enzymes in cumulus cells may be predictive of pregnancy outcome as an IVF 
patient, who had a positive pregnancy outcome, was missing expression of the isoform 
HSD11β2 (figure 2.19), whereas this enzyme was present in cumulus cell samples from 
pregnancy-negative patients. The expression profiles from cumulus cells seem to correlate 
with the findings of Michael et al (1995). Due to limited sample availability, further 
investigation involving larger sample sizes, quantification of genetic expression and activity 
of the additional isoform, HSD11β1, would be needed to identify a true relationship between 
steroidogenic enzyme expression patterns and pregnancy outcome and whether this could 
be useful in the process of choosing which embryos to transfer.  
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Figure 2.19: A schematic representation of steroidogenic pathway in human cumulus 
relating to possible pregnancy outcome. 
Preliminary findings of steroidogenic enzyme gene expression in cumulus cells from patients 
undergoing ART. Genes expressed in human cumulus cells are indicated by green text, genes not 
expressed are indicated by red text. Steroid synthesis in human cumulus cells seems to be limited to 
left hand branch of steroidogenic pathway. HSD11β2 was the only gene that showed differential 
expression between cumulus from donors who had either a positive or negative pregnancy outcome, 
Potential lower activity levels of HSD11β2 would lead to lower levels of cortisone to cortisol 
conversion, which has been implicated in increased pregnancy outcome (Michael et al. 1995).Genes 
indicated in black were not investigated in this study, but would be interesting to investigate for in 
future research. Diagram modified from (Holt & Hanley. 2007). 
 
In addition to the effect of cumulus cells on spermatozoa it has also been shown that human 
follicular fluid modulates sperm function (figure 2.14). [Ca2+]i signalling has been previously 
shown to be critical in sperm function (Jimenez-Gonzalez et al. 2006). The elevation of [Ca2+]i 
levels by follicular fluid, is perhaps unsurprising given that a component of follicular fluid is 
the well-known [Ca2+]i elevator, progesterone (Bar-Ami et al. 1994;Harper et al. 2004;). 
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The full steroid and proteomic profile of follicular fluid is still unclear, with a few studies 
using follicular fluid from ART patients, suggesting the progesterone concentration being 19 
– 32 µM (Tarlatzis et al. 1993;de Resende et al. 2010). However progesterone concentration 
measured from samples in this study ranged from 1 – 27.8 µM (Appendix I.viii).  
Exposure to all human follicular fluid samples elicited a similar [Ca2+]i response, regardless of 
the differing progesterone concentrations (figure 2.17) and initiated a greater response, with 
a lower concentration of progesterone, when compared to that of 3.2 µM progesterone 
control (figure 2.18). Progesterone was not the only steroid identified and quantified in this 
study. Steroids such as oestradiol, androstenedione and a selection of glucocorticoids were 
found (full list Appendix I.viii). It is plausible that spermatozoa may respond not only to 
progesterone but also to a number of other steroids or some other unidentified modulators 
found in follicular fluid. Recent data has demonstrated that the CatSper channels are at least 
one progesterone receptor on spermatozoa (Strunker et al. 2011) and these may be affected 
by an array of the other steroids in follicular fluid. 
Significantly different [Ca2+]i kinetics were observed when spermatozoa were exposed to 
50% (v/v) follicular fluid in comparison to 10% (v/v) dilutions, which is a novel finding. The 
differing, much sharper, kinetics of the initial spike may underlie physiological responses that 
we have not yet characterised. Only further experiments examining possible calcium channel 
or other specific antagonists of this response, flagellar movement and acrosome reaction will 
reveal what is occurring. It could be that this higher elevation is analogous to the ‘T-Channel’ 
spike seen when mouse spermatozoa are stimulated to acrosome react by ZP (Bhandari et 
al. 2010). 
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Currently it is not known how much follicular fluid spermatozoa are exposed to within the 
oviduct. Some data from porcine studies have suggested it might be as little as <0.01% of the 
initiation volume of the follicle (Hansen et al. 1991). Micromolar concentrations of 
progesterone have been shown to initiate a rapid [Ca2+]i elevation, with a proportion of the 
sperm population undergoing the acrosome reaction (AR) (Baldi et al. 1999). Spermatozoa 
have been known to present a different [Ca2+]i response when exposed gradually to 
progesterone gradient, which may be more representative of the exposure that 
spermatozoa experience in vivo. They exhibit a slower rise in [Ca2+]i with no apparent AR 
induction, but there is modulation of flagellar activity (Harper et al. 2004;Harper and 
Publicover 2005). In my experiments the exposure was as a follicular fluid bolus (comparable 
to single cell experiments in Kirkman-Brown et al. 2000 and those of Baldi et al. 1999 in cell 
populations). It may be that future presentation as a gradient would have differing effects. 
This may explain the differing [Ca2+]i  response at a 10% (v/v) dilution. It could be that the 
[Ca2+]i spike in the 50% (v/v) follicular fluid is due to very high abundance of a certain 
compound such as progesterone with a low-affinity receptor, or a trace of a very scarce, as 
yet unidentified, compound with a high-affinity receptor that is found at very low 
concentration in follicular fluid. Presenting sperm with fractionated human follicular fluid or 
preparing steroid solutions to create ‘synthetic’ follicular fluid may be useful to identify the 
important components of follicular fluid and the potential channels in involved [Ca2+]i. 
It is important to point out that the spermatozoa contributing to a successful pregnancy 
outcome were not the sperm population used for these studies, and to gauge a true 
reflection on pregnancy outcome the spermatozoa used for fertilisation must be used. 
However this provides practical challenges in itself. In addition it has to be considered that 
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pregnancy outcome may be affected by the single embryo transfer and blastocyst culture 
system employed and the patient diversity, ethnic background or other factors. However 
even so, this study has identified interesting avenues for further research which could lead 
to improved ART techniques. 
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CHAPTER 3 
In vitro oocyte development 
103 
 
3.1 Introduction 
The practical and ethical problems associated with collecting sufficient material to 
thoroughly investigate the interactions between human spermatozoa and oocytes, has 
forced scientists to rely heavily on animal models for human fertilisation. Researchers have 
primarily used murine models, however with the fundamental differences between the two 
species, especially within the protein composition of the zona matrix , there is an 
requirement for a new model to study human fertilisation (Lefievre et al. 2004).  
There have been a number of reports in the literature promoting the ability of embryonic 
stem (ES) cells (derived from the inner cell mass of the blastocyst prior to epiblast formation) 
to generate all cell lineages of the embryo in vitro and recent studies have shown embryonic 
stem cells are capable of differentiating into female and male germ cells (Hubner et al. 
2003;Toyooka et al. 2003;Clark et al. 2004a;Lacham-Kaplan et al. 2006;Qing et al. 2007;). If a 
human embryonic stem cell (hESC) line could be induced to produce oocytes this would 
clearly give a substantial, and genetically manipulatable, source of material for research. 
Studies in mouse embryonic stem cells (mESCs) demonstrated that oocyte-like structures 
could be produced from ES cells. Hubner et al., first reported the derivation of oocyte-like 
structures by enrichment of the germ cell population using the pluripotent and germline 
specific marker, Oct4 in a green fluorescent protein (GFP) reporter system. Progression of 
differentiation was assessed by analysis of germ cell-specific markers such as Scp3, Gdf3 and 
Vasa in addition to morphological evaluation (Hubner et al. 2003).  
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More recently, Lacham-Kaplan et al., directed differentiation of mESCs into ovarian 
structures containing oocytes that although lacking a zona pellucida, expressed the zona 
transcription factor, Fig-α and zona pellucida protein 3 (ZP3). Differentiation of mESCs was 
directed by culturing differentiating stem cell colonies, termed embryoid bodies, in testicular 
cell-conditioned medium. It was hypothesised that this could be as a result of large amount 
of growth factors within the media, such as bone morphogenetic protein 4 (BMP4) 
(Pellegrini et al. 2003;Lacham-Kaplan et al. 2006). 
A co-culture technique with murine ovarian granulosa cells used by Qing et al., induced the 
differentiation of mESCs into oocyte-like structures. After 14 days of culture, expression of 
germ cell markers: mouse vasa homologue (Mvh) and synaptonemal complex protein 3 
(SCP3) in addition to other female germ cell-specific genes, Fig-α and ZP genes, 1-3 were 
observed. It was suggested that the cellular interactions between developing EBs and 
granulosa cells help to propagate germ cell differentiation (Qing et al. 2007). 
Investigators have striven to replicate the results from mESCs in hESCs. Clark et al., detected 
spontaneously differentiated germ cells precursors from hESCs, with some cells in EBs 
identified as being positive for the expression of germ cell specific markers such as DAZL, 
VASA, SCP3 and GDF9 (Clark et al. 2004a). 
More recently human primordial germ cells (PGCs) were differentiated from hESCs by 
enriching the population using a VASA-GFP fluorescent reporter system, which was further 
enhanced by co-culture with BMPs (BMP4, BMP7 and BMP8b). Although only showing SCP3 
expression characteristic of later germ cell expression there was positive expression of DAZL, 
STELLAR, VASA and OCT4 characteristic of PGCs differentiation (Kee et al. 2009). 
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Male germ cells have also been produced from mESCs. Embryoid bodies were found to 
contain expression patterns of post-migratory primordial germ cells (PGCs) using an Mvh-
GFP reporter system. Expression was enhanced by EB co-culture with somatic cells secreting 
BMP4. The PGC population was enriched, and then co-cultured with gonadal cells before 
transplantation into host testis where they developed into morphologically normal 
spermatozoa (Toyooka et al. 2003). Male haploid PGCs were also spontaneously derived 
from mESCs by Geijsen et al. who noted that when these cells were isolated and injected 
into oocytes, blastocyst-like structures were formed (Geijsen et al. 2004). Only one study has 
reported the production of live offspring as a result of ICSI fertilisation with an in vitro 
developed male gamete (Nayernia et al. 2006). Sperm development was followed using 
Stra8-GFP and Prml-DsRed fluorescent reporter systems, utilising genes specific to 
spermatogenesis, and although offspring died only a few months after birth, it showed the 
potential of in vitro generated gametes (Nayernia et al. 2006). 
The work in this chapter investigates the development of a novel research model for human 
fertilisation, by directing hESC differentiation into the female germ cell lineage. Follicular 
fluid and an immortalised granulosa cell line were used to mimic the physiological 
environment of the ovarian follicle, with development being assessed by pluripotent ES cell 
and germ line specific markers. Successful generation of limitless human oocytes in vitro 
would overcome the shortage of human oocytes for research and therefore have potential 
to revolutionise the understanding of oocyte-spermatozoa interaction and fertilisation and 
provide a source of patient-specific oocytes for ART patients.  
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3.2 Aims 
 To develop a novel model system for in vitro oogenesis using hESC differentiation, by 
mimicking the follicular environment, using: 
o Human follicular fluid  
o An immortalised human granulosa cell line (COV434) 
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3.3 Materials  
3.3.1 Cells  
Product Name Company Product Number 
Human Foreskin Fibroblasts CCD-11125K  LCG Promochem, Middlesex, UK CRL-2429 
 
3.3.2 Cell Culture reagents 
Product Name Company Product Number 
0.25% (w/v) Trypsin-0.53mM EDTA Invitrogen, Paisley, UK. 25200-056 
Dimethyl sulfoxide (DMSO) Sigma, Dorset, UK. D4540 
Dulbecco’s Modified Eagle/F-12 Medium 
(DMEM/F-12) 
Invitrogen, Paisley, UK. 21041-033 
Fetal Bovine Serum (FBS) ES Cell Qualified Invitrogen, Paisley, UK 10439-024 
Gelatine Sigma, Dorset, UK. 271616 
Iscove’s Modified Dulbecco’s Medium (IMDM) Invitrogen, Paisley, UK 21980-032 
KnockOutTM Dulbecco’s Modified Eagle 
Medium 
Invitrogen, Paisley, UK 10829-018 
KnockOutTM Serum Replacement Invitrogen, Paisley, UK 10828-028 
L-Glutamine  Invitrogen, Paisley, UK 25030 
Non Essential Amino Acids (NEAA) Invitrogen, Paisley, UK 11140-035 
Phosphate buffered saline (PBS) Invitrogen, Paisley, UK 14040083 
Penicillin/Streptomycin Invitrogen, Paisley, UK. 15140-122 
Recombinant human FGF-basic Peprotech EC Ltd, London, UK 100-18B 
β- mercaptoethanol Invitrogen, Paisley, UK 21985-023 
 
3.3.3 Chemicals 
Product Name Company Product Number 
Agarose Bioline, London, UK.  41025 
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Product Name Company Product Number 
Deoxynucleoside triphosphates (dNTPs) Promega, Southampton, UK C1141 
Ethidium bromide Sigma, Dorset, UK.  160539 
Ethylenediaminetetraacetic acid disodium salt 
dehydrate (EDTA) 
Sigma, Dorset, UK E5134 
Glacial acetic acid Fisher Scientific, Loughborough, 
UK 
A/0400/PB17 
Tris(hydroxymethyl)aminomethane Sigma, Dorset, UK 25285-9 
 
3.3.4 Commercial Kits 
Product Name Company Product Number 
Sensiscript Reverse Transcriptase (RT) kit Qiagen, Crawley, UK. 205211 
Total RNA purification kit Norgen Bioteck Corp 17200 
 
3.3.5 DNA and Protein ladders 
Product Name Company Product Number 
25bp DNA Step Ladder Promega, Southampton, UK. G4511 
HyperLadder V Bioline, London, UK Bio-33031 
 
3.3.6 Dyes 
Product Name Company Product Number 
6X Blue/Orange loading dye Promega, Southampton, UK.  G1881 
 
 
3.3.7 Enzymes 
Product Name Company Product Number 
RNase Inhibitor  Bioline, London, UK. 65027 
Red Taq DNA Polymerase Bioline, London, UK 21038 
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3.4 Methods 
3.4.1 Human foreskin fibroblast (hff) cell culture 
A commercially available human foreskin fibroblast (hff) cell line was used as a cell feeder 
layer for hESCs. The cells were cultured in Iscove’s Modified Dulbecco’s medium (IMDM) 
supplemented with 10% (v/v) ES cell qualified FBS and 100 IU/ml (each) 
Penicillin/Streptomycin and incubated at 37°C, 6% CO2. Culture medium was changed every 
3-4 days.  
Once hff cells were fully 100% confluent, cells were subcultured. Cells were trypsinised with 
0.25% (w/v) trypsin-0.53mM EDTA and incubated at 37°C for approximately 5 min until cell 
detachment occurred. Cells were recovered in complete growth media and centrifuged for 5 
min at 500 x g. Cells were resuspended in an appropriate volume of growth medium at a 
typical subcultivation ratio 1:3. Cells were either used for further hff culture or treated with 
irradiation (35 Gy) before being used as substrate cells for hESCs.  
For long-term storage, frozen aliquots of hffs in cryoprotectant medium (IMDM, 10% (v/v) ES 
cell qualified FBS, 100 IU/ml (each) Penicillin/Streptomycin and 5% (v/v) DMSO) were stored 
in liquid nitrogen. If necessary frozen aliquots of hff cells were thawed in a 37°C water-bath 
and slowly rehydrated with complete growth medium in order to avoid osmotic shock. Cells 
were then centrifuged for 5 min at 500 x g, and then seeded in an appropriate volume of 
culture medium.  
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3.4.2 Human embryonic stem cell (hESC) culture 
A hESC cell line (HS181),derived by Hovatta et al., (Hovatta et al. 2003) was gifted by Dr Outi 
Hovatta, Karolinska Institute, Sweden. Irradiated hff cells were seeded onto a 1% (w/v) 
gelatine coated 6-well dish, in 2 ml of hff culture medium (section 3.4.1), cells were left to 
adhere for approximately 24 h before hESC addition. 
Embryonic stem cell colony morphology was assessed microscopically on a daily basis, when 
colonies were deemed large enough and morphologically ‘normal’, cells were sub-cultivated. 
Plated fibroblast cells were washed with culture sterile PBS to remove traces of hff media 
before the addition of hESC. Colonies were sub-cultivated via mechanical micro-dissection 
with a 19 gauge needle and colony fragments were transferred to freshly prepared feeder 
cells.  
Cells were cultured in Knockout DMEM supplemented with 20% (v/v) serum replacement, 2 
mM L-glutamine, 1% (v/v) non-essential amino acid (NEAA), 100 IU/ml (each) 
Penicillin/Streptomycin, 0.1 mM β-mercaptoethanol, 4 ng/ml bFGF at 37°C, 6% CO2. Media 
was exchanged every 24 h.  
When required for storage hESC colonies could be frozen in aliquots of cryoprotectant 
medium (20% (v/v) DMSO diluted in complete hESC growth medium) at a 1:1 ratio with 
complete hESC growth medium, and stored in liquid nitrogen. If necessary frozen hESC 
colonies could be thawed in a 37°C water-bath bath and slowly rehydrated with complete 
growth medium in order to avoid osmotic shock. Cells were then centrifuged for 5 min at 
500 x g, and then seeded in an appropriate volume of culture medium.  
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3.4.3 Immortalised Human Granulosa cell line (COV434) cell culture 
See section 2.4.4  
3.4.4 Human follicular fluid preparation 
See section 2.4.3. Prior to use in EB culture, three samples of human follicular fluid were 
pooled (table 3.1) and mixed before being added to cell culture medium.  
Donor number Pregnancy outcome Procedure 
119ECF11 Positive IVF 
119ECF22 Negative ICSI 
119ECF25 Positive ICSI 
 
Table 3.1: Human follicular fluid samples, pooled for EB cell culture. 
 
3.4.5 Embryoid body (EB) formation  
Hanging drop method 
Stem cell colonies that were visually deemed morphologically ‘normal’ were microdissected 
with a 19 gauge needle, and colony fragments were resuspended in 50 µl drops of EB 
medium (Knockout DMEM supplemented with 20% (v/v) serum replacement, 2 mM L-
glutamine, 1% (v/v) non-essential amino acid (NEAA), 100 IU/ml (each) 
Penicillin/Streptomycin and 0.1 mM β-mercaptoethanol). EB medium was ‘conditioned’ by 
incubation with 100% confluent hff cells at 37°C, 6% CO2, for 24 h prior to use in EB culture. 
Drops containing hESC colonies were inverted on a Petri dish lid and cultured at 37°C, 6% 
CO2 (figure 3.1 a). 
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Suspension method 
EBs were also cultured in suspension. Morphologically ‘normal’ stem cell fragments were 
transferred to non-treated tissue culture dishes and resuspended in EB medium. For some 
experiments EB medium was supplemented with 10% (v/v) human follicular fluid, pooled 
from three donors (table 3.1). EBs were cultured at 37°C, 6% CO2 for as long as desired until 
harvesting. Culture media was exchanged every 2-3 days (figure 3.1 b). 
Immortalised Human Granulosa cell line (COV434) co-culture method 
EBs were also co-cultured with COV434 cells. Morphologically ‘normal’ stem cell fragments 
were transferred to individual wells of a V bottomed 96 well plates with COV434 cells. Cells 
were cultured with EB medium incubated at 37°C, 6% CO2 for as long as desired until 
harvesting. Culture media was exchanged every 24 h (figure 3.1.c). 
 
Figure 3.1: Methods for embryoid body formation. 
Morphologically “normal” hESC colonies were mechanically dissected and transferred and cultured 
using one of the following EB culturing methods. (a) Hanging drop, (b) Suspension or (c) Co-culture 
with an immortalised granulosa cell line, COV434.  
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3.4.6 Embryonic stem cell and oocyte gene expression 
Total RNA was extracted from hESC, COV434 and EB samples using the Total RNA 
purification kit in accordance with manufacturers’ protocol, once extracted RNA was stored 
at -80°C.  
Reverse transcription was carried out with Sensiscript Reverse Transcriptase (RT) kit 
according to manufacturers’ protocol. Briefly reactions contained; 1 µM Oligo-dT primer, 1 X 
Buffer, 0.5 mM (each) dNTPs , 10 U RNAase inhibitor, 1 µl Sensiscript Reverse Transcriptase 
enzyme and 50 ng of RNA template. Reactions were incubated at 37°C for 1 h, and then 
stored at -20°C until PCR reaction. 
Primers were designed to screen for pluripotent hESC and germ cell specific genes at various 
stages of development. Primers used in PCR amplifications were obtained from Eurogentec, 
Southampton, UK. Oligonucleotide sequences with expected product size are indicated in 
table 3.2. 
PCR reactions contained 1 U Taq DNA polymerase, 0.5 µM (each) appropriate reverse and 
forward primers, 1 X Buffer, 0.5 mM (each) dNTPs, 2 mM MgCl2 and 2 µl of RT Sensiscript 
reaction. Each PCR reaction had a corresponding negative water control to ensure no 
contamination. Reactions were performed under the following conditions: 95°C, 2 min; 35 
cycles of 95°C, 30 s; 51°C, 30 s; 72°C, 45 s and one cycle of 72°C, 5 min. PCR products were 
then run on a 2% (w/v) agarose gel (section 2.4.7). 
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Primer Oligonucleotide sequence(5’-3’) PCR amplicon size (bp) 
GAPDH - Forward CAATGACCCCTTCATTGACC 159 
GAPDH - Reverse TTGATTTTGGAGGGATCTCG 
OCT4 – Forwarda
 
ACATCAAAGCTCTGCAGAAAGAAC 127 
OCT4 – Reversea
 
CTGAATACCTTCCCAAATAGAACC 
OCT4 – Forwardb
 
CTCACCCTGGGGGTTCTATT 234 
OCT4 – Reverseb
 
CTCCAGGTTGCCTCTCACTC 
STELLAR – Forwarda
 
GTTACTGGGCGGAGTTCGTA 168 
STELLAR – Reversea
 
TGAAGTGGCTTGGTGTCTTG 
STELLAR – Forwardb
 
CTCTCAAATCTCCTCCGAGACG 240 
STELLAR – Reverseb
 
GTACGAACTCCGCCCAGTAA 
C-KIT - Forward CCACACCCTGTTCACTCCTT 206 
C-KIT - Reverse TTCTGGGAAACTCCCATTTG 
BOULE - Forward TATAAGGATAAGAAGCTGAACATTGGT 171 
BOULE - Reverse CGAAGTTACCTCTGGAGTATGAAAATA 
VASA - Forward AGAAAGTAGTGATACTCAAGGACCAA 189 
VASA - Reverse TGACAGAGATTAGCTTCTTCAAAAGT 
DAZL - Forward ATGTTAGGATGGATGAAACTGAGATTA 172 
DAZL -  Reverse CCATGGAAATTTATCTGTGATTCTACT 
SCP3 - Forward AAATCTGGGAAGCCGTCTGT 150 
SCP3 - Reverse TGCAGAAGACCTTTTCTTCCT 
GDF3 - Forward AGACTTATGCTACGTAAAGGAGCT 149 
GDF3 - Reverse CTTTGATGGCAGACAGGTTAAAGTA 
FIGLA - Forward AATCTCAACCGTGGTTTTGC 212 
FIGLA - Reverse CTTGCCGAGGATGTATGTGA 
 
Table 3.2: hESC and germ cell specific gene oligonucleotide sequences and expected 
product size. 
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3.5 Results 
3.5.1 Embryoid body formation 
Initially EBs were cultured using the hanging drop method (see section 3.4.5, figure 3.1 a). 
This method is commonly used to form EBs from single ES cells, sub-cultured via 
trypsinisation. However trypsinisation was not a suitable subculture method for the HS181 
hESC line. Through both anecdotal advice and experimentation, I found that trypsinsation 
had a negative impact on the sub-cultivation process, so manual micro-dissection of hESCs 
was employed. This inability to split the hESCs into single cells unfortunately meant that the 
hanging drop method was inappropriate as colonies were too heavy to be supported for 
prolonged periods of time within the hanging drop, frequent and full media exchange was 
also difficult.  
The suspension method (see section 3.4.5, figure 3.1.b) was deemed a more appropriate EB 
culture method due to the cell line constraints described above. Media exchange was more 
convenient, and multiple EBs could be cultured within the same culture vessel. A 
disadvantage of the suspension method is that structural uniformity of the EBs was difficult 
to control and appeared random, irrespective of growth culture medium (figure 3.2). 
Another issue associated with growing EBs via the suspension method was EB adhesion to 
the culture vessel (figure 3.3). Multiple culture dishes were tested, but cellular adhesion 
even occurred with non-treated culture plastics. Daily agitation was required to minimise EB 
adhesion.  
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Figure 3.2: Suspension culture embryoid body formation. 
Bright field images of differentiating EB cultures via suspension method. Uniformity of EBs could not 
be guaranteed regardless of culture conditions. (a) and (b) were cultured in complete EB growth 
medium for 38 days. (c) and (d) were cultured in EB growth medium supplemented with 10% (v/v) 
follicular fluid for 55 days. Both conditions showed ideal spherical development as well as irregular 
EB formation. Scale bars = approximately 100 µm. 
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Figure 3.3: Embryoid body culture vessel adhesion. 
Bright field image of a differentiating EB, cultured via the suspension method. EB was cultured in EB 
medium and image was taken at 10 days of culture. Image demonstrated the problematic issue of EB 
adhesion to the culture vessel, even in non-treated cell culture plastics. Scale bar = approximately 
100 µm. 
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3.5.2 Embryoid body spontaneous differentiation 
To assess the developmental progression of differentiated EBs, a profile of various key 
markers, previously used by Clark et al., (2004a) was employed in this study. These markers 
were either germ cell-specific or highly expressed in the germ cell lineage and allowed 
differentiating EBs to be assessed from pluripotent hESC to differentiated oocyte (figure 3.4). 
Initial investigations confirmed the presence of pluripotent genes within our starting hESC 
population. In addition to the positive expression of RT-PCR positive control, GAPDH, the 
undifferentiated hESC line, HS181 (passage 66), showed positive expression of pluripotent 
genes OCT4, STELLAR and GDF3. There was also positive expression for DAZL a gene 
encoding for proteins containing RNA binding motifs, which are thought to be important for 
PGC formation (Kee et al. 2009) (figure 3.5). 
To investigate the possible spontaneous germ cell differentiation in hESCs, hESC colonies 
were cultured in suspension (section 3.4.5). Culture duration varied between different 
experiments (from 0 to 100 days). EBs were closely observed for any morphological changes 
relating to the development of oocyte-like structures. Some populations perished with EBs 
shrinking in volume and starting to fragment. Other populations contained both regular and 
irregular shaped EBs. However no observation indicated the development of oocyte-like 
structures.  
After analysis with RT-PCR spontaneously differentiated EBs retained expression of GAPDH, 
OCT4 and STELLAR, no other germ cell marker was identified (figure 3.6).  
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Figure 3.4: Gene expression in oocyte differentiation. 
Expected expression patterns of chosen germ cell genes at different stages of fetal and adult 
development. All genes are enriched in germ cells relative to somatic cells however germ cell-specific 
expression is highlighted in red. OCT4, STELLAR and GDF3 are known to be expressed in pluripotent 
embryonic stem cells. Genes expressed in PGC include DAZL, C-KIT. Genes expressed in gonocyte 
formation include VASA. Genes expressed during meiosis include SCP3 and BOULE. Adult germ cell 
specific markers include FIGLA. Modified from Clark et al. 2004a.  
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Figure 3.5: Stem and germ cell marker expression in human embryonic stem cells. 
Reverse transcription-polymerase chain reaction for the identification of pluripotent stem cell and 
germ cell specific genetic markers in human embryonic stem cells (HS181 hESC line, passage 66). 
White arrow denotes positive expression. Shown are PCR products separated by gel electrophoresis 
performed on the following genes: GAPDH; OCT4a; STELLARa; C-KIT; BOULE; VASA; DAZL; SCP3; GDF3 
and FIGLA.a denotes primer sequence used (see table 3.2).  
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Figure 4.6: Stem and germ cell marker expression in spontaneous embryoid body 
differentiation. 
Representative reverse transcription-polymerase chain reaction for the identification of pluripotent 
stem cell and germ cell specific genetic markers that spontaneously differentiate in EB population 
(cultured for 39 days). White arrow denotes positive expression. Shown are PCR products separated 
by gel electrophoresis performed on the following genes: GAPDH; OCT4b; STELLARb; C-KIT; BOULE; 
VASA; DAZL; SCP3; GDF3 and FIGLA. b denotes primer sequence used (see table 3.2). 
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3.5.3 Embryoid body culture with human follicular fluid 
In order to direct differentiation of EBs into the germ cell lineage, EBs cultured in suspension 
had their complete growth medium supplemented with human follicular fluid in order to 
expose EBs to potential differentiating promoting growth factors (section 3.4.4 and section 
3.4.5).  
EBs cultured with human follicular fluid exhibited positive expression for GAPDH, OCT4 and 
STELLAR, with no other germ cell-specific genes identified (figure 3.7). 
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Figure 3.7: Stem and germ cell marker expression in embryoid bodies cultured with human 
follicular fluid. 
Reverse transcription-polymerase chain reaction for the identification of pluripotent stem cell and 
germ cell specific genetic markers in embryoid bodies cultured with human follicular fluid (cultured 
for 35 days). White arrow denotes positive expression. Shown are PCR products separated by gel 
electrophoresis performed on the following genes: GAPDH; OCT4a; STELLARa; C-KIT; BOULE; VASA; 
DAZL; SCP3; GDF3 and FIGLA. a denotes primer sequence used (see table 3.2). 
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3.5.4 Embryoid body co-culture with an immortalised granulosa cell line (COV434) 
To further encourage germ cell differentiation, EBs were co-cultured with an immortalised 
human granulosa cell line (COV434) whose cellular characteristics may be useful in directing 
germ cell development (Zhang et al. 2000). As culturing EBs via the suspension method was 
ineffective in order to promote direct cellular contact and aggregation, a different culture 
method had to be used. Effective EB-COV434 co-culture was achieved by using V-bottomed 
96 well dishes (section 3.4.5, figure 3.1 c). 
The EBs that were co-cultured with COV434 cells showed positive expression for the 
previously seen bands GAPDH, OCT4 and STELLAR with no other germ cell markers identified 
(figure 3.8). There were however difficulties separating the EBs from the COV434 cells after 
co-culturing making the risk of cellular contamination difficult to rule out. So it seemed 
prudent to establish the germ cell marker expression profile of the COV434 cells themselves. 
Surprisingly the COV434 cells expressed the same pattern of expression of the EBs they were 
co-cultured with, having positive expression of GAPDH, OCT4 and STELLAR (figure 3.9). 
To establish if this pattern of expression was exclusive to the COV434 cell line, and not a true 
representation of native cumulus cells, the expression of germ cell markers in native human 
cumulus was examined. Cumulus cells stripped from an unfertilised oocyte (ICSI patient, 
donor number 119ECF08) showed the same pattern of expression with positive bands for 
GAPDH, OCT4 and STELLAR, when compared to the immortalised granulosa cell line (figure 
3.10). 
 
125 
 
 
Figure 3.8: Stem and germ cell marker expression in embryoid bodies co-cultured with 
COV434 cells. 
Reverse transcription-polymerase chain reaction for the identification of pluripotent stem cell and 
germ cell specific genetic markers in embryoid bodies co-cultured with an immortalised granulosa 
cell line, COV434 (cultured for 40 days, COV434 passage 19). White arrow denotes positive 
expression. Shown are PCR products separated by gel electrophoresis performed on the following 
genes: GAPDH; OCT4a; STELLARa; C-KIT; BOULE; VASA; DAZL; SCP3; GDF3 and FIGLA. a denotes primer 
sequence used (see table 3.2). 
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Figure 3.9: Stem and germ cell marker expression by COV434 cells. 
Reverse transcription-polymerase chain reaction for the identification of pluripotent stem cell and 
germ cell specific markers in an immortalised granulosa cell line, COV434 (passage 19). White arrow 
denotes positive expression. Shown are PCR products separated by gel electrophoresis performed on 
the following genes: GAPDH; OCT4a; STELLARa; C-KIT; BOULE; VASA; DAZL; SCP3; GDF3 and FIGLA. a 
denotes primer sequence used (see table 3.2). 
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Figure 3.10: Stem and germ cell marker expression by native human cumulus. 
Reverse transcription-polymerase chain reaction for the identification of pluripotent stem cell and 
germ cell specific markers in native human cumulus (ICSI recovered cumulus, donor number 
119ECF08). White arrow denotes positive expression. Shown are PCR products separated by gel 
electrophoresis performed on the following genes: GAPDH; OCT4a; STELLARa; C-KIT; BOULE; VASA; 
DAZL; SCP3; GDF3 and FIGLA. a denotes primer sequence used (see table 3.2). 
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3.6 Discussion 
Over the last decade ES cells have become an extremely valuable model in many research 
fields such as neurology and cardiology (Wobus et al. 2002;Kato et al. 2004). The prospects 
of creating an in vitro model producing human oocytes for research would lead to a much 
greater understanding of gametogenesis and the possible development of novel treatments 
for infertility.  
Initial examination of the genetic expression in the HS181 hESC line showed positive 
expression of a gene which is restricted to pluripotent ES and germ cell lines (Scholer et al. 
1990;Pesce et al. 1998) OCT4, in addition to pluripotency genes GDF3 and STELLAR. All genes 
have been previously reported to be expressed in hESCs (Thomson et al. 1998;Clark et al. 
2004b). Clark et al., (2004a) also reported the expression of a germ cell-specific gene DAZL in 
hESC populations, expression of which was also present in HS181 hESCs. However presence 
of CKIT, a marker of pre-meiotic germ cells which had been identified in hESC populations in 
the Clark et al., (2004a) paper was found to be absent in HS181 hESC line. To our knowledge 
there have been no reports of testing for CKIT expression in the HS181 hESC line, however 
genetic expression has been shown to vary greatly between hESC populations which may 
account for the absence of CKIT from our hESC population (Stahlberg et al. 2009) (figure 3.5).  
Clark et al., (2004) identified that the pre-meiotic germ cell gene, DAZL was not expressed in 
the inner cell mass (ICM) of the human embryo, from which hESCs are derived. The process 
of removing the ICM from the outer trophectoderm may result in vitro cultures exhibiting a 
change in genetic expression. DAZL expression in hESCs may be a result of unregulated gene 
expression, spontaneous germ cell differentiation, or it may be due to germ cells being the 
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closest in vivo equivalent to hESCs, explaining why they have similar genetic expression 
patterns, reviewed (Zwaka and Thomson. 2005). 
Germ cell differentiation appears to occur faster in EB culture systems, however EB 
formation in this study was fraught with a number of difficulties. The HS181 hESC line has 
been shown sensitive to different subculture methods, inducing karyotypic instability 
(Catalina et al. 2008). The inability to subculture the HS181 hESC line into single cells, 
created a lack of control over the number of cells seeded to form each EB, which has been 
showed to affect differentiation pathways (Park et al. 2007;Bauwens et al. 2008;Messana et 
al. 2008). The lack of single cell subculture also had an impact on the uniformity of the EBs 
(figure 3.2). The subculture method unfortunately ruled out the use of the hanging drop 
method which is commonly used for EB formation and is useful in controlling EB size (Keller. 
1995;Yamada et al. 2002). This lead to a requirement to use the suspension method for EB 
formation, which is known to give a wide array of EB sizes (Dang et al. 2002). The lack of 
uniformity of EBs was further exacerbated by the additional problem of EB adhesion to 
culture vessels (figure 3.3), however future studies could both address both the problems 
with uniformity and cellular adhesion by using a rotation suspension method (Cameron et al. 
2006). 
Regardless whether EBs were left to spontaneously differentiate or directed differentiation 
was attempted through culture with human follicular fluid and/or immortalised granulosa 
cell line (COV434), neither oocyte-specific morphological changes nor later germ cell genetic 
markers were identified in EBs (figures 3.6, 3.7 and 3.8). All cultures appeared to retain the 
expression of the pluripotency markers OCT4 and STELLAR, that were observed in hESCs 
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cultures. However they did lose expression of GDF3 and DAZL. The expression of OCT4 and 
STELLAR in human EBs has been shown to fall after three days of culture (Clark et al. 2004a) 
and no other reports of long term OCT4 and STELLAR retention was found, this makes the 
expression in EB cell cultures difficult to explain. However as only RT-PCR was used it would 
be useful to repeat experiments using real-time PCR which would allow quantification of 
OCT4 and STELLAR expression in such cultures. This observation may be HS181 hESC cell line-
specific, however it could be due to the EB culture medium being hff ‘conditioned’ prior to 
EB culture. ‘Conditioning’ the medium supported EB growth, however factors secreted by 
the hff cells into the growth medium could have potentially supported the continued 
expression of the pluripotency genes OCT4 and STELLAR. The use of a different hESC cell line 
in future experiments may help answer this question. 
Surprisingly OCT4 and STELLAR were also found to be expressed by COV434 cells themselves 
(figure 3.9). There are however studies identifying OCT4 and STELLAR expression in breast 
cell carcinomas and colon cancer cells and it has been hypothesised that OCT4 and STELLAR 
may play a large role in cancer cell self-renewal. (Ezeh et al. 2005;Chen et al. 2011;Kim and 
Nam. 2011). COV434 cells are an immortalised human granulosa cell line derived from a 
primary human granulosa cell tumour (van den Berg-Bakker et al. 1993), so this may explain 
the expression of OCT4 and STELLAR. This result however calls into question the expression 
profile of EBs co-cultured with COV434 cells, as it is not possible to exclude COV434 cellular 
contamination (figure 3.8).  
To compare the expression profile of COV434 cells to that of native human cumulus, the 
expression profile of donated cumulus cells from a patient undergoing ICSI fertility 
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treatment was examined. Surprisingly they exhibited the exact profile of that of COV434 
cells (figure 3.10). This could imply that OCT4 and STELLAR are important to the developing 
oocyte. To further investigate more cumulus samples would need to be investigated, in 
conjunction with real-time PCR in order to quantify expression levels.  
It also has to be noted that positive controls for germ cell-specific genes were not available. 
Most of the primer sequences were taken from published studies and annealing 
temperatures were set deliberately low to ensure no positive expression was missed. This 
explains why there is a certain level of unspecific binding.  
Although early PGC markers have been shown in both male and female karyotypes in hESCs, 
there have been differences in the level of expression (Clark et al. 2004a; Kee et al. 2009). 
The female karyotype (XX) of the HS181 hESC cell line could have a negative effect on germ 
cell differentiation, due to the instability of the X chromosomes (Zvetkova et al. 2005) and 
the complex requirements for X chromosomes inactivation and reactivation in developing XX 
germ cells (Chuva de Sousa Lopes et al. 2008). In mice, many studies showing female germ 
cell differentiation are from mESCs with an XY karyotype (Hubner et al. 2003;Lacham-Kaplan 
et al. 2006;Qing et al. 2007). Female development is known to be the default gamete 
developmental pathway, regardless of karyotype, in the absence of certain factors. Although 
oocyte-like structures have been shown to differentiate from XY ES karyotypes, to achieve 
the ultimate goal of an in vitro developed oocyte which can fertilise and producing live 
offspring, one needs differentiation of XX ES cells, which would be able to support the post 
fertilisation development (Amleh and Taketo. 1998;Villemure et al. 2007).  
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Due to the heterogeneous nature of hESC population it may not be possible to direct the 
differentiation of the population in its entirety. Many successful studies have enriched their 
hESC populations with germ cell specific markers, such as OCT4 and VASA reporter systems, 
prior to EB formation (Hubner et al. 2003;Toyooka et al. 2003;Kee et al. 2009). In vivo both 
follicular fluid and cumulus cells are vital in the later stages of development of the oocyte. It 
would be interesting to see if an enriched hESCs population would be more receptive to 
culture with human follicular fluid and COV434 cells. As the full proteomics profile of human 
follicular fluid and cumulus cells is unknown it is hard to hypothesise which factors might be 
beneficial in germ cell hESC differentiation. As mentioned previously, collaborative work 
provided the identification and quantification of steroids in the human follicular fluid used in 
EB culture (Appendix I.viii). EBs are known to secrete a measurable level of both estradiol 
and dihydrotestosterone (Aflatoonian et al. 2009) and testosterone. In conjunction with 
retinoic acid these secreted steroids can promote mES germ cell differentiation (Bowles et 
al. 2006;Koubova et al. 2006;Silva et al. 2009). So the hormonal niche provided by follicular 
fluid may be beneficial for hESC germ cell differentiation, however this needs further 
investigation. 
Ultimately the prospect of developing a novel in vitro oocyte development model using hESC 
differentiation is an exciting prospect in the field of reproductive biology. However since the 
initial reports of female germ cell differentiation from ES cells there is currently no reliable 
model for oocyte differentiation in vitro.  
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CHAPTER 4 
Investigation of the role of the zona pellucida in 
spermatozoa binding 
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4.1 Introduction 
A critical stage for natural fertility, prior to fertilisation, is the successful binding to and 
penetration of the zona pellucida (ZP) matrix by spermatozoa. The ZP is a glycoprotein layer 
comprised of a number of individual ZP proteins, that surrounds all mammalian oocytes and 
early embryos (Wassarman. 1990). 
The traditional dogma for the composition of the ZP matrix and sperm-zona binding (SZB) in 
mammalian fertilisation has been primarily based on a murine model. Investigations, many 
of which were led by Bleil and Wassarman (Bleil and Wassarman 1980a;Bleil and Wassarman 
1980b;Bleil and Wassarman. 1983;Vazquez et al. 1989), established that the murine zona 
matrix consists of three individual glycoproteins. Murine zona pellucida protein 3 (mZP3), 
was established as the primary spermatozoa binding ligand and inducer of the acrosome 
reaction. Murine zona pellucida protein 2 (mZP2) was found to subsequently bind to 
acrosome-reacted spermatozoa and is thought to be involved in events preventing 
polyspermy. The final murine protein, zona pellucida protein 1 (mZP1), appeared to have no 
functional role in sperm binding, and instead was proposed to have a role creating structural 
integrity in the zona matrix. 
However the number and combination of ZP proteins that form the zona matrix in fact 
varies, ranging from three to six ZP proteins (ZP1, ZP2, ZP3, ZP4, ZPD, ZPAX), across higher 
vertebrates (table 4.1) (reviewed in Goudet et al. 2008). Along with many other species of 
primate, human zona matrices have been identified as containing an additional fourth zona 
protein compared to mice, human zona pellucida protein 4 (ZP4). A mZP4 orthologue has 
been identified, however it appears to be a non-functioning pseudogene due to a number of 
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sequence deletions (Lefievre et al. 2004). Questions therefore exist over the relevance of the 
murine model for human fertilisation.  
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 ZP1 ZP2 ZP3 ZP4 ZPD ZPAX 
Human (Homo sapiens)          §  
Chimpanzee (Pan troglodytes)          §  
Rhesus macaque (Macaca mulata)          §  
Crab-eating macaque (Macaca fascicularis)          
White-tufted-ear marmoset (Callithrix jacchus)         
Yellow baboon (Papio cynocephalus)        
Bonnet monkey (Macaca radiate)           
Pig (Sus scrofa)          
Cow (Bos taurus) §         §  
Cat (Felis catus)          
Dog (Canis familiaris) §          
Rabbit (Oryctolagus cuniculus)          
Mouse (Mus musculus)       §    
Hamster (Mesocricetus auratus)           
Rat (Rattus norvegicus)           
Possum (Trichosurus vulpecula)          
Chicken (Gallus gallus)             
Quail (Coturnix japonica)            
African clawed frog (Xenopus laevis)            
Western clawed frog (Xenopus tropicalis)            
 
Table 4.1: The presence of ZP genes in higher vertebrates. 
Table modified from (Conner et al. 2005;Goudet et al. 2008) with additional information (Izquierdo-Rico et al. 2009;Sato et al. 2009;Kinoshita et al. 
2010;Serizawa et al. 2011). § denotes the presence of a pseudogene. Gaps denote that the presence/absence of the gene has not yet been 
investigated.  
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The identity of the zona receptor on spermatozoa still remains elusive, even after decades of 
research. Early in vitro studies identified a number of candidate receptors such as β-1,4-
galactosyltransferase 1 (B4galt1) and acrosin (Acr) as being involved in spermatozoa-zona 
binding (Lopez et al. 1985;Urch and Patel. 1991). However in subsequent gene knockout 
experiments, B4galt1 and Acr null male mice remained fertile (Baba et al. 1994;Adham et al. 
1997;Asano et al. 1997;Lu and Shur. 1997). 
Some mouse knockouts have exhibited defective SZB: Clgn -/- (Ikawa et al. 1997); Ace-/- 
(Hagaman et al. 1998); Adam1a-/- (Nishimura et al. 2004); Adam2-/- (Cho et al. 1998) and 
Adam3-/- (Shamsadin et al. 1999) null mice have defective SZB and are infertile. However 
Clgn is not expressed in mature spermatozoa and is a testis-specific endoplasmic reticulum 
(ER) molecular chaperone, leading to speculation that it is involved in the correct maturation 
of spermatozoa. The Adam family, in particular Adam3 seems to be one of the most 
important factors involved in SZB in mice, but as the human homologue of Adam3 has been 
identified as a pseudogene, other proteins must be involved in human fertilisation (Hall and 
Frayne. 1999;Grzmil et al. 2001). 
There is also debate over the role of protein glycosylation in SZB. Experiments using chimeric 
zona matrices replacing mZP2 and mZP3 with human zona proteins in genetically modified 
mice saw no binding by human spermatozoa. However mouse spermatozoa did bind to the 
humanised ZPs and were able to fertilise the oocyte (Rankin et al. 2003). Binding is also 
abolished between spermatozoa and zona by the removal of terminal galactose (Gal) or N-
acetylglucosamine (GlcNac) (Shur and Hall. 1982;Florman and Wassarman. 1985;Bleil and 
Wassarman. 1988) which are key enzymes in glycosylation of ZP proteins. Recent 
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investigations have identified the potential importance of a well know selectin ligand 
sequence, sialyl-Lewis-X sequence, found on N and O glycans of human ZP proteins. The 
inhibition of this sequence caused a significant reduction in human SZB (Pang et al. 2011). 
However the disruption of vital glycosylation enzymes, mannoside 
acetylglucosaminyltransferase1 (Mgat1) and T-synthase (C1galt1) in oocytes, did not affect 
SZB or fertilisation (Shi et al. 2004;Williams et al. 2007).  
Questions also remain over the interaction between the zona proteins themselves and how 
they interact to form the ZP matrix. The current model, based on mice, is composed of 
filaments of either ZP1/ZP3 or ZP2/ZP3 heterodimers (Dean. 2004). However the question 
remains of how relevant this can be to human zona, with its additional fourth ZP protein 
(Lefievre et al. 2004) (figure 4.1). 
 
 
Figure 4.1: Structural zona matrix model in mouse. 
Proposed model of the mZP matrix structure. From mouse knockout experiments it is hypothesised 
that the zona matrix is composed of mZP1/mZP3 and mZP2/mZP3 heterodimers, forming bonds 
between their zona domains. Arranged in a filamentous structure, cross linkages are formed 
between mZP1 and mZP2, with only mZP1 forming disulfide bonds. With the additional fourth hZP 
protein (hZP4), there are questions if this model can be translated into humans. Figure adapted from 
Dean. 2004. 
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As studies are limited by the availability of human zona, and the inability to use knockout 
experiments, recombinant ZP protein expression has been widely used. Groups have 
expressed ZP proteins in both prokaryotic (E. coli) and eukaryotic (insect cells and 
mammalian cells) protein expression systems (van et al. 1994;Chakravarty et al. 2005). 
Studies employing recombinant ZP proteins have shown they are functionally active on 
spermatozoa (van et al. 1994;Chapman et al. 1998;Tsubamoto et al. 1999;Chakravarty et al. 
2005;Chakravarty et al. 2008). 
Many of the studies in the field of SZB research have focused on individual molecules, rather 
than offering an unbiased approach which screens for all molecules that might be involved in 
SZB. The work in this chapter focuses on taking an unbiased approach to identifying 
potential key molecules in SZB by using surface plasmon resonance (SPR) technology. SPR 
enables real time detection of biomolecular events, providing a wealth of quantitative 
information about protein binding; in addition it can be used in association with mass 
spectrometry, offering the opportunity to identify protein binding partners (figure 4.2). This 
study explores the potential of using SPR technology with both recombinant human zona 
proteins and native zona material to screen human spermatozoa for potential zona 
receptors. 
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Figure 4.2: Surface plasmon resonance. 
Surface plasmon resonance (SPR) occurs when a polarised light source is reflected from a gold 
conducting film at the interface between two different mediums (the sample and a glass slide) which 
have a different refractive index. An optical detection unit detects the reflected light and expresses it 
as resonance units (RU). As protein binding occurs on the sensor chip it causes a reduction in the 
intensity of light reflected which causes changes in the refraction index, which is exhibited as an 
increase of RU. Image modified from (The University of Jerusalem. 2011). 
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4.2 Aims 
 Utilising both recombinant and native zona proteins with SPR technology to 
elucidate: 
o The roles of the individual zona proteins in spermatozoa binding. 
o The roles of the individual zona proteins in zona matrix formation. 
o Potential zona receptor candidates on spermatozoa.  
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4.3 Materials. 
4.3.1 Antibodies 
Product Name Company Product Number 
Penta-His antibody Qiagen, Crawley, UK. 34660 
Goat anti-mouse IgG HRP antibody Jackson ImmunoResearch 
Laboratories, Pennsylvania, 
USA. 
115035003 
 
4.3.2 Cells 
Product Name Company Product Number 
Alpha-select gold efficiency E.Coli Bioline, London, UK. BIO-85027 
 
4.3.3 Cell Culture reagents 
Product Name Company Product Number 
Bovine Serum Albumin (BSA) Millipore, Watford, UK. 82-002-4 
Dimethyl sulfoxide (DMSO)  Sigma, Dorset, UK. D4540 
Dulbecco’s Modified Eagle/F-12 Medium 
(DMEM/F-12) 
Invitrogen, Paisley, UK. 21041-033 
Fetal Bovine Serum (FBS) Biosera, Ringmer, UK.  S181X 
L-Glutamine  Invitrogen, Paisley, UK 25030 
Non-Essential Amino Acids (NEAA) Invitrogen, Paisley, UK 11140-035 
Opti-MEM I reduced serum medium Invitrogen, Paisley, UK 11058021 
Supplemented Earle’s balanced salt solution Geneflow, Fradley, UK 06-2010-03-18 
Penicillin/Streptomycin Invitrogen, Paisley, UK. 15140-122 
Zeocin InvivoGen, San Diego, USA, ant-2n-1 
0.25% (w/v) Trypsin-0.53mM EDTA Invitrogen, Paisley, UK. 25200-056 
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4.3.4 Chemicals 
Product Name Company Product Number 
1-ethyl-3-(3-dimethylaminopropyl)- 
carbodiimide hydrochloride (EDC), 
Sigma, Dorset, UK. 03449 
AB-NTA free acid NBS Biologicals Ltd A459-10 
Agarose Bioline, London, UK.  41025 
Ammonium persulphate Sigma, Dorset, UK. A3678 
Ampicillin sodium salt Sigma, Dorset, UK. A9518 
Bicinchoninic acid Sigma, Dorset, UK. B9643 
Bovine serum albumin (BSA) Millipore, Watford, UK 82-002-4 
Calcium Ionophore A23187 Sigma, Dorset, UK. C5149 
Complete, Mini, EDTA free protease inhibitor 
cocktail 
Roche Diagnostics, Burgess Hill, 
UK. 
04693159001 
Copper(II) sulphate Sigma, Dorset, UK. C2284 
Deoxynucleoside triphosphates (dNTPs) Promega, Southampton, UK C1141 
Dithiothreitol (DTT)  Sigma, Dorset, UK. D9163 
ECL Western blotting substrate Thermo Fisher Scientific, 
Rockford, USA. 
32109 
Ethanol  Fisher Scientific, Loughborough,  E/0650DF/17 
Ethanolamine  Sigma, Dorset, UK. 110167 
Ethidium bromide Sigma, Dorset, UK.  160539 
Ethylenediaminetetraacetic acid (EDTA) Sigma, Dorset, UK. E5134 
Ferrous sulphate Sigma, Dorset, UK. F8048 
Glacial acetic acid Fisher Scientific, Loughborough, 
UK 
A/0400/PB17 
Glycerol Sigma, Dorset, UK. G5516 
Glycine Sigma, Dorset, UK. G8898 
Glycine pH 2 GE Healthcare, 
Buckinghamshire, UK. 
BR100355 
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Product Name Company Product Number 
HBS-EP GE Healthcare, Bucks, UK. BR100188 
HBS-P GE Healthcare, Bucks, UK. BR100368 
Hydrochloric acid (HCl)  Sigma, Dorset, UK. H1758 
Hydromount Geneflow, Fradley, UK. HS-106 
Imidazole Sigma, Dorset, UK. I2399 
Isopropanol Sigma, Dorset, UK. I9516 
Lipofectamine 2000 Transfection Reagent Invitrogen, Paisley, UK. 11668-027 
Luria-Bertani (LB) agar powder Sigma, Dorset, UK. L2897 
Luria-Bertani (LB) broth powder Sigma, Dorset, UK. L3022 
Methanol  Fisher Scientific, Loughborough, 
UK. 
M/3950/17 
N hydroxysuccinimide (NHS), Sigma, Dorset, UK. 130672 
Nickel acetate tetrahydrate Sigma, Dorset, UK. 244066 
Nickel chloride  Sigma, Dorset, UK. 451193 
Phosphate buffered saline (PBS) Sigma, Dorset, UK P4417 
Poly D lysine solution  Sigma, Dorset, UK. P8920 
Propidium iodide Invitrogen, Paisley, UK P1304MP 
ProtoBlock Geneflow, Fradley, UK. CL-252 
ProtoGel (30%) Geneflow, Fradley, UK. A20072 
Silver nitrate Sigma, Dorset, UK. 209139 
Sodium acetate  Sigma, Dorset, UK. S8750 
Sodium chloride  Sigma, Dorset, UK. S9888 
Sodium citrate Sigma, Dorset, UK. S1804 
Sodium dodecyl sulphate(SDS) Sigma, Dorset, UK. L6026 
Tetramethylethylenediamine (TEMED) Sigma, Dorset, UK. T9281 
Tris(hydroxymethyl)aminomethane Sigma, Dorset, UK 25285-9 
Triton X-100 Sigma, Dorset, UK. T8532 
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Product Name Company Product Number 
TWEEN-20 Sigma, Dorset, UK. P1379 
 
4.3.5 Commercial kits  
Product Name Company Product Number 
Endo Free Plasmid Maxi kit Qiagen, Crawley, UK. 12362 
QIAprep Spin Miniprep kit Qiagen, Crawley, UK. 27104 
QIAquick Gel Extraction Kit Qiagen, Crawley, UK. 28704 
 
4.3.6 DNA and Protein ladders 
Product Name Company Product Number 
1Kb DNA Step Ladder Promega, Southampton, UK. G6941 
25bp DNA Step Ladder Promega, Southampton, UK. G4511 
6 X His Protein Ladder Qiagen, Crawley, UK. 34705 
HyperLadder I Bioline, London, UK BIO-33025 
 
4.3.7 Dyes 
Product Name Company Product Number 
6 X Blue/Orange loading dye Promega, Southampton, UK.  G1881 
Bromophenol blue Sigma, Dorset, UK. B5525 
Lectin from Pisum sativum (pea) (FITC-PSA) Sigma, Dorset, UK. L0770 
 
4.3.8 Enzymes 
Product Name Company Product Number 
EcoRV New England BioLabs, Hitchin, 
UK 
R0195T 
HindIII New England BioLabs, Hitchin, 
UK 
R0104S 
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Product Name Company Product Number 
Pfu DNA polymerase Promega, Southampton, UK. M7741 
PshAI New England BioLabs, Hitchin, 
UK 
R0593S 
RNase Inhibitor  Bioline, London, UK. 65027 
T4 DNA ligase Promega, Southampton, UK. M1801 
 
4.3.9 Equipment  
Product Name Company Product Number 
5 ml Polypropylene round-bottom tube Becton Dickinson Labware, New 
Jersey, USA. 
352063 
96 Well flat bottom plate Corning Incorporated, New 
York, USA.  
3595 
AcroSep IMAC HyperCell column PALL Life Sciences, Farlington, 
UK. 
20093-C001 
Centrifugal filter column 
Micron YM-10 10KDa  
Millipore , Watford,  UK. 42406 
Hybond ECL nitrocellulose membrane GE Healthcare, 
Buckinghamshire, UK. 
RPN3032D 
Hyper film GE Healthcare, 
Buckinghamshire, UK. 
RPN1675K 
Micro Cell- HAC slides Conception Technologies, San 
Diego, USA. 
MC-20-4 
Microlance needle 19G SLS, Nottingham, UK. SYR6102 
Pierce Concentrators 20K MWCO Thermo Fisher Scientific, 
Rockford, USA. 
87750 
Polyacrylamide spin desalting columns 7K 
MWCO 
Thermo Fisher Scientific, 
Rockford, USA. 
89849 
Sensor chip CM5 GE Healthcare, 
Buckinghamshire, UK. 
BR100012 
T75 cm2 Tissue culture flask SLS, Yorkshire, UK.  354638 
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4.3.10 Protein expression vectors 
Product Name Company Product Number 
pcDNA4 HisMax B Invitrogen, Paisley, UK. V86420 
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4.4 Methods 
4.4.1 Recombinant protein preparation  
Baculovirus-expressed recombinant human zona pellucida protein 2, 3 and 4 (Bac-rhZP2, 
Bac-rhZP3 and Bac-rhZP4) (gifted by Dr. Satish Gupta, National Institute of Immunology, New 
Delhi, India) and a control His-tagged recombinant protein (CΔ105) (gifted by Dr. Eva Hyde, 
University of Birmingham) were prepared for surface plasmon resonance (SPR) analysis.   
Buffer exchange 
The buffer for all recombinant proteins was exchanged using centrifugal filter columns. 
Briefly, 500 µl of PBS was added to the column and centrifuged at 14000 x g for 10 min, to 
remove potential contamination from the column filter. Recombinant protein solution was 
then added to the column along with an additional 200 µl of PBS, which were then 
centrifuged at 14000 x g for 10 min, this step was repeated a further two times. Finally the 
filter column was inverted and placed into a collection tube which was then centrifuged at 
1000 x g for 3 min. The eluate was then stored at -20°C. 
BCA protein assay 
In a flat bottomed 96 well plate, 200 µl of working solution (bicinchoninic acid and copper(II) 
sulphate, 50:1 respectively) was added to 25 µl of diluted recombinant protein samples 
(diluted at a concentration range 1:5, 1:10 and 1:20), and to a bovine serum albumin (BSA) 
standard (ranging from 0 µg/ml to 1000 µg/ml). The working reagent was left to incubate for 
30 min at 37°C. The optical density (OD) values were measured using a plate 
spectrophotometer at a 540 nm wavelength. The protein concentrations were determined 
149 
 
through OD comparison to BSA standards, and then diluted to 100 µg/ml with an 
appropriate volume of PBS. 
4.4.2 Surface plasmon resonance (SPR) analysis with Bac-rhZPs 
All experiments were performed using a BIAcore TM 3000 instrument with research-grade 
CM5 sensor chips (BIAcore, Uppsala, Sweden). 
Amine coupling 
Initially the CM5 chip was exposed to HBS-EP buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 
0.005% Surfactant P20 and 3 mM EDTA) at a flow rate of 30 µl/min. The chip was activated 
with a mixture of 0.2 M 1-ethyl-3-(3’-dimethylamino-propyl) carbodiimide hydrochloride and 
0.05 M N-hydroxysuccinimide (EDC:NHS) (35 µl, at a flow rate of 10 µl/min). Recombinant 
proteins were diluted to a concentration of 10 µg/ml in 10 mM sodium acetate pH 5. To 
immobilise proteins to the CM5 chip, via amine coupling, 35 µl of protein was injected at a 
flow rate of 5 µl/min, then the chip surface was blocked with 50 µl of 1 M ethanolamine pH 
8.5 (flow rate: 5 µl/ml). To ensure responses were not due to non-specific background 
binding, a control cell on the CM5 chip was activated with a 1:1 solution of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) and N-Hydroxysuccinimide (NHS) solution (35 µl, 
at a flow rate of 10 µl/min), then immediately blocked with 50 µl of 1 M ethanolamine pH 
8.5 (flow rate: 5 µl/min), without recombinant protein exposure (figure 4.3 a). 
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His tag coupling 
To immobilise His-tagged recombinant proteins, the surface of the BIAcore CM5 chip had to 
be modified with nitrilotriacetic acid, to allow binding of poly-histidine when in complex with 
nickel. One hundred microlitres of a 1:1 EDC:NHS solution was applied to the gold concave 
surface of a BIAcore CM5 sensor chip. The chip was incubated at room temperature for 20 
min and then rinsed with deionised H2O and dried using compressed air. The chip was then 
covered with 100 µl of (S)-N-(5-Amino-1-Carboxypentyl)iminodiacetic acid (NTA-NH2),pH 8.0 
and incubated for 30 min at room temperature. The chip was then rinsed with deionised H2O 
and dried using compressed air.  
Initially the modified CM5 chip was exposed to a 1:60 dilution of HBS-EP (0.01 M HEPES 
pH7.4, 0.15 M NaCl, 0.005% Surfactant P20, 3.4 mM EDTA) and HBS-P buffer (0.01 M HEPES 
pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20) giving rise to a modified HBS-EP buffer with a 
final concentration of: 0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20 and 50 µM 
EDTA at a flow rate of 30 µl/min. The chip was activated with 300 µM nickel chloride (10 µl, 
at a flow rate of 10 µl/min) and recombinant proteins were diluted to a concentration of 10 
µg/ml in 10 mM sodium acetate pH 5. To immobilise proteins to the CM5 chip, via his-tag 
coupling, 30 µl of protein was injected at a flow rate of 10 µl/min. Proteins were routinely 
stripped from the chip using 0.35 M EDTA pH 8 (30 µl, at a flow rate of 10 µl/min), however 
in cases where proteins could not be removed 10 mM glycine pH 2.2 (15 µl, at multiple flow 
rates of either 10 µl/min or 30 µl/min) was used (figure 4.3 b). 
Data was analysed using BIA evaluation 4.1 software (BIAcore, Uppsala, Sweden). 
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Figure 4.3: BIAcore immobilisation chemistries. 
BIAcore CM5 sensor chips have a carboxymethylated dextran matrix covalently attached to a gold 
surface. Ligands can be attached by various different chemistries such as (a) Amine coupling, where 
ligands are immobilised through a covalent chemical bond. (b) His-tag coupling, where NTA chelates 
with nickel ions to immobilise ligands that are attached to a poly-histidine tag. Image modified from 
(BIAcore. 2003). 
 
4.4.3 Construction of CHO-rhZP3 protein expression vector 
ZP3 polymerase chain reaction amplification 
To clone human ZP3 (hZP3) into the mammalian protein expression vectors pcDNA4/HisMax 
B, a pBluescript clone containing the complete coding sequence of hZP3 (clones ZP3-PB) was 
used as a template for PCR amplification. Primers used in PCR amplifications were obtained 
from Eurogentec, Southampton, UK. Oligonucleotide sequences are indicated in table 4.2. 
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PCR amplification reactions contained: 2 U of high fidelity Pfu DNA polymerase, 1 X Reaction 
Buffer, 0.5 µM (each) reverse and forward primers, 200 µM (each) of the four dNTPs and 1 µl 
ZP3-PB DNA template. PCR reaction had a negative water control to ensure no 
contamination. Reactions were performed under the following conditions: 95°C, 2 min; 35 
cycles of 95°C, 30 s; 51°C, 30 s; 72°C, 2 min 30 s and one cycle of 72°C, 5 min.  
PCR amplicons were run on 1% (w/v) agarose gel (section 2.4.7) and then purified using a 
QIAquick gel extraction kit, .according to the manufacturers’ protocol. 
Primer Oligonucleotide sequence(5’-3’) PCR amplicon size (bp) 
ZP3pcDNA4 HisMax-Forward CAACCCCTCTGGCTCTTG  
ZP3pcDNA4 HisMax-Reverse TTATTCGGAAGCAGACACAG 1209 
Table 4.2: Primer oligonucleotide sequence ZP3 amplification. 
 
Protein expression vector pcDNA4 HisMax preparation 
Prior to ligation, the mammalian protein expression vector pcDNA4 HisMax B was linearised 
with EcoRV. Digestion reactions contained 2 U EcoRV, 1 X NEBuffer 3, 100 µg/ml BSA, and 20 
µl of pcDNA4 HisMax B and reactions were incubated at 37°C for 4 h. Linearised protein 
expression vector was run on 1% (w/v) agarose gel (section 2.4.7) and products were 
purified according to manufacturers’ protocol using QIAquick gel extraction kit. 
Ligation 
For blunt end ligation reactions insert and vector DNA was mixed at a ratio of 3:1. All DNA 
concentrations were quantified by spectrophotometer analysis. Reactions also contained 3 U 
of T4 DNA ligase, 1 X Buffer and 10 U EcoRV, to minimise re-ligation of the vector to itself. 
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Ligations were incubated at 22°C for 1 h, followed by enzyme inactivation step for 10 min at 
65°C. 
E.Coli Transformation 
Fifty microlitre aliquots of Alpha-select gold efficiency E.Coli cells were taken from storage at 
-80°C and thawed on wet ice. Five microlitres of ligation reactions were added to individual 
aliquots and incubated on ice for 30 min. Cells were heat shocked at 42°C for 45 s, and then 
plunged into ice for a further 2 min. The E.Coli-DNA mixture was added to 945 µl of sterile 
Luria-Bertani (LB) broth with tubes then being incubated for 1 h at 37°C, shaking at 180 rpm. 
Fifty microlitres of cell transformation mixture was spread across sterile LB agar plates 
containing 50 ug/ml ampicillin and plates were incubated overnight at 37°C.  
DNA preparation  
To confirm correct vector:insert ligation, DNA digests were performed (section DNA digests). 
Initially DNA was prepared using a small scale method. Five millilitres of sterile LB broth 
supplemented with 50 µg/ml ampicillin was inoculated with individual colonies cultured 
from the incubated overnight transformation spread plates. Cultures were incubated for 12-
16 h at 37°C, shaking at 180 rpm. DNA was then prepared using a QIAprep Spin miniprep kit, 
according to the manufacturers’ protocol. DNA was then stored at -20°C. 
In preparation for mammalian cell transfection (section 4.4.5), DNA was prepared on a larger 
scale. Two hundred millilitres of sterile LB broth supplemented 50 µg/ml ampicillin, was 
inoculated with an individual colony from the incubated overnight transformation spread 
plates. Cultures were incubated for 12-16 h at 37°C, shaking at 180 rpm. DNA was then 
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prepared using an Endo-free plasmid maxi kit, according to the manufacturers’ protocol. 
Spectrophotometric DNA quantification, was completed before samples were stored at -
20°C. 
DNA digests  
To confirm vector:insert ligation, putative CHO-rhZP3 pcDNA4 HisMax DNA was linearised 
with HindIII. Reactions contained 2 U HindIII, 1 X Reaction buffer and 3 µl of DNA from mini 
DNA preparations. Digests were then incubated at 37°C for 1 h. Linearised DNA was run on 
1% (w/v) agarose gel (section 2.4.7).  
Vector DNA was also double digested with HindIII and PshAI to confirm the correct 
orientation of the ZP3 in the pcDNA4 HisMax protein expression vector. Reactions contained 
1 U HindIII, 1 U PshAI, 1 X Reaction buffer and 3 µl of DNA from mini DNA preparations. 
Digests were then incubated at 37°C for 1 h. Double digested DNA was run on 1% (w/v) 
agarose gel (section 2.4.7). 
Sequencing 
DNA sequencing was performed by the Functional Genomics and Proteomics Laboratory, 
University of Birmingham. Reactions contained 500 ng of CHO-rhZP3 pcDNA4 HisMax DNA, 
and 3.2 pmol of individual primers. Primers were obtained from Eurogentec, Southampton, 
UK. Oligonucleotide sequences are indicated in table 4.3. Results were analysed using 
Chromas Lite 2.01 and Mega 4.1. 
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Primer Oligonucleotide sequence(5’-3’) 
ZP3pcDNA4 HisMax-Forward CAACCCCTCTGGCTCTTG 
ZP3pcDNA4 HisMax-Reverse TTATTCGGAAGCAGACACAG 
ZP3_int_rev1 GGCCACGCAGTGGTCCACAA 
ZP3_int_rev2 TGCATGCTGTTGCCACACTGG 
Table 4.3: Primer oligonucleotide sequence CHO-rhZP3 pcDNA4 HisMax sequencing. 
 
4.4.4 Chinese hamster ovary (CHO) cell culture 
A Chinese hamster ovary (CHO) cell line (gifted from Beata Grygielska, University of 
Birmingham) was cultured in Dulbecco’s Modified Eagle’s Medium F-12 (DMEM/F-12) 
supplemented with 10% (v/v) FBS, 1% (v/v) NEAA, 100 IU/ml (each) penicillin and 
streptomycin and 4 mM L-glutamine at 37°C, 6% CO2. Culture media was exchanged every 3-
4 days.  
CHO cells were subcultured when fully confluent. Cells were trypsinised with 0.25% (w/v) 
trypsin-0.53 mM EDTA and incubated at 37°C for approximately 5 min until cell detachment. 
Cells were recovered in complete growth medium and centrifuged for 5 min at 500 x g. Cells 
were resuspended in an appropriate volume of growth medium at a typical subcultivation 
ratio 1:5.  
For storage, frozen aliquots of CHO cells in cryoprotectant medium (90% (v/v) FBS, 10% (v/v) 
DMSO) were stored in liquid nitrogen. If required frozen aliquots of cells were thawed in a 
37°C water-bath and slowly resuspended in complete growth medium in order to avoid 
osmotic shock. Cells were then centrifuged for 5 min at 500 x g, and seeded in an 
appropriate volume of culture medium.  
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4.4.5 Transfection 
CHO cells were cultured in 15 ml of growth medium minus antibiotics in T75 cm2 culture 
flasks until cells reached 90-95% confluency. At the time of transfection for each individual 
T75 cm2 culture flask, 24 µg of plasmid DNA and 60 µl Lipofectamine 2000 were each diluted 
into 1.5 ml of Opti-MEM I Reduced serum media and incubated for 5 min at room 
temperature. The DNA and Lipofectamine solutions were mixed and incubated for a further 
30 min at room temperature before adding to CHO cells. Growth medium was then 
exchanged 24 h after transfection. 
4.4.6 Selection of CHO-rhZP3 pcDNA4 HisMax transfected CHO cell line 
Approximately 3 days after transfection, rhZP3 pcDNA4 HisMax transfected CHO cells were 
subcultured using the normal CHO subcultivation procedures (section 4.4.4). Complete 
growth medium was supplemented with 250 µg/ml of the selection agent, Zeocin. Lethal 
levels of Zeocin were determined by culture with non-transfected CHO cells. CHO cells were 
cultured in Zeocin supplemented growth medium for 3 weeks to select for a population 
containing CHO-rhZP3 pcDNA4 HisMax protein expression vector. 
4.4.7 Mammalian rhZP3 protein expression  
rhZP3 protein recovery 
Cell culture medium from CHO-rhZP3 pcDNA4 HisMax transfected and non-transfected 
control CHO cells were analysed for CHO-rhZP3 protein expression. Medium was recovered 
after cell culture and was supplemented with 10% (v/v) EDTA free protease inhibitor media. 
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Medium was concentrated using a protein concentrator for easier protein purification. 
Samples were stored at -20°C. 
Cell lysates from CHO-rhZP3 pcDNA4 HisMax transfected and non-transfected control CHO 
cells were also analysed for CHO-rhZP3 protein expression. Cells were incubated with 0.25% 
(w/v) trypsin-0.53 mM EDTA at 37°C, until cell detachment. Cells were recovered with 
complete CHO growth medium then cells were centrifuged at 500 x g for 5 min. Cells were 
then lysed in 500 µl of lysis buffer (50 mM Tris-HCl ph 8, 150 mM NaCl and 1% (v/v) Triton X-
100) supplemented with 10% (v/v) EDTA-free protease inhibitor. Samples were vortexed for 
20 s and then incubated on ice for 15 min. Cell lysates were then centrifuged at 14000 x g for 
10 min, at 4°C. The supernatant was recovered and stored at -20°C.  
His-tag protein purification 
Media and cell lysates collected from (5 and 2 T75 cm2 culture flasks respectively) of 
successfully transfected CHO cells were purified via AcroSep IMAC HyperCell column. Briefly, 
columns were washed with 10 column volumes (CV) of ddH2O, then loaded sequentially with 
6 CV of 100 mM nickel acetate, 3 CV of 1 M sodium chloride and then further rinsed with 20 
CV of ddH2O. Prior to sample loading the column was prepared with 10 CV of loading buffer 
(50 mM tris-HCL pH 8.0, 400 mM NaCl, 15 mM imidazole). Either cell lysate preparations or 
collected culture medium were then loaded onto the column. Ten CV of loading buffer was 
further added to remove any unbound proteins from the column. To exclude non-specific 
proteins that were weakly bound to the column, 3 CV of 30 mM imidazole was applied prior 
to elution. To elute the His6 tagged recombinant zona protein from the column, 7 CV of 
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elution buffer (200 mM imidazole, 0.5 M NaCl) were passed through the column, and eluate 
was recovered and saved.  
SDS-PAGE and Western Blotting. 
Purified protein samples, controls and 6 X His protein ladder were heated at 98°C for 10 min 
in 5 X SDS-PAGE sample buffer (0.225 M Tris-Cl, pH 6.8, 5% (w/v) SDS, 50% (v/v) glycerol, 
0.05% (w/v) bromophenol blue and 0.25 M DTT). Proteins were resolved by electrophoresis 
on 12% SDS-PAGE gel in tris-glycine buffer (250 mM tris, 1.92 M glycine) supplemented with 
10% (w/v) SDS at a voltage of 200V. Proteins were electrophoretically transferred onto 0.20 
µm nitrocellulose membrane at a constant voltage of 100V for 1 h in tris-glycine buffer 
supplemented with 20% (v/v) methanol. Nonspecific binding sites on membranes were 
blocked with ProtoBlock according to manufacturers’ protocol for 30 min at room 
temperature with gentle agitation. The membranes were then incubated with an anti-his 
antibody at a concentration of 1:2000 either for 1 h at room temperature or overnight at 
4°C. Membranes were extensively washed with agitation in Tris-buffered saline (20 mM Tris, 
pH 7.5, 500 mM NaCl) supplemented with 0.1% (v/v) Tween-20) (TTBS) for 30 min, changing 
buffer three times at 10 min intervals. Membranes were then incubated with a 1:10000 
concentration of corresponding goat anti-mouse IgG-HRP secondary antibody for 1 h at 
room temperature with gentle agitation, followed by extensive washing with TTBS. Positive 
bands were detected by chemiluminescence with ECL Western blotting substrate, according 
to manufactures’ instructions.  
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Nitrocellulose membrane silver staining  
To detect total protein in purified protein samples nitrocellulose membranes were silver 
stained. Membranes were washed in ddH2O to remove residual ECL Western blotting 
substrate, then a silver stain was added (0.7 M sodium citrate, 0.3 M ferrous sulphate and 
0.1 M silver nitrate) and left to stain for approximately 5 min, with gentle agitation. To 
enhance protein bands, membranes were further stained with Farmers solution (2 mM 
potassium ferricyanide, 2 mM sodium carbonate and 6 mM sodium thiosulphate) for 
approximately 1 min. Membranes were further washed in ddH2O then air dried. 
4.4.8 Human sperm preparation 
Human spermatozoa were prepared via the direct swim up method (section 2.4.1). 
Capacitated spermatozoa were then diluted to 6 x 106 spermatozoa ml-1 with sEBSS + 0.3% 
(w/v) BSA.  
4.4.9 Acrosome reaction assay 
Human spermatozoa in 100 µl aliquots were incubated with either: 25 µl of crude purified 
medium from CHO-rhZP3 pcDNA4 HisMax transfected or non-transfected CHO cells; a 
negative control of sEBBS + 0.3% (w/v) BSA and a positive control containing 10 µM calcium 
ionophore. 0.2 µg/ml propidium iodide was added to each tube and then samples were 
incubated at 37°C, 6% CO2 for 15 min. Once the desired incubation period was completed, 
cells were centrifuged at 300 x g for 5 min and smeared on to pre-coated poly-D-lysine (20 
µg/ml) microscope slides. Slides were air dried and cells were then permeabilised with 100% 
methanol for 1 min. Slides were left to air dry, then cells were stained with 50 µg/ml FITC-
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PSA and incubated in a humidified chamber for 45 min at 37°C. Slides were rinsed with 
ddH2O, air-dried and coverslips mounted using Hydromount.  
Acrosome status was assessed using a fluorescent microscope. Cells were visualised using a 
60 X oil immersion lens. Only viable cells assessed by propidium iodide exclusion were 
scored with 500 cells being scored per slide. Duplicates of each treatment provided mean 
acrosome status for each treatment.  
The percentage of AR induction for both treatments (CHO-rhZP3 pcDNA4 HisMax transfected 
CHO medium and non-transfected CHO medium) were normalised to both the positive 
control (10 µM calcium ionophore) and spontaneous AR levels (sEBBS + 0.3% (w/v) BSA) and 
expressed as percentage (%) stimulation of acrosome reaction (see formula below). 
Statistical significance between the two treatments was assessed by a student’s 
independent t-test, which was completed using SPSS 14.0.  
                                     [
                            
                           
]        
4.4.10 Native sheep zona preparation  
Zona intact oocytes were collected from frozen thawed sheep ovaries by aspirating palpable 
antral follicles with a 19 gauge needle. Oocytes with a visible ZP were located with the aid of 
a microdissection microscope and collected and stored at -20°C until heat solubilisation. 
Prior to use, 150 sheep oocytes were thawed and resuspended in 500 µl of 1 X PBS. The ZP 
matrices were removed from the oocytes by vigorous pipetting through a small bore glass 
pipette. The suspension was centrifuged for 15 min at 2000 x g, then resuspended in 100 µl 
of 1 X PBS. Sheep ZP was then heat solubilised at 70°C for 90 min. 
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Before SPR experimentation, heat solubilised sheep zona underwent a buffer exchange using 
a polyacrylamide spin desalting column, according to manufactures’ protocol. Briefly, the 
column was placed into a microcentrifuge collection tube and centrifuged at 1500 x g for 1 
min to remove excess column liquid. Four hundred microlitres of 10 mM sodium acetate pH5 
was added to the column, which was then centrifuged at 1500 x g for 1 min. This step was 
repeated three times, discarding buffer recovered in the collection tube. Eighty microlitres of 
heat solubilised sheep zona was added to the column with an additional 30 µl of 10 mM 
sodium acetate pH 5 added on top of the column resin. The column was centrifuged at 1500 
x g for 2 min to recover heat solubilised sheep zona. 
4.4.11 Ram sperm lysate preparation 
Ram spermatozoa were collected from three ram testicles. The outer covering of the testes 
were removed and ram spermatozoa was aspirated from the cauda of the epididymis using a 
19 gauge needle. 
Ram spermatozoa were diluted to 100 x 106 sperm/ml with 1 X PBS supplemented with 1% 
(v/v) triton and 10% (v/v) protease inhibitor. Samples were then sonicated for 10 s, followed 
by an incubation period of 30 min at room temperature with gentle agitation. After 
incubation 1 mM dithiothreitol (DTT) was added to the samples which were then left for a 
further 30 min at room temperature with gentle agitation. Samples were then sonicated for 
10 s, and centrifuged at 14000 x g for 10 min. The supernatant was removed and stored at -
20°C until use.  
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4.4.12 Surface plasmon resonance (SPR) analysis with heat solubilised sheep zona 
All experiments were performed with a BIAcore TM 3000 instrument with research-grade 
CM5 sensor chips (BIAcore, Uppsala, Sweden). 
Heat solubilised sheep zona protein immobilisation  
Initially the CM5 chip was exposed to HBS-EP buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 
0.005% Surfactant P20 and 3 mM EDTA) at a flow rate of 30 µl/min. The chip was activated 
with a mixture of 0.2 M 1-ethyl-3-(3’-dimethylamino-propyl) carbodiimide hydrochloride and 
0.05 M N-hydroxysuccinimide (EDC:NHS) (50 µl, at a flow rate of 5 µl/min). To immobilise 
heat solubilised sheep zona proteins to the CM5 chip, via amine coupling, 90 µl of protein 
was injected at a flow rate of 10 µl/min, then the chip surface was blocked with 50 µl of 1 M 
ethanolamine pH 8.5 (flow rate: 10 µl/min). To ensure reposes were not due to non-specific 
background binding, a control cell on the CM5 chip was activated with the EDC:NHS solution 
(50 µl, at a flow rate of 5 µl/min), then immediately blocked with 50 µl of 1 M ethanolamine 
pH 8.5 (flow rate: 5 µl/min).  
Ram sperm binding and elution 
The ram sperm lysate solution was diluted in buffer HBS-EP (1:1 solution). Fifty microlitres of 
diluted ram sperm lysate was injected at a flow rate of 10 µl/min any binding proteins were 
recovered by injecting 15 µl of glycine pH 2 at a flow rate of 30 µl/min and collected. Ram 
sperm binding and elution cycles were repeated five times to collect maximum material for 
mass spectrometry analysis (section 4.1.13).  
163 
 
4.4.13 Mass spectrometry analysis 
The product from the ram sperm binding and elution cycles (section 4.4.12) in addition to a 
sample of the heat solubilised sheep zona pellucida protein (section 4.4.10) were sent for 
mass spectrometry analysis. This work was completed in by Dr. Ashley Martin, University of 
Birmingham.  
Briefly the samples were reduced with 10 mM dithiothreitol (DTT) in 50 mM ammonium 
bicarbonate for 1 h at 60oC and then alkylated using 20 mM iodoacetamide at room 
temperature in the dark. The proteins were then digested using porcine trypsin overnight at 
37oC. The tryptic peptides generated were separated using a gradient of 2-36% acetonitrilein 
and 0.1% formic acid over 60 min at 350 nl/min using a Dionex Ultimate 3000 High-
performance liquid chromatography (HPLC) system. The HPLC column was an Acclaim 
PepMap100 (75 M I.D. x 25 cm C18 3 uM particle size) connected to a Bruker ETD Amazon 
ion trap mass spectrometer with an online nanospray source fitted with a metal needle with 
a 10 M tip. 1600 V was applied to the end plate and the drying gas set to 6.5 l/min at 
180oC. An MS survey scan from 350 to 1600 m/z was performed and the 5 most intense ions 
in each survey scan were selected for collision induced dissociation (CID) fragmentation. 
After ions were fragmented twice they were placed on an exclusion list for 30 s.  
The raw data was processed using the Bruker DatAnalysis peak detection program to select 
peaks which were then searched using the Mascot search engine (version 2.1) using the 
SwissProt protein database for “all mammals”. The minimum mass accuracy for both the MS 
and MS/MS scans were set to 0.5 Da and trypsin protease selection used. The peptides were 
164 
 
filtered using a minimum Mascot score of 30. The data output was via the Bruker 
ProteinScape software package. 
This process alkylates the cysteine residues, preventing mixed disulphide generation during 
the subsequent analysis.   The mass change caused by the modification was included in the 
database search.   
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4.5 Results 
4.5.1 Bac-rhZP protein immobilisation  
Baculovirus-expressed recombinant human zona pellucida protein 2, 3 and 4 (Bac-rhZP2, 
Bac-rhZP3 and Bac-rhZP4) were donated by Dr. Satish Gupta, of the National Institute of 
Immunology, New Delhi, India (Chakravarty et al. 2005). To immobilise the Bac-rhZP proteins 
amine coupling was initially used (section 4.4.2, figure 4.3 a). There was no increase in 
Resonance Units (RU) after protein injection (figure 4.4) indicating that none of the Bac-rhZP 
proteins bound to the chip. One possible explanation could be binding interference caused 
by the glycosylation patterning of the rhZP proteins so alternate immobilisation chemistries 
were used.  
As the Bac-rhZP proteins have a poly-histidine tag, this feature was also utilised as a method 
to immobilise the proteins to the chip. To accommodate this different immobilisation 
chemistry, the existing CM5 chips had to be modified, by permanently attaching 
nitrilotriacetic acid (NTA) to the carboxymethylated dextran matrix. This surface could then 
be activated with nickel to bind with the Bac-rhZPs poly-histidine tags (section 4.4.2, figure 
4.3 b) (BIAcore. 2003).  
In order to validate the modified CM5 chip, a control poly-histidine tagged recombinant 
protein was immobilised. The control poly-histidine protein had previously shown to be 
immobilised via his-tag coupling. Upon injection there was identifiable binding of the control 
protein, with an increase of 2876 RU. When Bac-rhZP3 and Bac-rhZP4 were injected there 
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was no significant binding observed, however there was an increase in RU after two 
injections with Bac-rhZP2 (increase of 353 RU) (figure 4.5).  
Unlike the control protein, the Bac-rhZP2 could not be removed from the chip after protein 
injection. The RU units remained at 197 RU, after three successive rounds of 0.35 M EDTA 
(figure 4.6). Glycine (10 mM) was also used to attempt to remove the Bac-rhZP2 (Appendix 
II.i), however the RU still remained above the pre-injection baseline level. 
The inability of immobilising rhZP3 and 4 to the chip, along with the irregularities in rhZP2 
protein removal, lead to uncertainties about the structural integrity of the rhZP proteins. 
This doubt made them inappropriate for these studies, which lead to a rethink in 
experimental strategy.  
All work in this study was in collaboration with Dr. Stephen Young, University of Birmingham. 
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Figure 4.4: Bac-rhZP amine coupling immobilisation. 
BIAcore sensogram showing attempted amine coupling immobilisation of Bac-rhZP2, Bac-rhZP3 and Bac-rhZP4 (35 µl, at a flow rate of 5 µl/min). To 
BIAcore CM5 sensor chips. After injection there was no increase in resonance units (RU), consistent with no protein immobilisation. 
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Figure 4.5: Bac-rhZP his-tag coupling immobilisation. 
BIAcore sensogram showing attempted his-tag coupling immobilisation of Bac-rhZP2, Bac-rhZP3, Bac-rhZP4 and a control 6 X his-tag protein. A 
modified BIAcore CM5 sensor chips was used (section 4.4.2). To validate the CM5 chip, a control recombinant 6 X his-tagged protein, that had been 
immobilised via his-tag coupling previously, was used. For all proteins, 30 µl of protein was injected at a flow rate of 10 µl/min.  
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Figure 4.6: Removal of immobilised Bac-rhZP2, from modified CM5 chip. 
BIAcore sensogram showing attempted removal of his-tag immobilised Bac-rhZP2 from a modified BIAcore CM5 sensor chip (section 4.4.2). After two 
injections with Bac-rhZP2 (30 µl, at a flow rate of 10 µl/min), there showed an overall increase in 353 RU, however after three rounds of 0.35 M EDTA 
pH 8 (30 µl, at a flow rate of 10 µl/min), the RU did not fall to pre-injection RU, and remained at 197 RU above baseline levels. 
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4.5.2 CHO-rhZP3 pcDNA4 HisMax protein expression construct 
To pursue the SPR protein binding studies further, it was deemed prudent to begin 
expressing rhZP proteins. Initial work focused on the expression of CHO-rhZP3. 
A mammalian protein expression system was chosen, with the hope of providing a 
glycosylation pattern similar to native ZP glycosylation. A commercially available protein 
expression vector, pcDNA4 HisMax was used. The particular protein expression vector was 
chosen as it contained an N-terminal poly-histidine tag, which could be utilised in protein 
immobilisation. It also contained an enterokinase recognition cleavage site that could lead to 
his-tag removal if required (pcDNA4 HisMax B vector information, Appendix II.ii, iii, iv). 
The complete coding hZP3 DNA sequence was PCR amplified using a high fidelity Pfu DNA 
polymerase, from a pBluescript hZP3 containing vector (ZP3-PB), cloned by Dr. Sarah Conner, 
University of Birmingham. Primers were designed to amplify the CHO-hZP3 sequence devoid 
of the signal peptide, due to concerns of premature cleavage of the N-terminal poly-histidine 
tag (figure 4.7). 
CHO-hZP3 PCR amplicons were ligated to the EcoRV linearised pcDNA4 HisMax protein 
expression vector via blunt end ligation (figure 4.8 a, b). The complete CHO-rhZP3 pcDNA4 
HisMax construct was confirmed by HindIII and HindIII/PshAI digests, each providing the 
expected product sizes resulting from correct ligation (6468 bp and 5284 bp/1184 bp 
respectively) (figure 4.8 c, d).  
DNA sequence confirmation was also established by DNA sequencing (figure 4.9) and the 
complete CHO-rhZP3 pcDNA4 HisMax vector map is shown in figure 4.10. 
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1    TGCAGGTACC ATGGAGCTGA GCTATAGGCT CTTCATCTGC CTCCTGCTCT GGGGTAGTAC 
61   TGAGCTGTGC TACCCCCAAC CCCTCTGGCT CTTGCAGGGT GGAGCCAGCC ATCCTGAGAC 
121  GTCCGTACAG CCCGTACTGG TGGAGTGTCA GGAGGCCACT CTGATGGTCA TGGTCAGCAA 
181  AGACCTTTTT GGCACCGGGA AGCTCATCAG GGCTGCTGAC CTCACCTTGG GCCCAGAGGC 
241  CTGTGAGCCT CTGGTCTCCA TGGACACAGA AGATGTGGTC AGGTTTGAGG TTGGACTCCA 
301  CGAGTGTGGC AACAGCATGC AGGTAACTGA CGATGCCCTG GTGTACAGCA CCTTCCTGCT 
361  CCATGACCCC CGCCCCGTGG GAAACCTGTC CATCGTGAGG ACTAACCGCG CAGAGATTCC 
421  CATCGAGTGC CGCTACCCCA GGCAGGGCAA TGTGAGCAGC CAGGCCATCC TGCCCACCTG 
481  GTTGCCCTTC AGGACCACGG TGTTCTCAGA GGAGAAGCTG ACTTTCTCTC TGCGTCTGAT 
541  GGAGGAGAAC TGGAACGCTG AGAAGAGGTC CCCCACCTTC CACCTGGGAG ATGCAGCCCA 
601  CCTCCAGGCA GAAATCCACA CTGGCAGCCA CGTGCCACTG CGGTTGTTTG TGGACCACTG 
661  CGTGGCCACA CCGACACCAG ACCAGAATGC CTCCCCTTAT CACACCATCG TGGACTTCCA 
721  TGGCTGTCTT GTCGACGGTC TCACTGATGC CTCTTCTGCA TTCAAAGTTC CTCGACCCGG 
781  GCCAGATACA CTCCAGTTCA CAGTGGATGT CTTCCACTTT GCTAATGACT CCAGAAACAT 
841  GATATACATC ACCTGCCACC TGAAGGTCAC CCTAGCTGAG CAGGACCCAG ATGAACTCAA 
901  CAAGGCCTGT TCCTTCAGCA AGCCTTCCAA CAGCTGGTTC CCAGTGGAAG GCCCGGCTGA 
961  CATCTGTCAA TGCTGTAACA AAGGTGACTG TGGCACTCCA AGCCATTCCA GGAGGCAGCC 
1021 TCATGTCATG AGCCAGTGGT CCAGGTCTGC TTCCCGTAAC CGCAGGCATG TGACAGAAGA 
1081 AGCAGATGTC ACCGTGGGGC CACTGATCTT CCTGGACAGG AGGGGTGACC ATGAAGTAGA 
1141 GCAGTGGGCT TTGCCTTCTG ACACCTCAGT GGTGCTGCTG GGCGTAGGCC TGGCTGTGGT 
1201 GGTGTCCCTG ACTCTGACTG CTGTTATCCT GGTTCTCACC AGGAGGTGTC GCACTGCCTC 
1261 CCACCCTGTG TCTGCTTCCG AATAAAAGAA GAAAGCAAT 
 
Figure 4.7: CHO-rhZP3 pcDNA4 HisMax primer design. 
Primers were designed to amplify CHO-hZP3 sequence from a hZP3-pBluescript clone. Annealing sites 
for forward and reverse primers to hZP3 DNA sequence are illustrated by the red arrows. The 
forward primer (denoted by left to right arrow) was designed to avoid the signal peptide (denoted in 
green text), this was to ensure no premature cleavage of the N terminal His-tag, when ligated to the 
pcDNA4 HisMax B vector. (GeneBank sequence: M60504.1). 
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Figure 4.8: Cloning CHO-rhZP3 pcDNA4 HisMax protein expression vector. 
Agarose gel electrophoresis showing (a) CHO-rhZP3 PCR amplification (1209 bp), (b) linearised 
pcDNA4 HisMax B protein expression vector with EcoRV (5259 bp), (c) complete CHO-rhZP3 pcDNA4 
HisMax protein expression vector, linearised with HindIII (6468 bp) and (d) complete CHO-rhZP3 
pcDNA4 HisMax protein expression vector, digested with HindIII and PshAI (5285 bp/1184 bp). 
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Expected       GCAGATCAACCCCTCTGGCTCTTGCAGGGTGGAGCCAGCCATCCTGAGACGTCCGTACAG  
Actual         GCAGATCAACCCCTCTGGCTCTTGCAGGGTGGAGCCAGCCATCCTGAGACGTCCGTACAG  
               ************************************************************ 
 
Expected       CCCGTACTGGTGGAGTGTCAGGAGGCCACTCTGATGGTCATGGTCAGCAAAGACCTTTTT  
Actual         CCCGTACTGGTGGAGTGTCAGGAGGCCACTCTGATGGTCATGGTCAGCAAAGACCTTTTT  
               ************************************************************ 
 
Expected       GGCACCGGGAAGCTCATCAGGGCTGCTGACCTCACCTTGGGCCCAGAGGCCTGTGAGCCT  
Actual         GGCACCGGGAAGCTCATCAGGGCTGCTGACCTCACCTTGGGCCCAGAGGCCTGTGAGCCT  
               ************************************************************ 
 
Expected       CTGGTCTCCATGGACACAGAAGATGTGGTCAGGTTTGAGGTTGGACTCCACGAGTGTGGC  
Actual         CTGGTCTCCATGGACACAGAAGATGTGGTCAGGTTTGAGGTTGGACTCCACGAGTGTGGC  
               ************************************************************ 
 
Expected       AACAGCATGCAGGTAACTGACGATGCCCTGGTGTACAGCACCTTCCTGCTCCATGACCCC  
Actual         AACAGCATGCAGGTAACTGACGATGCCCTGGTGTACAGCACCTTCCTGCTCCATGACCCC  
               ************************************************************ 
 
Expected       CGCCCCGTGGGAAACCTGTCCATCGTGAGGACTAACCGCGCAGAGATTCCCATCGAGTGC  
Actual         CGCCCCGTGGGAAACCTGTCCATCGTGAGGACTAACCGCGCAGAGATTCCCATCGAGTGC  
               ************************************************************ 
 
Expected       CGCTACCCCAGGCAGGGCAATGTGAGCAGCCAGGCCATCCTGCCCACCTGGTTGCCCTTC  
Actual         CGCTACCCCAGGCAGGGCAATGTGAGCAGCCAGGCCATCCTGCCCACCTGGTTGCCCTTC  
               ************************************************************ 
 
Expected       AGGACCACGGTGTTCTCAGAGGAGAAGCTGACTTTCTCTCTGCGTCTGATGGAGGAGAAC  
Actual         AGGACCACGGTGTTCTCAGAGGAGAAGCTGACTTTCTCTCTGCGTCTGATGGAGGAGAAC  
               ************************************************************ 
 
Expected       TGGAACGCTGAGAAGAGGTCCCCCACCTTCCACCTGGGAGATGCAGCCCACCTCCAGGCA  
Actual         TGGAACGCTGAGAAGAGGTCCCCCACCTTCCACCTGGGAGATGCAGCCCACCTCCAGGCA  
               ************************************************************ 
 
Expected       GAAATCCACACTGGCAGCCACGTGCCACTGCGGTTGTTTGTGGACCACTGCGTGGCCACA  
Actual         GAAATCCACACTGGCAGCCACGTGCCACTGCGGTTGTTTGTGGACCACTGCGTGGCCACA  
               ************************************************************ 
 
Expected       CCGACACCAGACCAGAATGCCTCCCCTTATCACACCATCGTGGACTTCCATGGCTGTCTT  
Actual         CCGACACCAGACCAGAATGCCTCCCCTTATCACACCATCGTGGACTTCCATGGCTGTCTT  
               ************************************************************ 
 
Expected       GTCGACGGTCTCACTGATGCCTCTTCTGCATTCAAAGTTCCTCGACCCGGGCCAGATACA  
Actual         GTCGACGGTCTCACTGATGCCTCTTCTGCATTCAAAGTTCCTCGACCCGGGCCAGATACA  
               ************************************************************ 
 
Expected       CTCCAGTTCACAGTGGATGTCTTCCACTTTGCTAATGACTCCAGAAACATGATATACATC  
Actual         CTCCAGTTCACAGTGGATGTCTTCCACTTTGCTAATGACTCCAGAAACATGATATACATC  
               ************************************************************ 
 
Expected       ACCTGCCACCTGAAGGTCACCCTAGCTGAGCAGGACCCAGATGAACTCAACAAGGCCTGT  
Actual         ACCTGCCACCTGAAGGTCACCCTAGCTGAGCAGGACCCAGATGAACTCAACAAGGCCTGT  
               ************************************************************ 
 
Expected       TCCTTCAGCAAGCCTTCCAACAGCTGGTTCCCAGTGGAAGGCCCGGCTGACATCTGTCAA  
Actual         TCCTTCAGCAAGCCTTCCAACAGCTGGTTCCCAGTGGAAGGCCCGGCTGACATCTGTCAA  
               ************************************************************ 
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Expected       TGCTGTAACAAAGGTGACTGTGGCACTCCAAGCCATTCCAGGAGGCAGCCTCATGTCATG  
Actual         TGCTGTAACAAAGGTGACTGTGGCACTCCAAGCCATTCCAGGAGGCAGCCTCATGTCATG  
               ************************************************************ 
 
Expected       AGCCAGTGGTCCAGGTCTGCTTCCCGTAACCGCAGGCATGTGACAGAAGAAGCAGATGTC  
Actual         AGCCAGTGGTCCAGGTCTGCTTCCCGTAACCGCAGGCATGTGACAGAAGAAGCAGATGTC  
               ************************************************************ 
 
Expected       ACCGTGGGGCCACTGATCTTCCTGGACAGGAGGGGTGACCATGAAGTAGAGCAGTGGGCT  
Actual         ACCGTGGGGCCACTGATCTTCCTGGACAGGAGGGGTGACCATGAAGTAGAGCAGTGGGCT  
               ************************************************************ 
 
Expected       TTGCCTTCTGACACCTCAGTGGTGCTGCTGGGCGTAGGCCTGGCTGTGGTGGTGTCCCTG  
Actual         TTGCCTTCTGACACCTCAGTGGTGCTGCTGGGCGTAGGCCTGGCTGTGGTGGTGTCCCTG  
               ************************************************************ 
 
Expected       ACTCTGACTGCTGTTATCCTGGTTCTCACCAGGAGGTGTCGCACTGCCTCCCACCCTGTG  
Actual         ACTCTGACTGCTGTTATCCTGGTTCTCACCAGGAGGTGTCGCACTGCCTCCCACCCTGTG  
               ************************************************************ 
 
Expected       TCTGCTTCCGAATAAATCCAG  
Actual         TCTGCTTCCGAATAAATCCAG  
               ********************* 
 
Figure 4.9: Sequencing results for CHO-rhZP3 pcDNA4 HisMax protein expression vector. 
Sequence confirmation of CHO-rhZP3 pcDNA4 HisMax protein expression vector. The results from 
the vector sequencing (Actual), was compared to the expected DNA sequence (Expected). 
Nucleotides highlighted in blue correspond to sequence from protein expression (pcDNA4 HisMax B) 
with black nucleotides correspond to human ZP3 protein sequence. Asterisks denote sequencing 
matching.   
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Figure 4.10: CHO-rhZP3 pcDNA4 HisMax vector map. 
Vector map, showing key features of CHO-rhZP3 pcDNA4 HisMax protein expression construct. The 
CHO-hZP3 DNA sequence (labelled green arrow) is preceded by a poly-histidine tag (blue box) as well 
as an enterokinase recognition cleavage site (pink box).The completed vector DNA sequence is 6468 
bp. (Further information regarding pcDNA4 HisMax B vector features can be found in Appendix II.ii). 
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4.5.3 Transfection 
Initial attempts were made to transfect the rhZP3 pcDNA4 HisMax protein expression vector 
into an immortalised human granulosa cell line, COV434, with no success. Sequential 
attempts with a GFP-vector and a variety of transfection methods revealed this cell line was 
particularly resistant to transfection.  However successful transfection and creation of a 
stable rhZP3 pcDNA4 HisMax cell line was achieved by transfecting into a Chinese hamster 
ovary cell line (passage 11) (section 4.4.5). A Zeocin resistance cassette on the pcDNA4 
HisMax expression vector was utilised and Zeocin was used as a selection agent to enhance 
the population containing the CHO-rhZP3 pcDNA4 HisMax protein expression vector (section 
4.4.6) (figure 4.11). 
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Figure 4.11: Selection of CHO-rhZP3 pcDNA4 HisMax containing CHO cells. 
Bright field images of (a) non transfected CHO cells cultured in complete medium (passage 11), (b) non transfected CHO cells cultured in complete 
growth medium supplemented with 250 µg/ml of Zeocin (passage 11) and (c) CHO-rhZP3 pcDNA4 HisMax transfected CHO cells cultured in complete 
growth medium supplemented with 250 µg/ml of Zeocin (passage 11). All images were taken at x40 magnification.  
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4.5.4 CHO-rhZP3 protein expression 
To assess rhZP3 protein expression by CHO cells, both cell lysates and cell medium were 
collected and purified via poly-histidine tag on AcroSep IMAC HyperCell columns. Due to the 
unknown glycosylation patterning of the expressed rhZP3 the molecular weight can only be 
estimated. Based on information from sequence based molecular weight calculators, the 
protein backbone of CHO-rhZP3 can be predicted to be at least 50kDa. Western blot analysis, 
using an anti-his antibody of both samples showed no identifiable bands from cell lysate 
samples (data not shown), however samples of cell medium from transfected CHO-rhZP3 
pcDNA4 HisMax CHO cells exhibited two bands at approximately 50kDa. Samples from 
purified non-transfected CHO cell medium did exhibit one band in a similar position, 
implying a certain amount of non-specific binding (figure 4.12). 
Silver stain analysis of nitrocellulose membranes show that, even with the purification, cell 
medium from both CHO-rhZP3 pcDNA4 HisMax and non-transfected CHO cells remained 
heavily contaminated with other proteins (figure 4.13), leaving it difficult to quantify the 
CHO-rhZP3 present. 
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Figure 4.12: CHO-rhZP3 Western blotting. 
Western blot analysis, using an anti-his antibody to identify expression of his-tagged CHO-rhZP3, (a) 
from media collected and purified from CHO cells transfected with CHO-rhZP3 pcDNA4 HisMax 
protein expression vector. A doublet was identified at approximately 50kDa. (b) Media collected and 
purified form non-transfected CHO cells showed only one band, indicating that bands indicated by 
black arrows may be a result of unspecific binding, and the band indicated by the blue arrow may be 
that of CHO-rhZP3.  
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Figure 4.13: Nitrocellulose membrane protein silver stain. 
Silver staining of nitrocellulose membrane of (a) media collected and purified from CHO cells 
transfected with CHO-rhZP3 pcDNA4 HisMax protein expression vector and (b) media collected and 
purified from non-transfected CHO cells Multiple protein bands were identified in both samples, 
even after purification using the His-tag. 
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4.5.5 Acrosome reaction induction 
To establish if the crude medium purification from CHO-rhZP3 pcDNA4 HisMax transfected 
CHO cells had any functional effect on spermatozoa, purified mediums from both 
transfected and non-transfected CHO cells were incubated with human spermatozoa, then 
analysed for their ability to induce  acrosome reaction (AR) in the spermatozoa. 
Induction of spermatozoa AR was assessed by a characteristic loss of the bright FITC-PSA 
staining of the anterior portion of the spermatozoa head, often leaving a prominent band 
around the equatorial region (figure 4.14). 
Data showed there was an increase of AR induction in spermatozoa that were incubated 
with purified medium from CHO-rhZP3 pcDNA4 HisMax transfected CHO cells (58.5 ± 14.4) 
compared to that of spermatozoa incubated with purified medium from non-transfected 
CHO cells (35.5 ± 3.6). However the increase was not found to be statistically significant (P = 
0.166) (figure 4.15).  
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Figure 4.14: Acrosome reaction image scoring. 
Multiple fluorescent images were taken from AR slides, cells were visualised using a 60 X oil 
immersion lens (a), spermatozoa that had undergone the AR were characterised by loss of bright 
anterior region of the head and a characteristic brighter equatorial region (b) Spermatozoa with 
intact acrosomes were characterised by bright anterior region of the head (c).  
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Figure 4.15: CHO-rhZP3 pcDNA4 HisMax transfected CHO media acrosome induction. 
Mean percentage of AR stimulation, after incubation for 15 min with purified medium from both CHO-rhZP3 pcDNA4 HisMax transfected and non-
transfected CHO cells. Data is normalised to both maximum AR induction levels after incubation with 10 µM calcium ionophore A23187 and 
spontaneous AR induction levels after incubation with sEBSS + 0.3% (w/v) Bars represent mean (%) ± SEM and n = 3.  
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4.5.6 Ovis aries sperm-zona interaction 
There was also an investigation to assess the feasibility of using native ZP material from 
oocytes in SPR experiments, in order to identify spermatozoa-zona binding partners. Initial 
SPR experiments used heat solubilised sheep zona proteins and ram spermatozoa lysates.  
There was a small amount of binding detected when heat solubilised sheep zona was 
injected onto the chip (an increase of 90 RU) (figure 4.16). After zona immobilisation, there 
were multiple cycles of ram spermatozoa lysate injections followed by an elution phase, 
which was collected. However alignment of the sequential cycles shows that after the 
injection phase the actual binding of spermatozoa proteins to the immobilised zona was very 
low, with only a couple of cycles showing increases in the resonance unit levels (cycle B: 
11RU, cycle C: 8RU). It was noted that after every elution cycle resonance levels fell below 
initial baseline levels (figure 4.17).  
The composition of sheep zona matrix has currently not been reported, so both native sheep 
zona and recovered SPR eluate were sent for mass spectrometry analysis. Due to the lack of 
sequence information in relation to Ovis aries species, the results had to be compared to a 
general mammalian database, which generated a large number of results. 323 and 330 
proteins were identified in sheep zona and SPR eluate samples, respectively. Within the 
peptides identified bovine ZP3 and ZP4 were identified in sheep zona sample and the 
spermatozoa eluate identified members of the ADAM family (Appendix II.v, vi). 
This work was in collaboration with Dr. Stephen Young and Dr. Ashley Martin, University of 
Birmingham. 
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Figure 4.16: Native heat solubilised sheep zona immobilisation. 
BIAcore sensogram showing the amine-coupling immobilisation of native heat solubilised sheep zona. After sample injection there was an increase of 
90 resonance units (RU) (90 µl of protein was injected at a flow rate of 10 µl/min). 
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Figure 4.17: Alignments of sequential cycles of ram spermatozoa binding and elution. 
BIAcore sensogram showing three sequential cycles of attempted ram sperm binding and elution. Labelled arrows indicate the start and stop of ram 
sperm lysate solution injections (50 µl, at a flow rate of 10 µl/min). True assessment of ram sperm binding could only be made after injection had 
stopped. Elution with Glycine pH 2 (15 µl, at a flow rate of 30 µl/min) was then performed and elute was then collected.  
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4.6 Discussion 
Extracellular protein interactions are notoriously difficult to study. Often their hydrophobic 
residues leave proteins unable to solubilise, unless resorting to harsh denaturing conditions 
(Wright. 2009). Extracellular protein interactions also exhibit low affinity binding, often 
having half-lives of just seconds (van der Merwe and Barclay. 1994). The potential 
development of using SPR technology and other protein interaction techniques such as 
avidity-based extracellular interaction screening (AVEXIS) which is a novel technique for 
identifying low affinity extracellular interactions (Bushell et al. 2008) offers the opportunity 
for unbiased large scale protein screening. It is believed to be more likely that extracellular 
protein interaction events involve an array of receptors, which together increase the avidity 
enough to induce a significant signalling event (Wright. 2009). This may have contributed to 
the inability of identifying only one definitive zona receptor on spermatozoa, which could 
mean that SZB could be a result of a cohort of receptors that rely on low-affinity bonds, 
taking form as a multimeric zona recognition complex (Castle. 2002;Nixon et al. 2005). 
The inability to immobilise Bac-rhZP3 and 4 to the chip, along with the irregularities in Bac-
rhZP2 protein removal, lead to uncertainties about the structural integrity of the Bac-rhZP 
proteins. Bac-rhZP proteins could be quantified using a BCA protein assay; however, 
additional AR studies in our laboratory using the Bac-rhZP proteins showed no functional 
effect on spermatozoa (data not shown). Ultimately the Bac-rhZP proteins from 
collaborators in India were not suitable for use in these SPR studies, which led to a rethink in 
experimental strategy and led me to express my own zona proteins. 
188 
 
Purified medium from rhZP3 pcDNA4 HisMax transfected CHO cells did exhibit a band of the 
correct size for rhZP3 on a Western blot (figure 4.12 a) although rhZP3 protein recovery 
appeared low which could be due for numerous reasons. It could be as a result of low CHO-
rhZP3 protein expression or potential protein degradation. There is also the possibility that 
CHO-rhZP3 created small aggregates that may have masked the His- tag, leading to poor 
recovery after purification (Lichty et al. 2011). 
After His-tag purification, samples from CHO medium remained highly “dirty” with other 
protein contaminants that had a high affinity for positively charged nickel ions (figure 4.13 
a).The aim was to use the same His-tag chemistry to immobilise CHO-rhZP3 to the BIAcore 
sensor chip; however this level of protein contamination meant that the sole immobilisation 
of CHO-rhZP3 could not be guaranteed, making the CHO-rhZP3 purifications unsuitable for 
SPR studies. To solve this problem, dialysis of the medium or fractionation by High 
Performance Liquid Chromatography (HPLC) before purification could be useful in removing 
protein contamination in future preparations. To obtain the protein purity desired for SPR 
experiments using a different affinity tag such as FLAG or HPC might be more appropriate. 
Although purification using these tags produces a purer protein sample, it does result in a 
lower protein yield when compared to His-tag purification (Lichty at al. 2011). 
As samples were heavily contaminated it was not possible to isolate or quantify CHO-rhZP3, 
although purified CHO-rhZP3 pcDNA HisMax transfected CHO cell medium did appear to 
have an induction effect on spermatozoa AR. There was, however, still background AR 
induction caused by purified medium from non-transfected CHO cell medium (figure 4.15).  
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The possibility of immobilising native ZP in SPR studies was also investigated. Due to the 
limited availability of human ZP it was deemed appropriate to experiment and optimise 
using a more readily available source of mammalian ZP, in this case Ovis aries (sheep). As 
there is little research regarding sheep ZP, the protein content of sheep ZP had to be 
estimated based on the other mammals. Mammals such as pigs and mice contain 
approximately 4 ng and 6 ng, respectively in their zona matrices (Lowenstein and Cohen. 
1964;Noda et al. 1983). So it was estimated with 150 sheep oocytes amount of total ZP 
protein could be approximately 600-900 ng, however with only limited ZP protein we were 
not able to confirm this directly.  
Little binding of sheep zona occurred when immobilising to the SPR sensor chip, which could 
have been potentially due to low protein concentration or possible binding interference 
from native glycosylation (figure 4.16). Ram sperm lysate showed further poor binding, 
which may be due to zona denaturation by heat solubilisation during preparation; however 
there is evidence to show that ZP prepared by this method causes a functional response in 
spermatozoa (Bailey and Storey. 1994;Chiu et al. 2008a). The RU level after the elution phase 
did continuously fall below pre-spermatozoa lysate injection levels; however it cannot be 
ruled out that the elution phase was not removing the existing pre-bound sheep zona from 
the chip (figure 4.17). 
The eluate that was recovered and a sample of sheep ZP itself were sent to mass 
spectrometry analysis. Due to the lack of information regarding the sheep genome the 
peptides recovered had to be compared to a general mammalian database. This produced a 
large number of hits for both samples (Appendix II.v, vi). The identification of bovine ZP3 and 
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ZP4 in sheep zona sample and identified members of the ADAM family in the spermatozoa 
eluate suggests that binding of the ZP material to the chip and subsequently of the 
spermatozoa lysate did occur, albeit at low levels. ADAM proteins have previously been 
shown to have a role in SZB (Cho et al. 1998;Shamsadin et al. 1999;Nishimura et al. 2004). 
However without comparison to a sheep database no solid conclusions can be made. Future 
experiments need further optimisation to gain optimal binding. 150 sheep oocytes were 
used for this study; unless SPR interaction studies can be optimised using less zona material, 
this technique might not be feasible using the limited number of human oocytes available. 
Using either porcine or bovine oocytes would allow better information to be derived as mass 
spectrometry protein databases are available for these species. Using species such as rat or 
hamster would provide a physiological comparison to human SZB, due to their zona matrices 
comprising of four ZP proteins (table 4.1).  
SPR technology not only has the potential to assess protein interactions between 
spermatozoa and zona but it could also provide information of the assembly and interaction 
between the four hZP proteins themselves. As previously mentioned, whether SZB is a result 
of the peptide sequence or in fact regulated by the peptide’s carbohydrate moieties has 
been widely debated. Identification of potential binding partners through protein screening 
techniques could lead to further experiments comparing binding kinetics of glycosylated and 
deglycosylated proteins, analysing the importance of glycosylation patterning in SZB. 
This type of investigation has the potential not only to investigate the interactions between 
human spermatozoa and the zona matrix, but could also be used to elucidate other 
molecular interaction events important for fertilisation, such as interactions between 
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spermatozoa and the female reproductive tract, cumulus oophorus and oocyte plasma 
membrane.  
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CHAPTER 5 
General Discussion  
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5.1 General Discussion 
Many of the key interactions around the time of human fertilisation have not been fully 
characterised. By utilising a multi-pronged experimental approach, this study aimed to 
investigate the interactions between human spermatozoa and the released ovulatory 
components (the COC and follicular fluid), and their relationship to pregnancy outcome. 
Physiological selection  
When investigating the physiological interactions of spermatozoa and the ovulatory 
components it is important to ensure the ‘correct’ sperm population is used. In vivo the 
sperm population is selected by their ability to penetrate the viscous barriers of the cervical 
mucus (Karni et al. 1971;Wolf et al. 1977), oviduct (Jansen. 1980) and the cumulus cell 
matrix (Dandekar et al. 1992), this study aimed to develop a better selection method which 
replicated the physiological environment better than existing sperm preparation techniques. 
Data showed that motile and progressive spermatozoa were selected from raw semen 
effectively, comparable to that of the existing techniques. Preliminary unpublished data 
from within our laboratory suggests that spermatozoa penetrating through a viscous 
medium may possess lower levels of DNA damage, however this would need further 
investigation. 
The cumulus matrix and follicular fluid  
The cumulus matrix and follicular fluid are the first ovulatory components that spermatozoa 
‘see’ when they are on their final approach towards the waiting oocyte, creating a complex 
modulating environment.  
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Experiments identified higher velocity values in spermatozoa that had interacted with 
cumulus cells from ART patients who had a pregnancy-positive outcome. This suggests that 
surface receptors and/or secretory products from the cumulus cells modulate sperm 
motility. This correlates with studies showing that the cumulus oophorus produces 
modulators of sperm motility such as progesterone (Bar-Ami. 1994;Harper et al. 2004) and 
NO (Lewis et al. 1996;Machado-Oliveira et al. 2008). This is the first time to our knowledge 
that cumulus cell modulation of spermatozoa function has been reported to be indicative of 
pregnancy outcome. The mechanisms behind this interaction have not been fully elucidated 
nor has the functional role of increased sperm velocity, but it has been suggested that it may 
facilitate the penetrability of spermatozoa through the cumulus cell matrix and the ZP 
(Suarez. 2008). 
Whether the increase in velocity is a universal effect caused by cumulus cells from fertile 
patients or the effects on sperm motility are follicle-specific, would require further 
investigation to determine. Differences in sperm modulation between the cumulus cells 
from different follicles could be a marker for good oocyte quality and therefore an increased 
chance of successful ART treatment. There is evidence to suggest that cumulus cell-derived 
markers can be used to predict pregnancy outcome and our results concur with previous 
studies that expression of 11 beta-hydroxysteroid dehydrogenase, an enzyme that regulates 
the conversion of glucocorticoids, can be predicative of pregnancy outcome (Michael et al. 
1995).  
Cumulus cells may have other selective and functional effects on spermatozoa. There is 
evidence that cumulus cells select spermatozoa based on ‘normal morphology’ (Hong et al. 
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2004), and levels of DNA damage (Franken and Bastiaan. 2009); this would be interesting to 
investigate further as high levels of DNA damage in spermatozoa have previously been 
associated with poor pregnancy outcome (Simon and Lewis. 2011). It has also been 
suggested that the COC matrix and its products are responsible for inducing the AR in 
spermatozoa, challenging the traditional dogma that the ZP matrix induces the AR (Siiteri et 
al. 1988;Bedford et al. 2004;Jin et al. 2011;Watanabe and Kondoh. 2011). There may also 
chemotactic effects created by products secreted by cumulus cells, aiding spermatozoa 
migration to the oocyte (Sun et al. 2005). 
Using the modified swim-up method with cumulus or COV434 cells better replicates the 
physiological environment of the female reproductive tract. Such methods could prove 
beneficial for sperm selection for ART particularly for ICSI where current methods of 
spermatozoa selection are based on morphological characteristics and viability, which do not 
always reflect gamete quality.  
The observed increase in [Ca2+]i initiated by follicular fluid was not surprising given that 
progesterone is a known component of follicular fluid (Wen et al. 2010), and is a recognised 
initiator of Ca2+ signalling in spermatozoa (Blackmore et al. 1990;Harper et al. 2004). 
However the responses seen were larger than the progesterone controls, implying that 
other components of the follicular fluid could be causing additional [Ca2+]i  responses. In 
particular, at higher concentrations, follicular fluid elicited a novel [Ca2+]i response, which 
has not previously been reported in response to progesterone. The differing kinetics of the 
initial spike may underlie physiological responses that are not yet characterised. It could be 
that this elevated response is analogous to the ‘T-Channel’ spike seen when mouse 
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spermatozoa are stimulated to acrosome react by ZP (Bhandari et al. 2010). Further 
investigation is required to assess the possible mechanisms and the functional effects on 
spermatozoa, examining possible calcium channel or other specific antagonists of this 
response, flagellar movement and AR induction. 
The zona pellucida  
Once spermatozoa have traversed the cumulus matrix barrier, they must bind and penetrate 
the ZP in order to fuse with the oocyte plasma membrane. The molecular mechanisms 
behind this spermatozoa-zona binding (SZB) remain elusive despite decades of investigation. 
Much research in this area has relied on using a mouse model; however studies have 
highlighted intrinsic differences between mouse and human zona matrices (Lefievre et al. 
2004), calling into question the relevance of using the mouse for human fertilisation.  
Unlike cumulus cells and follicular fluid, ZP is not a surplus by-product of fertility treatment 
and obtaining sufficient human oocytes to provide ZP material for research is difficult. The 
lack of human oocytes for research, and also as donor gametes for ART treatment, has led to 
attempts to develop in vitro models of oogenesis (Hubner et al. 2003;Clark et al. 2004a;Qing 
et al. 2007). Such a model would also have the advantage of being amenable to genetic 
manipulation. Although over recent years several groups have reported hESC differentiation 
into oocyte-like structures that express some oocyte-specific markers, we are still far off 
achieving the goal of a reliable and replicable method for producing human oocytes. There is 
recent evidence that adult stem cells can be obtained from the ovarian surface epithelium 
which differentiate into of oocyte-like structures (Parte et al. 2011), and germ line markers 
have also been identified in bone marrow of mice (Johnson et al. 2005). Whether these adult 
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stem cells are more useful than hESC in developing an in vitro oogenesis model is yet to be 
determined.  
Many studies have used human recombinant ZP proteins as an alternative to native material 
and, although a useful tool, it has to be noted that there are limitations. There is still debate 
over the importance of native ZP glycosylation in SZB (Rankin et al. 2003;Shi et al. 
2004;Williams et al. 2007;Pang et al. 2011). Caution must be taken when using rhZP proteins 
that, dependent upon the heterologous system used, might not necessarily replicate the 
native glycosylation pattern. Also questions remain over how individual rhZP proteins can 
accurately reflect the three dimensional structure of the ZP matrix and how they can 
replicate the effects that the native ZP matrix elicits in spermatozoa.  
Many researchers have chased after the elusive sole zona receptor on spermatozoa; often 
using a biased approach focusing on a single protein for in vitro studies (Lopez et al. 
1985;Urch and Patel. 1991), but often in vivo fertility remained (Baba et al. 1994;Adham et 
al. 1997;Asano et al. 1997; Lu and Shur. 1997). To identify new candidate receptors and to 
address the possibility that the ZP receptor on spermatozoa is a multimeric complex, 
involving several proteins with multiple low-affinity bonds (Castle. 2002;Nixon et al. 2005), 
and an unbiased protein screening approach is vital to establishing the proteins that may 
play a role in SZB. 
Other animals such as the chimpanzee, Rhesus macaque, hamster and rat have all been 
identified as having four ZP proteins within their ZP matrices (table 4.1). These offer the 
opportunity of animal models more relevant for human fertilisation. 
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Elucidation of the interactions between human spermatozoa, the oocyte vestments and 
follicular fluid is a challenging field of research due to ethical and practical restrictions on 
using human subjects and it requires novel approaches. Elucidation of the molecular 
mechanisms could be of clinical relevance, leading to better treatment and diagnosis for ART 
patients. Improved sperm selection could be particularly useful in patients undergoing ICSI, 
where spermatozoa are currently selected based on morphology and viability. Markers 
predictive of fertilisation success expressed in cumulus cells could also aid oocyte/embryo 
selection. New clinical pathologies could be discovered which could provide a diagnosis for 
some of the 23.9% of patients with unexplained infertility (HFEA. 2008). Sequence variations 
in human ZP genes have already been shown to have a direct correlation with ART 
fertilisation success (Männikkö et al. 2005). In addition to promoting fertilisation, elucidation 
of key interactions critical to fertilisation success could provide targets for novel non-
hormonal contraceptives. 
Although further investigation is needed within this field it does appear that the ovulatory 
components, the COC and follicular fluid are not mere bystanders in the process of 
fertilisation and are critical to fertilisation success.  
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APPENDIX 
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Appendix I: Chapter 2 
Appendix I. i 
Supplemented Earle’s Balanced Salt Solution (sEBSS) 
1 mM Sodium Dihyd. Phosphate   
5.4 mM Potassium Chloride    
0.81 mM Magnesium Sulphate.7H2O   
5.6 mM Dextrose Anhydrous    
2.7 mM Sodium Pyruvate    
41.8 mM DL-Lactic Acid, Sodium   
5 mM Calcium Chloride.2H2O   
26.2 mM Sodium Bicarbonate    
85.6 mM Sodium Chloride    
10 mM HEPES     
 
sEBSS had an osmolarity of 285-295 mOsm, with pH 7.3-7.4, produced by Geneflow, Fradley, UK.  
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Appendix I.ii  
Straight line velocity (VSL) P values 
 IVF ICSI COV434 
IVF  0.850 0.834 
ICSI 0.850  0.886 
COV434 0.834 0.886  
 
 Positive pregnancy outcome Negative pregnancy 
outcome 
Positive pregnancy outcome  0.086 
Negative pregnancy 
outcome 
0.086  
 
P values from students independent t-test relating to figure 2.6 a, b.  
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Appendix I.iii 
Average path velocity (VAP) P values  
 IVF ICSI COV434 
IVF  0.961 0.874 
ICSI 0.961  0.741 
COV434 0.874 0.741  
 
 Positive pregnancy outcome Negative pregnancy 
outcome 
Positive pregnancy outcome  0.054 
Negative pregnancy 
outcome 
0.054  
 
P values from students independent t-test relating to figure 2.7 a, b 
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Appendix I.iv 
Curvilinear velocity (VCL) P values  
 IVF ICSI COV434 
IVF  0.720 0.782 
ICSI 0.720  0.944 
COV434 0.782 0.944  
 
 Positive pregnancy outcome Negative pregnancy 
outcome 
Positive pregnancy outcome  0.211 
Negative pregnancy 
outcome 
0.211  
 
P values from students independent t-test relating to figure 2.8 a, b 
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Appendix I. v 
Lateral head displacement (ALH) P values 
 IVF ICSI COV434 
IVF  0.635 0.789 
ICSI 0.635  0.708 
COV434 0.789 0.708  
 
 Positive pregnancy outcome Negative pregnancy 
outcome 
Positive pregnancy outcome  0.950 
Negative pregnancy 
outcome 
0.950  
 
P values from students independent t-test relating to figure 2.9 a, b. 
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Appendix I.vi 
Beat cross frequency (BCF) P values  
 IVF ICSI COV434 
IVF  0.810 0.611 
ICSI 0.810  0.335 
COV434 0.611 0.335  
 
 Positive pregnancy outcome Negative pregnancy 
outcome 
Positive pregnancy outcome  0.06 
Negative pregnancy 
outcome 
0.06  
 
P values from students independent t-test relating to figure 2.10 a, b. Green boxes highlighting 
statistical significance, P<0.05. 
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Appendix I.vii 
Sperm population responses 
 
IVFPos  
10% (v/v) 
IVFNeg  
10% (v/v) 
ICSIPos 
10% (v/v) 
ICSINeg  
10% 
(v/v) 
 
IVFPos 
10% 
(v/v)  
2nd app 
IVFPos  
50% (v/v) 
 
ICSIPos  
10% (v/v)  
2nd app 
ICSIPos 
50% 
(v/v) 
Prog  
(3.2 µM) 
IVFPos 10% (v/v)  0.405 0.270 0.526 0.899 0.825 0.352 1.000 0.039 
IVFNeg  10% (v/v) 0.405  0.491 0.522 0.415 0.386 0.949 0.405 0.691 
ICSIPos 10% (v/v) 0.270 0.491  0.861 0.332 0.283 0.431 0.270 0.058 
ICSINeg 10% (v/v) 0.526 0.522 0.861  0.562 0.478 0.456 0.526 0.123 
IVFPos 10% (v/v) 
2nd app 
0.899 0.415 0.332 0.562  0.749 0.309 0.899 0.042 
IVFPos 50% (v/v) 0.825 0.386 0.283 0.478 0.749  0.334 0.825 0.039 
ICSIPos 10% (v/v) 
2nd app 
0.352 0.949 0.431 0.456 0.309 0.334  0.352 0.739 
ICSIPos 50% (v/v) 1.000 0.405 0.270 0.526 0.899 0.825 0.352  0.039 
Prog (3.2 µM) 0.039 0.691 0.058 0.123 0.042 0.039 0.739 0.039  
P values from students paired t-test relating to figure 2.15. Green boxes highlighting statistical significance, P<0.05. 
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Appendix I.viii  
Quantification of human follicular fluid components 
 #119ECF01 #119ECF04 #119ECF05 #119ECF06 #119ECF07 #119ECF08 #119ECF10 #119ECF11 
Oestrone 118.5926 396.7556 170.637 163.7778 171.3037 143.4259 297.5778 124.8074 
Oestradiol 512.989 817.3676 947.8456 846.8824 912.0956 612.4743 1705.857 554.5809 
Progesterone 978.7383 4409.552 2360.979 7279.966 6776.985 16716.87 10834.14 15140.27 
17-hydroxyprogesterone 2610.246 6504.997 5260.637 7444.616 6808.218 6868.412 8981.477 5567.998 
Pregnenolone 453.6076 234.1456 418.7658 1092.848 557.9747 302.4367 694.9367 718.3861 
17-Hydroxypregnenolone 4.98494 9.86747 20.1747 24.4006 10.54819 20.16566 24.00904 9.490964 
Glucocorticoid S 0.893064 3.375723 1.765896 4.306358 1.430636 2.219653 6.927746 3.520231 
Glucocorticoid E 4.476732 11.12721 6.463621 23.16123 11.03599 15.84141 28.73242 9.338035 
Glucocorticoid F 28.24461 42.49506 30.45082 83.25166 46.73122 57.64213 82.63942 43.26655 
Glucocorticoid B N/A N/A N/A N/A N/A N/A 0.305063 1.950535 
Dehydroepiandrosterone N/A N/A N/A N/A N/A N/A N/A N/A 
Androstenedione 336.0979 140.2448 165.2098 101.5175 54.44755 147.8776 672.3811 168.3636 
Testosterone 0.854167 N/A 0.607639 N/A N/A N/A 5.864583 0.107639 
Dihydrotestosterone 1.927586 0.786207 1.489655 N/A 1.017241 1.913793 5.075862 0.834483 
Values represent nM concentrations. This work was in collaboration with Dr. Angela Taylor and Dr. Wiebke Arlt, University of Birmingham   
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 #119ECF16 #119ECF18 #119ECF19 #119ECF20 #119ECF21 #119ECF22 #119ECF23 #119ECF25 
Oestrone 107.7333 88.69259 275.9519 112.2667 341.1444 107.6704 77.28889 290.6296 
Oestradiol 558.6875 597.5735 1375.158 432.8309 1260.195 601.0772 887.1324 576.8493 
Progesterone 10913.77 27863.76 19796.74 18607.8 8051.036 38077.9 14965.77 13701.41 
17-hydroxyprogesterone 3270.886 4016.742 8815.08 1994.037 5877.967 7405.614 4566.279 3289.448 
Pregnenolone 473.2595 1424.494 1249.146 450.981 700.1899 1655.38 922.3734 308.1646 
17-Hydroxypregnenolone 25.15663 5.942771 22.25 17.62952 28.75602 8.927711 0.674699 10.23494 
Glucocorticoid S 2.141618 0.867052 6.569364 0.794798 4.482659 2.578035 2.442197 1.855491 
Glucocorticoid E 18.94589 15.21609 18.43746 6.604525 12.88567 16.6207 -3.1459 15.59509 
Glucocorticoid F 58.50188 43.68508 39.15042 24.28032 62.38185 47.94864 N/A 40.453 
Glucocorticoid B N/A N/A N/A N/A N/A N/A N/A N/A 
Dehydroepiandrosterone 13.55556 N/A N/A N/A 9.510417 N/A N/A N/A 
Androstenedione 1313.448 47.77622 154.3042 74.53497 2003.748 45.48252 477.601 95.42657 
Testosterone 4.052083 N/A 0.006944 N/A 17.94444 N/A 0.934028 N/A 
Dihydrotestosterone 1.568966 3.786207 1.924138 0.424138 2.155172 2.941379 3.086207 1.7 
Values represent nM concentrations. This work was in collaboration with Dr. Angela Taylor and Dr. Wiebke Arlt, University of Birmingham. 
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Appendix II: Chapter 4 
Appendix II.i 
 
 
BIAcore sensogram showing attempted removal of Bac-rhZP2, with three rounds of 10mM Glycine pH 2.2, two successive rounds of 15 µl at a flow 
rate of 30 µl/min, followed by one round of 15 µl at a flow rate of 10 µl/min. RU levels stayed at 19727.8, above pre-bound Bac-rhZP2 RU levels. 
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Appendix II.ii 
pcDNA4 HisMax B vector map 
 
 
(Invitrogen. 2011c)  
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Appendix II.iii 
pcDNA4 HisMax B polylinker  
 
 
(Invitrogen. 2011a)  
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Appendix II.iv 
rhZP3 pcDNA4 HisMax B sequence  
GACGGATCGGGAGATCTCCCGATCCCCTATGGTCGACTCTCAGTACAATCTGCTCTGATGCCGCATAGTT 
AAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCGCGAGCAAAATTTAAGCTACA 
ACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTGCTTAGGGTTAGGCGTTTTGCGCTGCTTCGCG 
ATGTACGGGCCAGATATACGCGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTC 
ATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCG 
CCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCC 
ATTGACGTCAATGGGTGGACTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCC 
AAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTA 
TGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGC 
AGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAA 
TGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACG 
CAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCTGGCTAACTAGAGAACCCA 
CTGCTTACTGGCTTATCGAAATTAATACGACTCACTATAGGGAGACCCAAGCTGGCTAGCGTTTAAACTT 
AAGCTTAGCGCAGAGGCTTGGGGCAGCCGAGCGGCAGCCAGGCCCCGGCCCGGGCCTCGGTTCCAGAAGG 
GAGAGGAGCCCGCCAAGGCGCGCAAGAGAGCGGGCTGCCTCGCAGTCCGAGCCGGAGAGGGAGCGCGAGC 
CGCGCCGGCCCCGGACGGCCTCCGAAACCATGGGGGGTTCTCATCATCATCATCATCATGGTATGGCTAG 
CATGACTGGTGGACAGCAAATGGGTCGGGATCTGTACGACGATGACGATAAGGTACCTAAGGATCCAGTG 
TGGTGGAATTCTGCAGATCAACCCCTCTGGCTCTTGCAGGGTGGAGCCAGCCATCCTGAGACGTCCGTAC 
AGCCCGTACTGGTGGAGTGTCAGGAGGCCACTCTGATGGTCATGGTCAGCAAAGACCTTTTTGGCACCGG 
GAAGCTCATCAGGGCTGCTGACCTCACCTTGGGCCCAGAGGCCTGTGAGCCTCTGGTCTCCATGGACACA 
GAAGATGTGGTCAGGTTTGAGGTTGGACTCCACGAGTGTGGCAACAGCATGCAGGTAACTGACGATGCCC 
TGGTGTACAGCACCTTCCTGCTCCATGACCCCCGCCCCGTGGGAAACCTGTCCATCGTGAGGACTAACCG 
CGCAGAGATTCCCATCGAGTGCCGCTACCCCAGGCAGGGCAATGTGAGCAGCCAGGCCATCCTGCCCACC 
TGGTTGCCCTTCAGGACCACGGTGTTCTCAGAGGAGAAGCTGACTTTCTCTCTGCGTCTGATGGAGGAGA 
ACTGGAACGCTGAGAAGAGGTCCCCCACCTTCCACCTGGGAGATGCAGCCCACCTCCAGGCAGAAATCCA 
CACTGGCAGCCACGTGCCACTGCGGTTGTTTGTGGACCACTGCGTGGCCACACCGACACCAGACCAGAAT 
GCCTCCCCTTATCACACCATCGTGGACTTCCATGGCTGTCTTGTCGACGGTCTCACTGATGCCTCTTCTG 
CATTCAAAGTTCCTCGACCCGGGCCAGATACACTCCAGTTCACAGTGGATGTCTTCCACTTTGCTAATGA 
CTCCAGAAACATGATATACATCACCTGCCACCTGAAGGTCACCCTAGCTGAGCAGGACCCAGATGAACTC 
AACAAGGCCTGTTCCTTCAGCAAGCCTTCCAACAGCTGGTTCCCAGTGGAAGGCCCGGCTGACATCTGTC 
AATGCTGTAACAAAGGTGACTGTGGCACTCCAAGCCATTCCAGGAGGCAGCCTCATGTCATGAGCCAGTG 
GTCCAGGTCTGCTTCCCGTAACCGCAGGCATGTGACAGAAGAAGCAGATGTCACCGTGGGGCCACTGATC 
TTCCTGGACAGGAGGGGTGACCATGAAGTAGAGCAGTGGGCTTTGCCTTCTGACACCTCAGTGGTGCTGC 
TGGGCGTAGGCCTGGCTGTGGTGGTGTCCCTGACTCTGACTGCTGTTATCCTGGTTCTCACCAGGAGGTG 
TCGCACTGCCTCCCACCCTGTGTCTGCTTCCGAATAAATCCAGCACAGTGGCGGCCGCTCGAGTCTAGAG 
GGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCTGTTGTTTGCCCCTC 
CCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAATGAGGAAATTGCA 
TCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAGCAAGGGGGAGGATT 
GGGAAGACAATAGCAGGCATGCTGGGGATGCGGTGGGCTCTATGGCTTCTGAGGCGGAAAGAACCAGCTG 
GGGCTCTAGGGGGTATCCCCACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGC 
AGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCA 
CGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGCATCCCTTTAGGGTTCCGATTTAGTGCTTTACG 
GCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTT 
TTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCA 
ACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGGGGATTTCGGCCTATTGGTTAAAAAATGA 
GCTGATTTAACAAAAATTTAACGCGAATTAATTCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCC 
CAGGCTCCCCAGGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGT 
CCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCC 
CCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATT 
TTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGCTATTCCAGAAGTAGTGAGGAGGCTTTT 
TTGGAGGCCTAGGCTTTTGCAAAAAGCTCCCGGGAGCTTGTATATCCATTTTCGGATCTGATCAGCACGT 
GTTGACAATTAATCATCGGCATAGTATATCGGCATAGTATAATACGACAAGGTGAGGAACTAAACCATGG 
CCAAGTTGACCAGTGCCGTTCCGGTGCTCACCGCGCGCGACGTCGCCGGAGCGGTCGAGTTCTGGACCGA 
213 
 
CCGGCTCGGGTTCTCCCGGGACTTCGTGGAGGACGACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTG 
TTCATCAGCGCGGTCCAGGACCAGGTGGTGCCGGACAACACCCTGGCCTGGGTGTGGGTGCGCGGCCTGG 
ACGAGCTGTACGCCGAGTGGTCGGAGGTCGTGTCCACGAACTTCCGGGACGCCTCCGGGCCGGCCATGAC 
CGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCCTGCGCGACCCGGCCGGCAACTGCGTGCACTTC 
GTGGCCGAGGAGCAGGACTGACACGTGCTACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGG 
GCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTT 
CGCCCACCCCAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACA 
AATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCT 
GTATACCGTCGACCTCTAGCTAGAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTA 
TCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTG 
AGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGC 
ATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCAC 
TGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTA 
TCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTA 
AAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTC 
AAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTG 
CGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGC 
TTTCTCAATGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCA 
CGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGA 
CACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTA 
CAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCT 
GAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGT 
GGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTT 
CTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAG 
GATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACT 
TGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCA 
TAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGC 
AATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCC 
GAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG 
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTC 
GTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTG 
TGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCAC 
TCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGG 
TGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATA 
CGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAA 
AACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTC 
AGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGA 
ATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGG 
GTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCAC 
ATTTCCCCGAAAAGTGCCACCTGACGTC 
 
Black text denotes pcDNA4 His Max B DNA sequence from (Invitrogen. 2011b), red text denotes 
human ZP3 sequence.  
 
214 
 
Appendix II.v 
Sheep zona 
Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score 
H4_MOUSE 6 45.6 LONF1_HUMAN 2 1.4 HBB_SUNMU 1 15.1 TRIMM_HUMAN 2 5.2 
DCD_HUMAN 5 28.2 DYH1_HUMAN 1 0.5 LASP1_MOUSE 2 7.6 TET1_HUMAN 1 1.4 
CASA1_BOVIN 4 17.8 UBP54_MOUSE 1 1.8 NAP1_RAT 2 5.1 DLG5_HUMAN 1 1.1 
H33_PONAB 4 24.3 PK3CA_HUMAN 3 2.2 PSMD9_RAT 2 9.9 MRRP1_RAT 2 5.8 
H2AJ_HUMAN 3 20.9 CH10_HUMAN 1 23.5 KLH26_MOUSE 1 2.3 BIRC6_HUMAN 1 0.4 
GFAP_BOVIN 3 6.8 CCD52_PONAB 2 2.7 K1C9_RAT 1 3.6 YD026_HUMAN 1 2.7 
ZP3_BOVIN 3 9.7 NUMA1_HUMAN 2 1.5 PAF_RAT 1 16.4 SPA2L_HUMAN 1 3.5 
CTRO_MOUSE 3 2.5 MCM6_MOUSE 2 2.1 METH_HUMAN 1 1.3 NSUN6_HUMAN 1 6.4 
H2AV_MOUSE 3 23.4 SPTN5_HUMAN 2 0.4 CCD71_MOUSE 2 3.7 SAMD7_MOUSE 1 11.1 
H2B2E_PONAB 3 18.3 ITPR3_HUMAN 2 0.4 ZKSC4_HUMAN 1 6.1 PHF20_HUMAN 1 1.4 
TITIN_HUMAN 2 0.2 CKAP5_HUMAN 1 1.3 CELR2_RAT 1 1.3 TMPS7_HUMAN 1 2.2 
NSD2_MOUSE 3 2.1 ARFG3_MOUSE 1 2.9 BANK1_MOUSE 2 2.3 RPA34_HUMAN 1 1.6 
ASPM_SHEEP 2 1.6 CSTFT_MOUSE 2 4.3 LMO7_HUMAN 1 1.4 MMP20_PIG 1 5.4 
BPAEA_HUMAN 3 1.2 POL2_MOUSE 2 1.2 LPHN3_RAT 2 1.2 CE152_HUMAN 1 1.4 
ZP4_BOVIN 1 2.2 HMCN1_HUMAN 1 0.9 LCMT2_HUMAN 1 2.3 E41L1_HUMAN 1 3.2 
TITIN_MOUSE 3 0.1 DEN5B_HUMAN 1 2.8 LAMB2_MOUSE 2 1.4 PLD1_RAT 1 2.0 
DYH17_MOUSE 2 1.3 CJ079_HUMAN 1 1.6 MYOM3_MOUSE 2 1.4 CROCC_HUMAN 1 1.0 
ARI2_MOUSE 2 6.5 CP250_HUMAN 1 0.8 PTHB1_HUMAN 1 3.6 ADAD1_HUMAN 1 1.6 
SRRM2_MOUSE 2 1.8 FSIP2_HUMAN 1 1.2 ADCYA_RAT 2 0.7 CO039_MOUSE 1 2.2 
H11_BOVIN 2 23.1 CAC1A_RAT 2 0.5 NLRC3_HUMAN 1 2.2 Z518A_RAT 1 0.9 
DYH11_HUMAN 1 0.8 NR1D1_MOUSE 1 5.7 ARHGB_RAT 1 1.0 SODE_HUMAN 1 12.5 
APOA1_BOVIN 1 8.3 IGS10_MOUSE 1 1.3 EIF3C_BOVIN 2 2.0 WDR33_HUMAN 1 2.0 
RHG05_MOUSE 3 1.4 DYSF_MOUSE 1 1.2 GEMI5_MOUSE 1 1.8 IFIX_HUMAN 1 5.9 
SYNE1_HUMAN 2 0.4 SLIT1_MOUSE 2 1.8 ZN407_HUMAN 1 1.5 CD244_MOUSE 1 6.3 
SYNC_HUMAN 2 6.2 TRFL_HUMAN 1 2.4 RS30_HUMAN 1 10.2 BAI1_HUMAN 1 1.3 
SYRC_CRILO 2 3.6 CM038_MOUSE 2 8.4 H90B4_HUMAN 1 6.1 IF4G3_MOUSE 1 1.7 
GNN_RAT 1 1.8 APC1_MOUSE 2 1.2 MDR3_MOUSE 1 2.2 MN1_HUMAN 1 1.7 
KDM3A_MOUSE 2 1.1 AP4M1_HUMAN 2 4.9 ROR2_HUMAN 1 3.1 RNF14_MOUSE 1 3.9 
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Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score 
NRX1A_MOUSE 1 2.0 CFAH_HUMAN 1 0.8 C2TA_HUMAN 1 2.1 APBA2_PONAB 1 1.1 
ACE_RAT 1 2.3 ZFHX3_HUMAN 1 0.3 ZBT38_RAT 1 0.9 CMYA5_HUMAN 1 0.5 
NKTR_MOUSE 1 0.8 CE164_HUMAN 1 0.7 TRI13_MOUSE 1 3.2 PLMN_MACEU 1 2.2 
EIF3D_MOUSE 1 3.8 PER1_RAT 1 0.8 LCN10_MOUSE 1 3.8 TLR8_HUMAN 1 1.2 
S10A8_HUMAN 1 11.8 SCN4A_MOUSE 1 0.7 HOT_MOUSE 1 4.1 ANO9_MOUSE 1 1.3 
TNR17_HUMAN 1 8.7 NWD1_MOUSE 1 0.6 PDE11_MOUSE 1 1.3 KCNB2_HUMAN 1 1.2 
ASXL3_MOUSE 1 1.2 TMM9B_HUMAN 1 3.0 K1C23_HUMAN 1 2.8 GRAB_MOUSE 1 4.0 
SIA4B_RAT 1 1.7 AA2AR_HORSE 1 4.6 UBN1_MOUSE 1 0.7 TBCD1_BOVIN 1 2.7 
ZN512_MOUSE 1 2.1 ADA19_MOUSE 1 1.4 ATL1_MOUSE 1 2.9 TRAF3_HUMAN 1 2.6 
FETUA_BOVIN 1 2.8 FA18B_MOUSE 1 4.4 NOTC1_RAT 1 0.6 AGRIN_MOUSE 1 0.6 
PCGF1_RAT 1 5.3 RBM5_MOUSE 1 1.2 TRM2_MOUSE 1 2.6 CNDH2_BOVIN 1 1.6 
RN19B_HUMAN 1 1.1 CENPS_BOVIN 1 5.1 SECR_BOVIN 1 22.2 HSP74_RAT 1 1.1 
IPO5_MOUSE 1 2.1 GP176_RAT 1 2.5 INHBA_MOUSE 1 4.2 ZN391_HUMAN 1 4.5 
CE192_HUMAN 1 0.5 MYO1G_MOUSE 1 1.2 ESX1_HUMAN 1 3.7 AT1A1_PIG 1 0.8 
KBTB8_MOUSE 1 2.5 TLR13_MOUSE 1 1.5 LACB2_RAT 1 4.2 DDHD1_MOUSE 1 1.8 
M3K12_MOUSE 1 0.7 WNT1_HUMAN 1 2.2 NCOA6_RAT 1 3.3 CP048_BOVIN 1 4.3 
NPA1P_HUMAN 1 0.4 IMPA3_MOUSE 1 2.2 VIP_CANFA 1 21.4 URP2_MOUSE 1 1.2 
CASA2_BOVIN 1 5.0 FUT10_BOVIN 1 2.3 PEX5_HUMAN 1 2.8 RNAS1_NIVCR 1 14.8 
ZFP57_HUMAN 1 3.1 MX2_SHEEP 1 2.0 CP21A_MOUSE 1 3.5 ZNRF2_HUMAN 1 4.1 
CCND1_CANFA 1 4.7 NKD2_HUMAN 1 4.0 XPOT_MOUSE 1 1.7 CI068_RAT 1 2.0 
ANKR6_MOUSE 1 2.2 MS3L2_HUMAN 1 2.5 OSBL8_HUMAN 1 1.3 PHTNS_PIG 1 1.3 
SPX3_BOVIN 1 1.6 GDF8_TAUDE 1 2.7 GP152_HUMAN 1 1.3 CB088_HUMAN 1 20.0 
MESD_MOUSE 1 2.2 YETS4_HUMAN 1 4.4 ABCA3_MOUSE 1 0.9 UBP43_MOUSE 1 0.8 
QRSL1_MACFA 1 2.7 RBBP5_MOUSE 1 2.0 ERF3B_PONAB 1 1.6 DEF2_RABIT 1 23.5 
ID1_HUMAN 1 7.1 CP042_MOUSE 1 5.3 TF2LX_PAPHA 1 5.5 ZN467_HUMAN 1 2.7 
ATP4B_HUMAN 1 6.5 SUNC1_BOVIN 1 3.1 P2RY2_HUMAN 1 3.4 COQ4_BOVIN 1 7.9 
HECAM_BOVIN 1 1.7 UHRF2_HUMAN 1 1.0 OSBL6_HUMAN 1 0.9 GSCR2_HUMAN 1 1.5 
ES8L2_MOUSE 1 1.1 FR1L5_HUMAN 1 0.4 SPKAP_RAT 1 0.5 SCRN3_HUMAN 1 3.5 
SPY1_HUMAN 1 4.4 INAR1_BOVIN 1 2.9 RN219_HUMAN 1 1.9 REST_HUMAN 1 0.7 
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Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score 
GALT8_HUMAN 1 3.3 MYD88_HUMAN 1 3.7 SBNO1_RAT 1 0.7 
HXD1_MOUSE 1 4.6 AP2A_SHEEP 1 2.6 TFB2M_MOUSE 1 3.8 
CAH4_RABIT 1 2.9 ELFN1_MOUSE 1 2.1 ZN251_HUMAN 1 1.1 
RENBP_MOUSE 1 1.4 TFP11_RABIT 1 1.0 LPIN2_HUMAN 1 1.8 
GP158_HUMAN 1 0.7 F161A_MOUSE 1 1.8 UBE2C_BOVIN 1 7.8 
CP2E1_BOVIN 1 2.4 EFR3A_MOUSE 1 1.8 ZN414_RAT 1 3.0 
ZCHC8_PONAB 1 2.1 NDRG4_HUMAN 1 3.7 FOG1_HUMAN 1 2.1 
RBL2_MOUSE 1 0.6 T2AG_MOUSE 1 10.1 ROMO1_PIG 1 30.4 
BIRC5_BOVIN 1 12.7 P4R3A_MOUSE 1 1.2 EHBP1_HUMAN 1 0.7 
TVB5_MOUSE 1 14.8 TAF9_BOVIN 1 5.3 CC075_MOUSE 1 8.6 
DIP2B_MOUSE 1 0.6 EID3_BOVIN 1 4.0 LRP2_RAT 1 0.3 
S46A3_HUMAN 1 4.6 GASP2_MOUSE 1 1.0 VTDB_MOUSE 1 4.2 
GPN1_MOUSE 1 4.6 RHG07_MOUSE 1 1.3 ARRD3_BOVIN 1 4.8 
EMAL5_RAT 1 0.5 VPS35_HUMAN 1 1.3 PELO_MOUSE 1 6.2 
ACTBL_HUMAN 1 4.8 TLR2_HORSE 1 1.4 ENPP2_RAT 1 1.5 
PCSK5_MOUSE 1 1.1 BMCC1_HUMAN 1 0.5 PAPOA_MOUSE 1 1.9 
ABCA2_HUMAN 1 0.6 S41A1_HUMAN 1 3.5 MPRB_MOUSE 1 2.0 
GTPB3_MOUSE 1 4.7 GP124_HUMAN 1 0.8 THTPA_MACFA 1 10.0 
ANR40_HUMAN 1 2.2 ZDBF2_HUMAN 1 0.5 TDRD5_MOUSE 2 2.3 
SIN1_MOUSE 1 1.0 ASPP2_MOUSE 1 1.1 WDR44_RAT 1 2.3 
RCBT1_HUMAN 1 2.4 KDM6A_MOUSE 1 0.9 TLR9_PIG 1 1.3 
PTN6_MOUSE 1 2.7 CC110_MOUSE 1 1.7 VWA3A_RAT 1 4.6 
ESRP1_HUMAN 1 2.1 CHERP_HUMAN 1 0.5 
   SCEL_HUMAN 1 2.2 YK006_HUMAN 1 3.5 
   HBAZ_HORSE 1 7.0 TRI45_MOUSE 1 1.6 
   CC129_HUMAN 1 1.9 PKHA5_HUMAN 1 1.3 
   LMTK3_MOUSE 1 0.8 YD002_HUMAN 1 2.5 
   EFR3B_MOUSE 1 1.5 MTND_RAT 1 8.9 
   BMP3B_BOVIN 1 2.3 GFPT1_RAT 1 3.4 
    
216
 
217 
 
Appendix II.vi 
Sperm elute  
Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score 
BPAEA_HUMAN 2 1.3 TRY3_RAT 2 11.3 F132B_HUMAN 1 3.1 KIFC3_MOUSE 1 2.5 
RBP2_HUMAN 2 1.3 NEBU_HUMAN 2 0.4 PKN3_HUMAN 2 3.5 CPZIP_MOUSE 1 3.4 
ASPM_MACFA 2 1.1 NUMA1_HUMAN 2 1.0 GG6L6_HUMAN 2 2.4 PTN11_HUMAN 1 2.5 
SYNE1_HUMAN 1 0.6 CENPF_HUMAN 1 1.6 TBX18_MOUSE 2 2.9 MIDA_BOVIN 1 4.8 
S10A8_HUMAN 1 11.8 APOB_RAT 1 0.5 MRCKB_HUMAN 1 1.5 NASP_HUMAN 1 2.7 
SYNE2_HUMAN 1 0.8 NPT2A_SHEEP 2 3.4 ZN252_CANFA 1 1.7 PININ_BOVIN 1 3.4 
TARA_HUMAN 2 1.6 LTBP4_HUMAN 1 1.8 FEN1_MOUSE 1 5.3 PYC_MOUSE 1 1.5 
UBP38_MOUSE 2 2.4 MYH1_HUMAN 1 1.6 PCDG7_PANTR 1 2.3 IGEB_MOUSE 1 3.2 
FBN2_HUMAN 2 2.7 EP400_HUMAN 2 1.1 XIRP2_RAT 2 0.6 SMC1B_HUMAN 1 1.6 
DYH1_RAT 1 0.6 SLN13_HUMAN 1 3.0 PK3CA_HUMAN 2 1.2 ZN296_HUMAN 1 3.6 
ABCF1_MOUSE 1 1.3 PRGR_ATEPA 1 2.5 HORN_HUMAN 1 1.3 DIDO1_HUMAN 1 1.4 
MACF1_HUMAN 2 0.7 SPTCS_HUMAN 2 1.5 ATS15_MOUSE 1 2.5 SAC1_MOUSE 1 2.7 
SYNJ1_BOVIN 2 2.3 ASPM_MOUSE 1 0.9 PLAK_MOUSE 1 3.1 SRBD1_PONAB 1 2.0 
PDE1A_HUMAN 2 4.3 ANKF1_HUMAN 2 4.2 TIM_MOUSE 1 2.1 CR058_HUMAN 1 4.3 
OPTN_PONAB 3 3.6 CASA2_BOVIN 2 8.1 MASTL_MOUSE 1 1.3 BIG1_BOVIN 1 1.5 
XAF1_BOVIN 1 2.7 TIAM2_MOUSE 1 0.6 PCLO_MOUSE 1 0.6 IRF3_PIG 1 3.8 
MTL5_RAT 3 4.2 RPP38_BOVIN 3 13.5 CP4B1_RAT 2 4.7 DOP2_HUMAN 1 0.6 
CHD2_HUMAN 3 1.0 MYH9_RAT 2 1.2 FA5_PIG 2 1.0 OAS3_HUMAN 1 1.7 
KIF11_HUMAN 1 2.5 ASAP2_MOUSE 2 1.4 EWS_MOUSE 1 2.9 BRI3_BOVIN 1 7.3 
AGRIN_MOUSE 3 1.4 ZN567_HUMAN 2 2.2 TRIMM_HUMAN 1 3.4 LIN9_MACFA 1 4.1 
THAP4_RAT 1 4.0 ZN492_HUMAN 1 4.3 ATS12_MOUSE 1 0.8 F75A6_HUMAN 1 2.0 
DNJC2_RAT 2 3.5 ANR50_HUMAN 1 1.2 ASPM_CANFA 1 0.8 HAUS5_MOUSE 1 1.9 
TTLL5_CERAE 1 0.8 PPIP1_MOUSE 1 6.3 MYOME_HUMAN 2 1.4 ASPM_BOVIN 1 0.4 
SLX4_HUMAN 2 2.0 LRRN1_MOUSE 2 2.2 ATS19_HUMAN 1 1.3 CI117_RAT 1 1.3 
CALL5_HUMAN 2 6.2 MT3_MACFA 1 29.4 HRT7A_BOVIN 1 1.0 FURIN_BOVIN 1 4.9 
RBM44_MOUSE 2 3.1 CBPC2_MOUSE 1 2.8 CA189_HUMAN 1 27.7 SPT5H_MOUSE 1 2.8 
SCFD1_RAT 2 4.4 CKAP4_HUMAN 2 5.3 GPSM3_HUMAN 1 18.1 MK06_RAT 1 2.6 
CKP2L_BOVIN 2 5.1 CCD33_MOUSE 1 1.3 SVEP1_HUMAN 1 0.6 DSCL1_HUMAN 1 0.9 
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Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score 
PKHG5_MOUSE 1 2.4 KRI1_HUMAN 1 2.1 TM2D2_RAT 1 3.3 SOSSC_MOUSE 1 12.5 
DYH6_HUMAN 1 0.5 CT177_HUMAN 1 2.9 KANK4_HUMAN 1 1.2 K1C40_HUMAN 1 2.8 
GOGB1_HUMAN 1 0.6 CELR1_HUMAN 1 0.3 OCAD2_MOUSE 1 6.5 NOL3_MOUSE 1 3.2 
SETX_HUMAN 1 0.7 TULP3_MOUSE 1 2.0 RL18_MOUSE 1 10.1 FBX18_HUMAN 1 1.6 
LBXCO_HUMAN 1 3.0 LRC41_MOUSE 1 2.6 SRRM2_MOUSE 1 0.3 ASIP_HUMAN 1 17.4 
CC114_RAT 1 2.3 RGPA2_RAT 1 0.6 STABP_RAT 1 1.4 CP11A_RAT 1 2.5 
CAN11_RAT 1 4.6 EPN2_HUMAN 1 4.4 PRPS2_HUMAN 1 4.1 AT1B2_MOUSE 1 5.2 
TR10A_HUMAN 1 4.7 SSPO_HUMAN 1 0.2 K1143_HUMAN 1 9.1 PR2B1_MOUSE 1 5.3 
CCD39_MOUSE 1 1.0 ATS17_HUMAN 1 1.1 ADAM2_CAVPO 1 1.6 U633B_HUMAN 1 18.1 
ZN287_MOUSE 1 2.2 IKBZ_HUMAN 1 1.4 TEC_MOUSE 1 1.9 CB053_HUMAN 1 1.9 
TBCK_MOUSE 1 2.2 RMTL1_MOUSE 1 5.3 GNTK_HUMAN 1 7.0 BAZ2A_MOUSE 1 1.2 
EPHB3_MOUSE 1 3.0 NF1_RAT 1 0.7 GDE1_MOUSE 1 3.9 PGRP1_BOSIN 1 5.8 
CHD9_MOUSE 1 1.2 ARL6_MOUSE 1 3.8 SYCP1_MOUSE 1 1.4 K1462_MOUSE 1 0.6 
NRAP_MOUSE 1 1.2 STAB1_HUMAN 1 0.5 CRY1_RAT 1 2.4 TFG_HUMAN 1 4.2 
TES_OTOGA 1 5.0 SAFB2_HUMAN 1 0.9 SYT2_HUMAN 1 2.1 DCTN4_MOUSE 1 4.3 
CBX4_MOUSE 1 4.9 SEP13_HUMAN 1 4.2 PREX1_MOUSE 1 1.3 CCNT2_HUMAN 1 2.3 
SH3G2_RAT 1 3.1 TP53B_MOUSE 1 0.8 ENOF1_PONAB 1 2.7 ZMYM4_MOUSE 1 0.5 
LSP1_MOUSE 1 2.7 KLDC4_PONAB 1 1.7 FAH2A_HUMAN 1 5.4 SPB6_BOVIN 1 2.4 
ZFY19_HUMAN 1 3.2 ILEUB_MOUSE 1 4.2 GGTA1_CEBAP 1 2.7 MMP8_HUMAN 1 3.2 
KIN17_MOUSE 1 4.1 RAB4B_HUMAN 1 6.1 KCNA6_MOUSE 1 1.9 GUAD_MOUSE 1 3.3 
USP9X_HUMAN 1 0.4 CJ052_HUMAN 1 11.6 MLF1_BOVIN 1 4.4 IF44L_HUMAN 1 1.5 
MKRN2_MOUSE 1 1.9 DDX41_MOUSE 1 3.1 MTMR6_HUMAN 1 2.7 MDHC_FELCA 1 4.8 
SBK1_RAT 1 2.2 DUS2L_MOUSE 1 2.6 CP2CV_CAPAE 1 4.2 COR2A_MOUSE 1 1.3 
B3A4_RABIT 1 1.0 NCOA1_HUMAN 1 1.8 RUVB1_MOUSE 1 2.2 T10IP_BOVIN 1 1.6 
SPAS2_MOUSE 1 2.8 RHPN2_MOUSE 1 2.9 CC142_HUMAN 1 0.9 MYC_BOVIN 1 2.1 
ESPNL_MOUSE 1 0.9 LONM_BOVIN 1 1.2 WDR49_HUMAN 1 3.0 ZEP2_MOUSE 1 0.7 
ZN841_HUMAN 1 2.0 NUD13_MOUSE 1 1.7 RL9_PONAB 1 8.3 GSDMC_MOUSE 1 1.3 
MYO7B_HUMAN 1 0.9 CSPG2_MOUSE 1 0.3 RIN1_HUMAN 1 2.0 KR192_HUMAN 1 48.1 
ADA2B_ELEMA 1 2.1 AMRP_RAT 1 2.8 GCDH_PIG 1 4.7 PRD10_PONAB 1 0.7 
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Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score Protein Peptides  Score 
CP110_HUMAN 1 1.0 DYHC2_RAT 1 0.3 PLXB1_HUMAN 1 0.4 DIP2A_MOUSE 3 1.2 
IAC1_BOVIN 1 19.0 OGR1_HUMAN 1 5.5 PO5F1_MOUSE 1 3.7 AKA12_MOUSE 1 1.0 
VIGLN_PONAB 1 0.6 ARSH_HUMAN 1 2.7 CELR1_MOUSE 1 0.5 DBF4A_MOUSE 1 2.6 
SCML1_PYGBI 1 4.3 PR3D1_MOUSE 1 4.0 REBL1_BOVIN 1 8.8 ACTBM_HUMAN 1 2.9 
RM09_PAPAN 1 3.4 CELA1_MACFA 1 1.9 LPP_HUMAN 1 2.3 GPC3_MOUSE 1 1.4 
TTC36_HUMAN 1 6.9 DJB14_MOUSE 1 2.9 DDX47_MOUSE 1 2.4 ZBT41_HUMAN 2 2.4 
ABRA_PIG 1 3.4 1B58_HUMAN 1 3.0 CD97_HUMAN 1 1.2    
CAH15_MOUSE 1 2.5 SMKX_MOUSE 1 1.4 ACINU_MOUSE 1 1.0    
ASPX_MOUSE 1 11.5 ADCY4_RAT 1 1.7 FBXL8_MOUSE 1 2.4    
BBS12_MOUSE 1 1.0 SIVA_HUMAN 1 16.0 NAP1_HUMAN 1 1.1    
DSG4_MOUSE 1 0.9 IQCG_MOUSE 1 1.7 NPT2B_MOUSE 1 2.2    
HBB_MYOVE 1 8.2 RTTN_MOUSE 1 1.1 POTE1_MOUSE 1 1.7    
CTTB2_HORSE 1 1.3 BACH_HUMAN 1 4.2 SUIS_RABIT 1 0.5    
P2Y13_MOUSE 1 5.0 STF1_PIG 1 2.8 AGT2_RAT 1 2.9    
GGLO_BOVIN 1 1.8 TTLL5_HUMAN 1 1.5 PI3R6_HUMAN 1 2.3    
CLSPN_MOUSE 1 1.1 PECR_MOUSE 1 4.0 IFFO2_RAT 1 5.9    
LHPP_HUMAN 1 1.9 ALKB3_BOVIN 1 4.2 MYO7A_HUMAN 1 0.6    
ADCY8_RAT 1 0.8 CYB_PLAIN 1 2.6 SO1B3_HUMAN 1 2.7    
SUSD3_MOUSE 1 4.1 CS2LB_RAT 1 10.1 CABP1_HUMAN 1 2.4    
KAIN_HUMAN 1 1.9 TGS1_HUMAN 1 0.8 M3K14_MOUSE 1 2.0    
COOA1_MOUSE 1 1.2 GSX1_MOUSE 1 6.1 FJX1_HUMAN 1 4.3    
MCP62_HUMAN 1 2.9 JERKY_MOUSE 1 2.7 INO80_MOUSE 1 0.4    
B3GT4_CANFA 1 3.7 ENPP6_HUMAN 1 2.0 PHF2_MOUSE 1 0.9    
TRPM2_HUMAN 1 1.5 HMOX1_PONAB 1 5.2 JPH3_MOUSE 1 1.3    
DY12L_HUMAN 1 1.7 STX8_BOVIN 1 4.7 RECK_HUMAN 1 0.8    
ACOXL_HUMAN 1 2.7 PI2R_HUMAN 1 2.6 ATL4_RAT 1 0.9    
VPS39_MOUSE 1 1.7 PKD2_HUMAN 1 1.7 SYLC_MOUSE 1 0.6    
ROBO1_HUMAN 1 0.7 ABC3G_ERYPA 1 0.0 KCMA1_RABIT 1 2.2    
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Appendix III: Poster and abstracts 
Maternal interaction with Gametes and Embryo 2nd General Meeting (COST-GEMINI), Italy 
(2009). Modulation of human sperm by the cumulus oophorus. R.L. Frettsome, J.C. Kirkman-
Brown and S.J. Conner. 
College of Medicine and Dental Sciences Research Day, University of Birmingham (2008). 
Structural and Functional Studies of the human zona pellucida. R.L. Frettsome and S. J. 
Conner.  
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